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ABSTRACT 
The diagnosis of peripheral lung lesions is done by pathological 
testing of tissue samples collected from the lung by needle 
biopsy. Lesion positional information is obtained by direct 
measurement of film negatives taken from two perpendicular X-ray 
views. Accurate positioning of the biopsy needle, based on this 
information and under manual control, is difficult to achieve. 
Sampling accuracy of lesions less than 2cm in diameter (those 
offering the best chance of a cure if accurate diagnosis is 
obtained) is poor. 
The aim of this project was to devise a means of accurately 
sampling small peripheral lesions (less than 2cm diameter) with a 
computer guided biopsy needle using a 'C-arm' rotatable X-ray 
machine to supply the positional information. 
The existing needle biopsy technique is evaluated and a practical 
error analysis done using a developed mechanical analogue of the 
X-ray and patient arrangement to determine how the technique 
might best be developed to reveal all the necessary geometrical 
information. A marker arrangement is developed which will reveal 
such geometrical information. 
The possible methods of image analysis which might be applied to 
obtain the relevant X-ray information from the C-arm T.V. monitor 
are examined. In view of the complicated X-ray image obtained 
these techniques are dismissed and a manual technique is 
developed instead in which the information is input to the 
computer by the surgeon using a mouse. The technique is evaluated 
using an optical analogue of the X-ray machine. 
A biopsy machine, its computer control system and the mechanism 
by which the biopsy needle is positioned pointing towards the 
lesion is developed. Accuracy and reproducibility studies of 
needle positioning are also detailed and indicate that with 
selected X-ray views needle positioning should lie within 2-5mm 
of the centre of the lesion, the exact error being dependent upon the 
lesion position and depth relative to the biopsy machine. 
Details of the biopsy machine link-up to the C-arm X-ray machine, 
its accuracy testing and the first clinical trials are given. 
Problems, inherent to the X-ray machine, are detailed and 
recommendations for further work are made. 
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1.1. Introduction - Functions of the Lung 
The lungs have many functions including water evaporation 
(important for heat and fluid regulation), filtration of toxic 
materials from the circulation and blood storage. Their main 
purpose, however, is to provide a medium across which gaseous 
exchange can occur between atmospheric air and blood. 
Atmospheric air is drawn into the body through either the nose or 
mouth and passes down through the trachea, which divides into two 
bronchi, one leading to the left lung, the other to the right, as 
illustrated in Figure 1.1. These bronchi branch out further into 
all the lobes of the lung, gradually becoming much shorter and 
narrower, and terminate in alveoli, air sacs of about 0.3mm in 
diameter. 
The pulmonary artery 
the heart and splits 
There they subdivide 
of approximately 5 - 
surround the alveoli 
area of between 50 - 
of about 0.5 microns 
carries blood 
into two, one 
into numerous 
20 microns in 
and result in 
100 m 2 and a 
from the right ventricle of 
branch going to each lung. 
blood vessels and capillaries 
diameter. These capillaries 
a gaseous exchange surface 
very thin blood - gas barrier 
Gas exchange is carried out by simple diffusion: Oxygen in the 
inspired air and at a relatively high partial pressure diffuses 
into the blood, which has a low partial pressure of oxygen. 
Carbon dioxide, at a high partial pressure in the blood diffuses 
out into the airways and is expired. 
The capillaries, containing oxygenated blood, join to form the 
pulmonary vein which returns blood to the left atrium of the 
heart. The blood passes through to the left ventricle from where 
L--- us ti 
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Figure 1.1 - The Anatomy of the Tracheobronchial Tree 
12 
it passes out to the rest of the body via the aorta. 
If the lungs are diseased the lung function becomes impaired. 
Common conditions include tuberculosis, pneumoconiosis, emphysema 
and lung cancer. Lung cancer is the major cause of premature 
death in industrialised countries. Most lung cancer, if caught in 
an early stage, is potentially curable. However, by the time lung 
cancer is diagnosed it is often well advanced with a poor 
prognosis. 
1.2. Rates of Incidence and Death for Cancer 
Over the period 1940 - 1983 the U.S. incidence rate of various 
cancers altered (1). The incidences of stomach and uterine 
cancers decreased by 70% over the period but now appear to be 
levelling off. However laryngeal and kidney cancer rates greatly 
increased as did pancreatic cancer. Breast cancer incidence 
increased by 30%, prostate, colon and bladder cancer by over 65%, 
thyroid by over 75% and lung cancer incidences soared by 225% 
among men and 400% among women. 
The U.S. mortality rates do not always display similar trends to 
the incidence rates. Laryngeal cancer mortality among males and 
kidney cancer mortality among females decreased. Mortality rates 
for prostate, colon and bladder cancers showed no major change 
and for thyroid cancer have decreased. Breast cancer mortality 
has remained constant but lung cancer mortality has increased, 
remaining comparable with the incidence rate. 
Lung cancer incidence and mortality rates exceed those for other 
cancer sites (1). The male incidence rate underwent a massive 
increase but levelled off in the mid 1970's and is expected to 
decrease. The female incidence rate is considerably lover than 
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Figure 1.2 - U.K. Lung Cancer Incidence Rates for Men and Women 
over the period 1940 to 1985. 
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(2), following a similar trend to the male rate but lagging 
almost 20 years behind. It has recently overtaken breast cancer 
as the major cause of death among women. 
34,772 people died from lung cancer in 1982 in the U.K. alone 
(3). The incidence rate for Scotland, at 120 per 100,000, is the 
highest in the world. 
1.3. Cancer Manifestation Versus the Immune System 
It may initially seem strange that cancers at one site within the 
body can be controlled, even cured, while at others can progress 
almost unhindered. The word 'cancer', however, is an umbrella 
term covering a wide range of different diseases, each requiring 
an individual treatment approach. Different cancers attack 
different sites within the body and one site may be attacked by 
several different cancers. Thus the system is complicated by 
different patterns of spread and responses to therapy (4). It is 
impossible to describe in detail the numerous biological and 
biochemical changes which occur in cancer, indeed many are not 
yet understood; but a brief summary of the known and postulated 
general cellular changes and immune response to these changes is 
given below. 
The actual process by which cancer occurs is unknown. All cells 
have the ability to multiply and replace those cells lost by 
death or exfoliation in the normal cell cycle but usually, once a 
critical mass is reached, they cease multiplying, thus preventing 
overgrowth. In cancerous cells, however, multiplication does not 
stop at the critical mass and uncontrolled growth continues until 
eventually the patient dies. 
It is generally assumed that the plasma membrane (the cell 
surface) will be affected in a cancerous cell. Certain cell 
surface molecules may occur in large amounts, e.g. proteins, 
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glycoproteins or glycolipids (5). Interferons (a complex set of 
proteins and glycoproteins) are also produced. They have a potent 
anti-tumour effect. 
Several cell types within the body exhibit anti-tumour effects. 
These include natural killer (NK) cells, macrophages, 
T-lymphocytes, B-lymphocytes and cells which secrete cytotoxic 
factors. 
In a normal healthy body a large quantity of these NK cells exist 
in lymph, a plasma-like fluid which bathes the body tissues. They 
are a form of lymphocyte and can rupture (or 'lyse') the plasma 
membrane of tumour cells and virally infected cells allowing the 
cell contents to escape. It is thought that these 14K cells play 
an important part in the mechanism of host defence against 
neoplasia (6,7,8). 
T-lymphocytes have a delayed hypersensitivity and respond to 
antigens on the cancerous cell, reacting to produce lymphokines. 
These lymphokines can modulate 14K cell activity (9) and activate 
and influence the behaviour of macrophages (10). 
B-lymphocytes bind to antigens and result in the production of 
immunoglobulin, a form of antibody. The antibody is large and is 
generally confined to the bloodstream. Antibodies do not play a 
large part in carcinoma rejection: Cell mediated immune responses 
do (11). 
Mononuclear phagocytes are scavenger cells which engulf and 
digest bacteria, cells, cell debris, etc. It is generally 
believed that phagocytes play a fundamental role in immune 
stimulation, antigen recognition and in lymphocyte (white blood 
cell) proliferation and differentiation. 
Unlike NK cells phagocytes do not normally display cytotoxicity 
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towards cancerous cells. They require to be 'activated' (becoming 
'activated macrophages') in a process which may take several days 
to perform. Mononuclear phagocytes can be activated by many 
naturally occurring and synthetic materials such as lymphokines, 
bacterial lipopolysaccharide, double stranded RNA, chronic 
exposure to noxious gases such as cigarette smoke and various 
microorganisms. Once activated these macrophages can display 
cytotoxicity towards cancerous cells while leaving normal cells 
unharmed. They carry out 'phagocytosis', consisting of two 
separate steps. The first step is recognition and attachment of 
the particle. The second step is the fusion of the plasma 
membrane with the lysosomal membranes and release of lysosomal 
enzymes into the cell (10). Tumours with a high concentration of 
infiltrating macrophages sometimes have a lower growth rate than 
those with low macrophage concentration (12, 13). However others 
(14) have observed the opposite effect of tumour growth 
enhancement. It has therefore been suggested that activated 
macrophages can induce both suppressor cells and cytotoxic cells 
but the conditions favouring one rather than the other have not 
yet been determined. 
These activated macrophages only retain their tumoricidal 
properties for a short time, decay rapidly and are unable to 
undergo reactivation. Unfortunately the process of macrophage 
activation may also be accompanied by side reactions, one of 
which is the suppression of NK ce 11 activation but the link 
between NK cells and macrophages is unknown (15). 
Generally it appears that NK cells, present before immunisation, 
act as the first line of defence prior to macrophage and 
T-lymphocyte responses. Thereafter, however, their actions are 
interlinked, often unpredictable , and not always beneficial. 
Several possibilities exist for tumour cells to evade the defence 
system (4): 
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- When tumours result from chemical carcinogens tumour cells 
may have different levels of immunogenicity. Those cells 
releasing large quantities of antigens will be destroyed but 
those releasing small quantities may remain. Eventually, 
after continuous stimulation to low quantities of antigens, 
the immune system will become tolerant and will not reject 
the tumour cells. 
- Many aetiologic agents, whether viral or chemical, are 
immunosuppressants and thus prevent a host immunologic 
reaction. Once established the tumour itself may produce 
immunosuppressants. 
- Very early cancers, consisting of only a small number of 
cancerous cells, may not be recognised as such and continue 
to multiply and become established. By the time they are 
recognised the cancer is too far advanced for the immune 
system to deal with. 
1.4. Lung Cancer Metastasis 
Tumour cells are able to spread from the site of origin (primary 
tumour) to surrounding structures and other organs (secondary 
tumour). This is done by a process known as metastasis in which 
cancerous cells separate from the tumour, float away in body 
fluids (lymph, blood), lodge in another site and continue to 
divide. 
There are several common sites of lung cancer metastasis: 
- A peripheral tumour can invade the pleura or chest wall. 
Fluid accumulates in the pleural space and assists in the 
spread of tumour cells. 
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- Mediastinal tumours can invade the trachea, bronchi, 
oesophagus, laryngeal and phrenic nerves or blood vessels. 
-Once into the blood stream secondary tumours may occur in 
the brain, liver, bone marrow, bone and suprarenal glands. 
1.5. Types of Lung Cancer 
There are many different histological types of lung cancer. 
Matthews et al (15) and Rosenow and Carr (16) describe the four 
main types which between them make up over 90% of all lung cancer 
occurrences. 
- Squamous (epidermoid) cell is a slow growing cancer which 
constitutes around 40-70% of all lung cancers (17). Most 
squamous carcinoma are observed in males. They often 
ulcerate, bleed and obstruct a major bronchus. Squamous 
carcinoma manifests itself mainly within the central area of 
the lung (67%) (often obstructing a major bronchus) but 
sometimes peripherally (33%). As a result abnormalities are 
initially identified by radiography or cytology. Peripheral 
lesions may be cavitated or necrotic. 
- Small (oat) cell carcinoma is a rapidly spreading form of 
cancer which is manifest mainly in the proximal area (root) 
of the lung. It accounts for 20-30% of all bronchial 
carcinoma. 
- Adenocarcinoma makes up 10% of lung cancers. It does not 
spread as quickly as small cell carcinoma and is associated 
with pulmonary diseases, eg tuberculosis. Such lesions are 
mainly peripheral (75%) and identified radiographically. 
- Large cell carcinoma occurs in 10-15% of lung cancers and 
is mainly peripherally located. 
1.6. Symptoms of Lung Cancer 
Lung cancer is not often detected until it has become 
symptomatic, around 10 years after it first began (17). It may 
present many different symptoms: 
- Haemoptysis- coughing up of blood. A common symptom 
although it is also attributable to other causes such as 
tuberculosis and pneumonia. It is associated with ulceration 
in the bronchus. 
- Thrombophiebitis - inflammation of the wall of a vein, 
commonly in the leg. 
- Chest pains from local spread of the tumour. 
- Clubbing of fingers and toes - thu :kening of the tissues at 
the base of the finger and toe nails so that the normal angle 
between the nail and digit is filled in. The nail becomes 
convex in all directions. It occurs in about 30% of lung 
cancer cases although it can also occur naturally as a 
harmless congenital abnormality. 
- Hypoglycaemia - glucose deficiency in the blood stream 
causing muscular weakness and incoordination, mental 
confusion and sweating. 
- Breathlessness, although this is more often attributed to a 
resulting complication of lung cancer. 
- Cough or change in smokers cough due to a tumour in the 




- Weight loss, tiredness and anorexia 
-Recent onset of epilepsy, behaviour disorders or Vomiting 
are common indications of a cancer spread to the brain. 
Enlargement of the liver may indicate a liver metastasis. 
These symptoms are not associated solely with lung cancer and 
further investigation is necessary befor e a diagnosis can be 
made. 
1.7. Causes of Lung Cancer 
Squamous and small cell carcinoma are associated with asbestos 
fibres, polycyclic hydrocarbons, coal tar, radioactive chemicals, 
and probably the best known carcinogen, tobacco smoke. 
Large cell and adenocarcinomas are linked with chemical gases and 
fine dusts of less than 0.5 microns diameter (which includes 
asbestos, silica and coal dusts) 
Other known carcinogens include nickel 	(18), 	arsenic, 
chloromethyl ether and printing ink (2) as well as chromates. 
Current epidemiological evidence suggests that some cancer forms 
are caused by other chemicals and viral infections. 
Over 30% of all cancers and 90% of lung cancers are caused by 
smoking (19). The lung cancer incidence rate for non-smokers 
(including ex-smokers) is 10 -13 per 100,000 compared with the 
overall incidence rate of 120 per 100,000 in Scotland. Tobacco 
smoke contains over 4,700 different chemical substances (2) which 
include carcinogens and mutagens such as benzyprene, polonium 210 
and nitrosamines. 
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Different tobacco types have different associated lung cancer 
risks - pipe and cigar tobacco have almost one quarter of the 
lung cancer risk associated with cigarette tobacco (20). Filter 
tips have ventilated filters which dilute the inhaled smoke with 
air, reducing the quantity of tar and nicotine inhaled. However 
these low tar cigarettes still have high risk factors which 
increase with the quantity of cigarettes smoked daily, the 
duration of smoking and the tendency to inhale. 
DeVita, Hellman and Rozenburg (21) describe how cancer arises 
from a sequential two stage process of initiation followed by 
promotion, where each step change is produced by different 
agents, these agents determining the site and type of lung 
cancer. 
Tobacco smoke is generally regarded as being a promoting agent 
since the risk of lung cancer decreases soon after smoking has 
ceased, although it is only after 10 non-smoking years that the 
lung cancer risk approaches that of a lifelong non-smoker. If, 
therefore a smoker comes into contact with an initiator he is 
very susceptible to lung cancer. 
Smokers, however, do not merely increase their own lung cancer 
risk but also increase the risk for those around them. It is now 
believed that passive smoking may put many people into the high 
risk category. This increased risk for non-smokers is most easily 
examined for smokers' non-smoking spouses (22, 23, 24, 25). 
Estimates of increased lung cancer risk vary between 30% and 50% 
but most agree that the risk increases with the amount smoked by 
the spouse and the longterm exposure to tobacco smoke. Outwith 
the home 'environmental' passive smoking is difficult to analyse 
but will play a significant role in risk increase. 
Such passive smoking is generally associated with squamous cell 
and small cell carcinoma, i.e. the histological types commonly 
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associated with active smoking (22, 24, 26). 
Although smoking accounts for a large proportion of lung cancers 
only a fraction of smokers develop the disease. Studies of 
patients diet were compared with that of a control group and 
reveal that a high dietary intake of certain vitamins and 
minerals may have a preventative effect for lung cancer. Vitamin 
A, from animal products and green and yellow vegetables is 
required for normal growth and differentiation of respiratory 
membranes and inhibits neoplastic transformation (27). This is 
most evident for male non-smokers over the age of 60 (28). It 
provides protection against squamous and small cell carcinoma but 
not adenocarcinoma (29). Other vitamins and minerals examined 
include Vitamin C, Vitamin E and selenium. It appears unlikely 
that Vitamins C and E give protection against cancer but it is 
possible that selenium may provide protective action (27). 
Silica, encountered in the pottery industry, quarrying and mining 
can also cause lung disorders. When silica fibres are inhaled 
into the lung they become deposited in the alveoli. Alveolar 
macrophages engulf the fibres and die. The length, diameter and 
shape of the particles influences how toxic such inhaled 
particles can be. Particles of > 3-4 microns diameter are trapped 
by cilia lining the airways and are expelled by cough or sneeze. 
Finer particles, in the range 0.1-1.0 microns diameter are 
deposited in the alveoli. 
Asbestos, generally regarded as being a promoting agent of lung 
cancer, is the most important occupational health hazard. For 
asbestos workers the lung cancer risk increases with duration of 
employment in the industry but there appears to be excessive risk 
for those employed less than six months in total (30). For 
surveyed UK workers diagnosed as having asbestosis, lung cancer 
was present at death in 44% of cases (31). Of these, 
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adenocarcinoma was the most common histological type, present in 
41% of the lung cancer cases. Squamous carcinoma is also common 
(17). 
Radiation exposure affects lung cancer risk. Japanese atomic bomb 
survivors had a lung cancer risk of at least twice the normal 
rate (32). 222Radon and radon daughter products, decay products 
of uranium, are suspected as increasing the lung cancer rate. 
Uranium miners may be exposed to such sources by inhaling dusts 
(33, 34). 
People with a personal history of respiratory problems such as 
chronic bronchitis, emphysema, and asthma are at higher risk of 
developing lung cancer (35). Those with parents who died of lung 
cancer are at risk 5 times higher than normal and a parental 
malignancy of any type also increases the risk. 
Susceptibility may be enhanced if a person is in contact with 
more than one carcinogen. An asbestos worker who smokes is 4-7 
times more likely to develop lung cancer than an asbestos worker 
who does not smoke (2) and is 92 times more likely to develop 
lung cancer than a person who neither smokes nor works with 
asbestos (21) i.e. the agents have synergistic effects. 
1.8. Rate of Growth of Lung Cancer 
Collins, Loeffler and Tivey (36) suggest that if lung cancer 
begins as a single mutated cell, 10 microns in diameter, and this 
divides into 2 cells, and these two divide into four, etc then in 
twenty such doublings the tumour will be 1mm in diameter and in 
30 doublings will be 1cm in diameter, as illustrated by Figure 
1.3. By 40 doublings they estimate the tumour to weigh about Mg 
and the cancer will be approaching termination. 
All cells undergo a cell cycle of resting, DNA synthesis and 
ai 
duplication of chromatin, followed by mitosis (cell division) 
(4). The growth rate of tumours depends upon the number of cells 
in a cycle, the length of the cycle and the fate of the daughter 
cells. Only a fraction of cells, the growth fraction (GF), are 
involved in the active cycle. The growth fraction is given by: 
CF = P / (P + Q) 
where P is the number of cells actively proliferating and 0 is 
the Quiescent cells not involved in the active cycle. The value 
of the CF varies over the range 30-80% (4). 
Spratt and Harlan (37), estimating the rate of growth and 
duration of primary pulmonary carcinomas approximated the tumour 
shape with a sphere and measured tumour diameters on 
roentgenograms at different stages in the tumour growth. They 
used the information to decide upon the site of cell division 
within the tumour. They recognised three possible different 
growth processes: 
- All fully grown cells within the tumour divide. In this 
case an exponential plot of tumour volume versus time will be 
obtained. 
- Only fully grown cells on the tumour periphery divide, 
those inside the tumour being inert. In this case the plot of 
radius versus time will be linear. 
- Either of the above may apply but the growth rate may vary 
because of limited space for growth, lack of food, etc. The 
resulting radius vs time plot should reveal periods of 
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Figure 1.3 - Growth Curve of a Hypothetical Tumour 
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Results tentatively suggested that all parent cells within the 
tumour divide but this was by no means conclusive: A few plots 
showed linearity suggesting that only the peripheral cells 
divide. However, several problems are inherent in this growth 
rate estimation: 
- Tumours are rarely spherical (or even approximately 
spherical), are not visible with clearly defined boundaries 
and do not grow at a constant rate but are limited by lack of 
blood supply, attack from immune cells etc (3). 
- Lesions are unlikely to be detected radiographically until 
they are at least 1 - 1.5 cm in diameter, often larger, by 
which time they will have already been established for around 
10 years. Early growth patterns cannot therefore be observed. 
- It is necessary to treat the lung cancer patient and 
therefore longterm uninterrupted tumour growth cannot be 
observed. 
- Not all tumours are solid - some are cavitated or necrotic, 
in which case the rate of external growth does not indicate 
the rate of cell proliferation. 
Several authors have tried to assign a tumour growth factor to 
observed tumours. These vary widely between patients and 
histological cancer types (37, 38, 39) and it is not possible to 
assign growth constants to cell types. Tumour volume doubling 
times, in which the exponential radius versus time plot is an 
inherent assumption, also vary widely: 30 - 160 days (40) and 7 - 
500 days (41). Tumour doubling time is the overall result of a 
number of factors, including growth fraction, extent of cell 
loss, grade of differentiation and mean tumour cell cycle time. 
Generally the volume doubling time for small cell carcinoma is 
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short (<1 month) whereas squamous, large cell and adenocarcinoma 
are slower. The doubling time remains approximately constant for 
an individual tumour but on occasions when they change they do so 
towards the end of the tumour life, becoming larger (43). Benign 
nodules usually either have a much slower or a much faster 
doubling time than malignant tumours (41). Nodules which do not 
alter size for over 2 years or are calcified are generally 
regarded as benign although occasionally calcification can occur 
in malignant tumours. 
1.9. Detection of Lung Cancer 
It is desirable to detect and diagnose lung cancer at an early 
stage when it is treatable and chances of longterm survival are 
higher. Unfortunately the average tumour size at detection varies 
between 3 - 4cm (43). 
It is generally assumed for most cancers that regular mass 
screening (annual or 6 monthly) of entire populations over a 
certain age range or alternatively of high risk groups (smokers, 
asbestos workers, etc) will indicate many cancers while they are 
still asymptomatic, i.e. at an early stage when treatment will be 
more effective, decreasing the mortality rate. This is 
particularly true for breast and cervical cancers (32) but there 
is doubt whether mass lung cancer screening will be beneficial 
(40, 45, 32, 46). Such lung cancer screening commonly involves 
lateral and posteroanterior (back-front) chest X-rays 
(abnormalities appear as shadows) and sputum cytology (testing 
cells taken from bronchopulmonary secretions). 
Sputum samples found to contain cancerous cells are often 
indicative of lung cancer. Sputum testing was found to have a 
sensitivity of approximately 71% and is around 99% specific (47). 
Results are better with central than peripheral lesions. In 
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tests, squamous cells appeared in sputum in 80% of patients with 
squamous cell carcinoma, and in 36% of patients with no 
carcinoma. These false positive results tended to occur in the 
sputum of heavy smokers. 
Shadows may arise for many different reasons. Tuberculosis (TB) 
sufferers and former TB victims have calcified (bony) lesions 
which show up clearly on radiographs whereas a pulmonary 
haemorrhage often gives a diffuse shadow. Tumours may appear 
differently, depending upon the histological type of cancer. They 
may be necrotic or occasionally calcified and will hence appear 
similar to TB or Lung abscesses. 
According to Boucot and Weiss (46) a general screening programme 
should be "inexpensive, simple, convenient, reliable, sensitive 
and specific; and it should provide a good yield of curative 
cases". 
A 5 year screening trial has been reported, involving 10,040 male 
smokers (45). They were split into two screening schedules: 
- Annual chest radiographs 
- Annual chest radiographs along with 4-monthly sputum 
cytology examinations. 
In the dual screening programme sputum cytology examination and 
chest radiographs generally detected different lung cancer cases, 
as shown in Table 1.1. Lung cancer mortality for the dual 
programme was expected to be less than for radiographic screening 
alone since more cases were treated earlier. This assumption was 
proved wrong. 
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Table 1.1 - Method of Detection versus Lung Cancer Cell Type in 
Dual Screen of 4968 Men. 
Histology Determined Determined 	Determined Interval Total 
by cytology by radiograph by both 	cases 
Epidermoid 20 8 8 10 46 
Adenocarcinoma 5 44 3 21 73 
Large Cell 1 3 0 2 6 
Oat Cell 1 5 3 12 21 
Carcinoid 0 0 0 1 1 
Total 27 60 14 46 147 
* Interval cases were determined during the screening period but 
by means other than the two screening methods studied. 
Sputum cytology detects only squamous and adenocarcinoma, both 
slow growing types. Although these tumours did not, in general, 
appear on the radiographs they are still potentially curable when 
they are eventually detected radiographically. 
There is hence controversy about the effect of dual screening on 
lung cancer survival. Generally radiographic screening will not 
detect the tumour until it is at least 1cm in diameter. Sputum 
cytology may detect central cancers at an earlier stage but not 
much earlier than radiography and so the dual programme does not 
appear to have much effect on survival when compared with 
radiographic screening alone. 
All patients in the programme underwent regular chest radiography 
and the effect of radiographic screening on lung cancer mortality 
was not investigated. However, the overall 5 year survival rate 
for both screening schedules was 35% compared with an estimated 
13% in the US generally. 
A massive 3 year study involving 55,000 men aged 40 or over has 
been carried out (49). Two groups were formed: The test group 
contained 29,723 men who underwent regular 6-monthly chest 
radiographs. 25,311 men in the control group had a chest 
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radiograph taken at the beginning and end of the study period. 
101 patients in the test group developed lung cancer. 65 of these 
were detected radiographically but the remaining 36 were 
symptomatic at detection. The 5 year survival rates for patients 
who developed lung cancer was 23% in the test group compared with 
6% in the control group. Of the patients who underwent surgical 
resection 32% in the test group and 23% in the control group 
survived 5 years. The author suggests that early radiographic 
detection resulted in improved resectability of lung cancer 
although the 5 year survival of resectable patients was similar 
in both groups. 
Another 10 year study (46) involved 6,136 male volunteers, aged 
45 years or over, drawn from the general population who initially 
shoved no signs of any respiratory abnormalities. 121 new cases 
of lung cancer were found over the period. Of these lung cancer 
cases 67 had regular 6 monthly X-rays but 25% of these were 
detected only after symptoms developed. Of the 54 cases who had 
greater than 6 months between their last screening and detection 
50% were symptomatic. 
Survival rates between the 	radiographic and symptomatically 
detected lung cancers for those undergoing regular 6 monthly 
checks were similar in the longterm, i.e. 13.% and 11% at 5 years 
respectively, but in the short term (1 year) those detected 
radiographically had much higher survival rates, 63% compared 
with 11%. For those who had greater than 6 months between their 
last checkup and detection of cancer the 1 year survival was 
again better for radiographically detected than symptomatic, 69% 
compared with 7%, and 8% and nil for the 5 year survival 
respectively. 
Although high risk groups have a higher expected lung cancer 
incidence and screening may yield a higher proportion of lung 
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cancers the associated 'cure' rate is low because the prognosis 
for these patients is bad. 
Mass screening is hindered by false positive tests. Chest X-ray 
screening is 97% specific (46). On the surface this would appear 
satisfactory but the 3% of patients with false positive results 
represents a considereble number in mass screening programmes. 
All require further clinical study, which is expensive on 
resource time and funding. 
Mass screening is expensive, but when TB was rife and a major 
killer such screening processes were worthwhile. If TB patients 
are found in early stages (and chest X-rays normally revealed 
early stages) they can be cured by chemotherapy. Lung cancer 
'finds' were regarded as an added bonus of the system. The cost 
benefits at that time, in terms of patients cured, were thus 
high. Nowadays TB incidence is low and chest screening among 
either mass population or high risk groups, yielding only a very 
small cure rate, has a very low cost benefit (46). Current 
asymptomatic lung cancer patients have usually been detected by 
regular industrial screening of high risk groups, such as 
asbestos workers. 
Abnormalities of < 1cm in diameter, and often larger, are not 
usually visible on chest radiographs. They tend to be obscured by 
the ribs or do not have a large difference in X-ray attenuation 
from that of the surrounding tissue and so are missed by the 
radiologist. 
Other detection methods may pick up such obscured lesions. 
Tomography is an X-ray technique which involves focussing X-rays 
at a certain depth and deliberately blurring out structures at 
other depths. This may pick out lesions obscured behind ribs. 
A great improvement on this technique has been computed 
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tomography (CT). Its use in lung disease is detailed elsewhere 
(50). Collimated X-rays are focussed on a thin 'slice' of 
patient, 2-13mm thick, without interference from blurring of 
surrounding structures. Several views are taken from different 
angles and the images are projected onto sensitive scintillation 
detectors, allowing accurate measurement of transmitted 
radiation. the images are matched by a computer using the X-ray 
attenuation information. The resulting image can be displayed 
either on a T.V. monitor as a grey level picture, on radiographic 
film or stored as intermediate information on a disc for future 
analysis. 
In order to locate a lesion several such slices must be built up. 
To locate lesions of less than 1cm in diameter a maximum slice 
separation of 1 cm is required. 10 consecutive slices however 
delivers a radiation exposure of 3.5 r to the skin (51). 
Conventional Tomography can reliably detect nodules down to 6mm 
diameter whereas CT can detect those of 3mm reliably. Although it 
can often detect tumours at an earlier stage and reveal more 
information about the extent of spread of disease. CT has not 
been widely used in routine chest examinations. The equipment is 
vastly expensive compared with that for conventional radiography. 
Ultrasound, used to scan many sites within the body, 	is 
inappropriate for the lungs due to their air content. Peripheral 
lesions may, however, be observed through the rib spaces at full 
expiration. 
The tumour visibility may be improved using radio-nuclides (66) ( 
a high activity and low radiation dose is required). These 
radioactive tracers are administered either orally or 
intravenously and, after a time delay accumulate at the site of 
inflammation. A gamma camera will detect the gamma radiation 
emitted as the radionuclide decays. This technique is commonly 
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used to detect blood clots which have travelled to the lung and 
cannot be observed easily on radiographs. Labelled microspheres 
are administered and become trapped in the lung capillaries, 
illustrating abnormalities. 
197Hg (with a half life of 65 hours) is commonly used in locating 
small lung tumours with X-rays. 
Gallium scanning may also be used to detect some types of lung 
cancer. Ga67, with a half life of only 78 hours is able to be 
used within the body. It binds to lymphocytes and is therefore 
drawn into and concentrated in inflamed areas of the body (52). 
It is also absorbed into bone, liver and spleen and some leaves 
in the urine. Ga67 can detect small cell carcinoma of the lung 
but is expensive and not readily available (51). As a detection 
or location technique this may be satisfactory, but it is not a 
suitable technique for mass screening. 
Research is currently underway on 'biomarkers' and tumour markers 
for use as detection agents for cancers. These are antigens, 
hormones or enzymes which are secreted by cancerous cells and are 
hence present in abnormally large quantities in body fluids when 
cancer is present (15, 53, 54). Lung Tumour Associated Antigen 
(LTAA) has been discovered in serum from lung cancer patients. 35 
- 75% of lung cancer patients show elevated levels.of calcitonin 
(55). Springer et al, using T-antigen, (57) claim to detect 90% 
of T'M°N° NSCC in the lung with a high (unquantified) 
specificity. The population size was, however, small. Serum 
levels were raised in 69% of newly diagnosed SCC of the lung. 
Serum NSE was raised in 39% of patients with limited stage 5CC, 
87% with extensive stage disease, 84% with 1 or 2 metastasis 
sites and all patients with metastasis at 3 or more sites (58). 
However, none of these markers are specific either to cancer 
sites or to histological types of cancer. In addition many 
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people, e.g. heavy smokers, have high levels of such antigens etc 
in the absence of cancer. Ideally such chemical markers could be 
used in mass screening for early detection, staging and siting of 
cancers. Thereafter they may also be useful in monitoring 
response to therapy (58, 59, 60, 61). 
Hence, although their uses are presently limited, tumour markers 
have a major potential for improving cancer detection. 
1.10. Diagnosis of Lung Cancer 
Once an abnormality in the lung has been indicated, further tests 
are required for diagnosis. To accurately diagnose cancer and 
also to find its cell type at present requires direct 
histological examination of the suspected cancer itself and hence 
that a tissue sample be taken from the indicated abnormality (or 
'lesion'). 
Several investigative methods exist for inspecting and sampling 
the lesion for cell typing and the pleura and nodes for testing 
for metastases. 
Mediastinoscopy may be carried out under general anaesthetic to 
examine the mediastinum and associated nodes (41) and they may be 
biopsied directly. The patient is positioned supine and a small 
incision is made in the neck, above the suprasternal notch and a 
'tunnel' cleared between the fascia and the trachia. The fascia 
is cut to allow access to the lymph nodes. The mediastinoscope, a 
hollow, rigid instrument, 8cm long by 2 cm wide, is inserted 
through the tunnel and directed towards the lymph nodes for 
examination and sampling, if required. 
Thoracotomy, again carried out under general anaesthetic, 
involves surgically opening the chest cavity to inspect and/or 
sample the lungs, pleura, chest wall, etc and thus enable more 
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accurate staging. The operation can, however, be extremely 
distressing and painful for the patient. Many patients are old, 
ill and may not be fit enough to undergo such a traumatic 
experience as surgery or even general anaesthetic. 
Several other techniques much less invasive, simpler to perform 
and generally much less costly, have been developed in recent 
years. 
The normal investigative procedure for the lung involves the 
insertion of a fibre-optic bronchoscope through the respiratory 
tract into the bronchi and the removal of cell samples from 
suspect areas for test. The patient is placed in the supine 
position with head held back and the end of the fibrescope, which 
is coated in lubricant, is inserted through the nasal passages. 
The surgeon, viewing the position of the fibrescope end through 
the eyepiece, directs it down trachea, into the correct lung and 
bronchus until the suspect tumour is observed. A long brush or 
forceps is then inserted down through the tubes of the fibrescope 
and by either brushing or snipping, cell samples are taken from 
the suspicious areas, transferred to slides, soaked in formalin 
and sent to the pathology laboratory. The bronchoscope, however, 
cannot obtain samples either from the superior segments of the 
lower lobes or from the medial sections of the upper lobes as it 
cannot bend sufficiently to reach these areas. The fibreoptic 
bronchoscope can sample 28-38% of peripheral lesions and 19% of 
small nodules (41). 
A bronchio-alveolar lavage may help when the fibrescope (7mm in 
diameter) cannot approach a lesion. This involves injecting 
100-300m1 of saline solution down through the fibrescope into the 
bronchus and out into the alveoli. By applying a backpressure 
most of the saline may be sucked back up the fibrescope, store& 
and examined for cancerous cells. 
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Alternatively, when the lesion cannot be viewed through the 
bronchoscope but is visible radiographically, a bronchial biopsy 
may be carried out under fibreoptic guidance. This involves 
directing the forceps out from the end of the bronchoscope 
through the bronchi towards the lesion and removing a small 
tissue sample from the tumour area. 
General reported yields of these fibreoptic bronchoscope 
techniques are shown in Table 1.2. 
It appears that for large, visible, centrally occurring tumours 
bronchial brushing is most accurate whereas for peripheral 
tumours bronchial biopsy under fluoroscopic guidance is 
preferred. Kvale et al (62) noted that in many cases, especially 
peripheral lesions, positive results were obtained by either 
brushing or biopsy and thus combining the two techniques 
increased the overall yield to 79%. 
Tumour size is also important: Large tumours are more easily 
detected than smaller ones. Radke (63) suggested that fibreoptic 
bronchial biopsy may be satisfactory for lesions greater than 2cm 
diameter but unsatisfactory for those less than 2cm diameter. 
These bronchoscope methods are satisfactory for sampling lesions 
which occur in central areas of the lung, but peripheral lesions, 
especially those less than 2 cm in diameter, cannot be approached 
by the fibrescope and transthoracic needle biopsy is carried out 
instead. 
In this method a needle is passed through the chest wall and lung 
into the lesion and a cell sample drawn off for pathology or 
cytology. There are two main types of biopsy needle: Cutting 
needles and aspiration needles. 
Cutting needles have a large bore and are thick walled. They are 
Table 1.2- General reported diagnostic 
the flexible fibreoptic bronchoscope. yields of positive specimens 	when 	using 
Authors Tumour Information 
percentage of Positive specimens on 
Diameter Location Bronch. Bronch. Bronch. 	Bronch. Post Brushing Biopsy Brushing washing bronch 
+saline 	(lavage) sputum 
P A Kval 
et 	al 	(62) 
all Central 
visible 
77 71 70 	63 48 	71 total 
all peripheral 20 50 40 33 33 	biplane 
fluoro s copy  
used in 
Positioning 
Radke (63) <2cm Peripheral 28 
(6 	total) 
>=2cm peripheral 64 biplane all peripheral 56 opjcay fluorosc 
Stringfield guided 
(97) <2cm <2 or >6 
48% 
27% not visible 
from hilum through 
>2cm 2-6cm from 71% bronchoscope 
hilurn 
Ellis 	(98) >4cm  57 81 <4cm 29 58 29 	biopsy 
forceps guided 





designed to remove a core of tissue for pathological examination. 
Aspiration needles are much finer, usually 18-22 gauge. They 
remove a much smaller tissue sample for cytology. 
The patient is positioned on the table generally either in the 
prone or supine position to allow easy, usually vertical, needle 
access to the lesion. The skin is cleaned and a local anaesthetic 
is given along the proposed approach of the needle towards the 
lesion which, of course, must avoid puncture of arteries or any 
other organs. A small incision is made with a scalpel through the 
skin and subcutaneous tissue and the needle inserted and 
advanced, in a vertical direction, towards the lesion. The 
patient is asked to hold his breath as the needle breaks through 
the lung or 'pleura' to avoid the occurrence of tears to the lung 
surface. The patient resumes gentle breathing and the needle 
advance is continued until the appropriate depth is reached, 
sometimes indicated by a change in the lung consistency. The 
needle position is then viewed on the monitor, using the 
fluoroscope, and the depth is checked by taking an X-ray or 
fluoroscopic view from the side, perpendicular to the original 
vertical fluoroscope view, the needle remaining in position while 
this check X-ray is processed and studied. Any adjustments to the 
needle position are made at this stage. For cutting needle biopsy 
the inner stylet is fully inserted and the outer cutting edge 
then advanced, gathering tissue as it progresses through the 
tumour. The needle is then removed. 
For aspiration needle biopsy the stylet in the needle annulus is 
removed and the surgeon blocks off the end with his thumb to 
avoid the ingress of air into the chest cavity which could cause 
pneumothorax, a partial collapse of the lung. A syringe is 
attached to the end of the needle and suction applied. The needle 
is sawed back and fore over a roughly 1cm distance to obtain 
tissue samples and, maintaining the suction, the needle is 
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withdrawn and the suction is released. 
The tissue, held in the needle annulus, is transferred to glass 
slides, soaked in formalin solution and sent for pathological 
examination. 
Immediately after the biopsy a frontal X-ray is taken, with the 
patient in an upright position, to ensure that pneumothorax has 
not occurred. Reported accuracies of percutaneous needle biopsies 
are shown in Table 1.3. There appear to be large discrepancies in 
the reported needle biopsy diagnostic accuracies, which are 
dependant on the lesion size, its position within the lung and 
the size of needle used. 
Lesions greater than 2cm diameter have accuracies of 86% while 
lesions less than 2cm diameter are not so easily sampled and 
diagnostic accuracies are lover, around 69% (64). 
Needle biopsies are most accurate for use on peripheral lesions 
greater than 2cm in diameter. They have also been used to sample 
lesions inaccessible to the bronchoscope (such as the mediastinal 
and hilar areas) with good accuracy, although Rudd et al (65) 
reported accuracies of only 61% for those lesions not accessible 
by bronchoscope. They used 'ultrathin' needles of 24-25 gauge 
which not only bend easily (although their final position was 
checked fluoroscopically) but also remove a very small piece of 
tissue for cytology. If the sample is badly crushed it becomes 
very difficult to diagnose disease and this may result in a low 
diagnostic accuracy. 
Ultrathin needles are best used for the initial puncture of a 
mediastinal lesion when the cause is uncertain. Should accidental 
puncture of the heart or artery occur then the fine needle will 
not cause as much damage as one of smaller gauge, ie larger 
Table 1.3 - Reported Accuracies of Percutaneous Needle Biopsies 
Author Tumour Information 	Needle Diagnostic Common 	Comments 
• Diameter 	Location 	Type Accuracy Complications 
Harris et all all 	cutting 92% 26% pneumothorax 
al 	(99) 19% haemorrhage 
• 	 Gibney aspirated 73.6% 30% pnuemothorax 
(64) 
Berquist all all 	aspirated 82% 49% pneumothorax 
(100) >8cm all 88% 11% haemoptysis 25 cases 
4-8cm all 91% 26% haemorrhage 94 cases 
2-4cm all 84% 193 cases 
1-2cm all 69% 84 cases 
<=1cm all 65% 34 cases 
<=1cm peripheral 85% 
1-2cm peripheral 75% 
>4cm mediastina]. 92% 
central 78% 100 cases 
peripheral 82% 297 cases 
mediastinal 92% 24 cases 
pleural 88% 9 cases 
Lalli all all 	aspirated 86% 24.2% pneumothorax 
(101) (most work done by 
inexperienced 
residents) 
Dr Wightman aspirated 95% 15% pneumothorax 
 
Westcott all 	aspirated 97% 7% haemoptysis 
 21% pneumothorax 
Zavala all all 	aspirated 87% 25 patients 
• 	 (104) (used ultrathin needles of 24 
or 25 gauge). 
Rudd et all those not 61% 
al 	(65) accessible by 
bronchoscope 
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diameter. Once the lesion has been located and the surgeon is sure 
that the cause is not an artery, etc then a smaller gauge needle 
can be inserted to obtain a more sufficient sample. 
Complications are more frequent for deeper lesions. This is 
especially so for cutting needles which can result in 
haemorrhages. It has been proposed that cutting needles be 
restricted to peripheral lesions where complication rates are low 
and aspiration needles be used elsewhere. 
Generally percutaneous needle biopsy is only performed on 
cooperative patients who are able to maintain a fixed position 
and to suspend respiration on demand. Since a pneumothorax can 
easily occur such patients should be able to withstand such a 
complication. 
Originally it was believed that the needle biopsy technique may 
encourage seeding to occur along the needle track but such 
occurrences are infrequent (41). 
In order to correctly site the needle into the lesion with the 
minimum amount of repositioning requires that the lesion position 
within the lung is known, preferably relative to a radio-opaque 
external marker which can be seen by the surgeon. A marker, in 
the form of a file, paper clip or coin, is taped to the chest 
wall and used as a guide. 
Several means exist for the determination of lesion position: 
Two perpendicular radiographs may be used, one taken PA the 
other lateral. Both radiographs are approximately actual 
size. In such arrangements the source-detector distance is 
about 6m. The patient, with marker attached, is positioned up 
against the detector so magnification effects are negligible. 
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Provided that the patient holds his breath at the same point 
in the breathing cycle for each X-ray take it is possible to 
measure the distance and direction of the lesion from the 
external marker directly from the radiograph using a ruler. 
One lateral radiograph in conjunction with a fluoroscope. The 
X-ray source is positioned either above or below the patient. 
the external marker may be positioned directly over the 
lesion by viewing the relative positions using a fluoroscope 
and, when correctly positioned, an indentation is made on the 
skin by pressing down firmly on the marker. An X-ray is taken 
from the side and to indicate the lesion depth and the marker 
is removed, its position indicated by the skin indentation. 
1.11. Staging of Lung Cancer 
The extent to which lung cancer has progressed at the time of 
detection is a major factor during consideration of the best 
treatment and in determination of the expected lifespan of the 
patient. 
A cancerous tumour will begin initially as one cell and will grow 
to engulf many cells within the organ. The cancer may then spread 
to the lymph nodes and finally metastasise to other organs. 
The extent of spread within the chest may be determined by X-ray, 
CT, bronchoscopy, mediastinoscopy, thoracotomy, etc. More distant 
metastases may be more difficult to detect. If the patient is 
symptomatic then the symptoms may suggest spread, for example 
brain metastases is related to behavioural problems. Otherwise 
routine testing of common sites of metastases should be done. 
Such sites include brain, liver, bone, and bone marrow. 
Lung cancer staging is based on the 'Tumour - Nodal - Involvement 
- Metastasis' (TNM) system, described in detail by Little et al 
Table 1.4 - Staging of Lung Cancer. 
TNM 	 Definition 
Classification 
Primary Tumour(T) 
TX 	 Tumour proven by the presence of malignant 
cells in bronchopulmonary secretions but not 
visualised roentgenographically or 
bronchoscopically; 
or any tumour that cannot be assessed 
TO 	 No evidence of primary tumour 
T1S 	 Carcinoma in situ 
Ti 	 Tumour 3cm or less in greatest diameter, 
surrounded by lung or visceral pleura, and 
without evidence of invasion proximal to a 
lobar bronchus at bronchoscopy 
T2 	 Tumour more than 3cm in greatest diameter, or 
a tumour of any size that either invades the 
visceral pleura or has associated atelectasis 
or obstructive pneumonitis extending to the 
hilar region. At bronchoscopy, the proximal 
extent of demonstrable tumour must be within a 
lobar bronchus or at least 2cm distal to the 
carina. Any associated atelectasis or 
obstructive pneumonitis must involve less than 
an entire lung and there must be no pleural 
effusion. 
T3 	 Tumour of any size with direct extension into 
an adjacent structure such as the parietal 
pleura or the chest wall, the diaphragm, or 
the mediastinum and its contents; or a tumour 
demonstrated bronchoscopically to involve a 
main bronchus less than 2cm distal to the 
carina ; or any tumour associated with 
atelectasis or obstructive pneumonitis of an 
entire lung or pleural effusion. 
Nodal 
Involvement (N) 
NO 	 No demonstrable metastasis to regional lymph 
nodes 
Ni 	 Metastasis to lymph nodes in the peribronchial 
or the ipsilateral hilar region, or both, 
inciuciing direct extension 
N2 	 Metastasis to lymph nodes in the mediastinum 
Distant 
Metastasis (M) 
MX 	 Not assessed 
MO 	 No (known) distant metastasis 
Ml 	 Distant metastasis present 
Stage Grouping 
Occult Carcinoma 	Stage 1 	Stage 2 	Stage 3 
TX NO MO 	 T1S NO MO 	T2 Ni MO 	T3; any N or M 
Ti NO MO N2; any T or N 
Ti Ni MO 	 Ml; any t or N 
T2 NO MO 
Several of these TNM groupings combined form the stage grouping: 
An early cancer, confined to the initial organ of manifestation, 
is classed as stage 1 and a far spread cancer as stage 3. 
Confusingly the staging system has recently been rearranged in an 
attempt to associate staging with survival rates (68). The TNM 
basis has been retained but the number of classifications has 
increased, as shown in Table 1.5. The individual stage 
classification has also changed with the addition of a stage 4 
category. T1N1, previously classified as stage 1 is now in stage 
2. The overall effect will be to improve the appearance of the 
mortality rates associated with each stage. 
La 
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(67). It categorises the cancer into groups, depending upon the 
size and site of the primary tumour (T); the extent of the cancer 
spread to lymph nodes (N); and the extent of spread (metastasis) 
to other organs, such as the brain, liver, opposite lung and 
bones (M). These groups are described in an ?xtract (16), shown 
in Table 1.4. 
Several of these TNM groupings combined form the stage grouping: 
An early cancer, confined to the initial organ of manifestation, 
is classed as stage 1 and a far spread cancer as stage 3. 
Confusingly the staging system has recently been rearranged in an 
attempt to associate staging with survival rates (68). The TNM 
basis has been retained but the number of classifications has 
increased, as shown in Table 1.5. The individual stage 
classification has also changed with the addition of a stage 4 
category. T1N1, previously classified as stage 1 is now in stage 
2. The overall effect will be to improve the appearance of the 
mortality rates associated with each stage. 
According to (67), patients are often understaged when either 
cancerous lymph nodes or small distant metastases are not 
detected. They state that a quarter of patients may be 
understaged and hence receive insufficient treatment. Staging 
should be a repetitive process:Rather than relying merely on 
uninvasive testing using X-rays, bronchoscopy, etc the staging 
should be constantly updated as the surgeon gains more 
information both during surgery and from the pathological 
examination of resected tissues. Three main stage classifications 
are mentioned (69): 
Clinical classification based on results from physical 
examination, radiology, bronchoscopy, mediastinoscopy, 
mediastinotomy or thorascopy. 
Table 1.5 - The New International Staging System for Lung Cancer: 
TNM Definitions 
Primary Tumour (T) 
TX Tumour proven by the presence of malignant 
cells in bronchopulmonary secretions but not 
visualised by roentgenography or bronchoscopy, 
or any tumour that cannot be assessed as in a 
retreatment staging. 
TO No evidence of primary tumour. 
T1S Carcinoma in Situ. 
Ti A tumour that is 3cm or less in greatest 
dimension surrounded by lung or visceral pleura 
and without evidence of invasion proximal to a 
lobar bronchus at bronchoscopy. 
T2 A tumour more than 3cm in greatest dimension, 
or a tumour of any size that either invades the 
visceral pleura or has associated atelectasis 
or obstructive pneumonitis extending to the 
hilar region. At bronchoscopy the proximal 
extent of demonstrable tumour must be within a 
lobar bronchus or at least 2.0 cm distal to the 
carina. Any associated atelectasis or 
obstructive pneumonjtis must involve less than 
an entire lung. 
T3 A tumour of any size with direct extension 
into the chest wall (including superior sulcus 
tumours), diaphragm, 	or the mediastjnal pleura 
or pericardium without involving the heart, 
great vessels, 	trachea, oesophagus, or 
vertebral body, or a tumour in the main 
bronchus within 2.0cm of the carina without 
involving the carina. 
T4 A tumour of any size with invasion of the 
mediastinum or involving heart, great vessels, 
trachea, oesophagus, 	vertebral body, 	or carina 
Nodal Involvement 
(N) or with presence of malignant pleural effusion. 
NO No demonstrable metastasis to regional lymph 
nodes. 
Ni Metastasis to lymph nodes in the peribronchial 
or he ipsilateral hilar region, 	or both, 
including direct extension. 
N2 Metastasis toipsilateral mediastinal lymph 
nodes and subcarinal lymph nodes. 
N3 Metastasis to contralateral mediastinal lymph 
nodes, contralateral hilar lymph nodes, 	or 
ipsilateral or contralateral scalene or 
supraclavicular lymph nodes. 
Distant Metastasis (M) 
MO No (known) distant metastasis 
Ml Distant metastasis present- specify site(s) 
Ui 
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Surgical evaluative classification using results from 
thoracotomy and biopsy. 
Post surgical treatment classification based on the results 
of the pathological examination of resected tissue. 
At each classification the stage is upgraded and initial stage 1 
patients may end up classified as stage III (or now even stage 
IV). Over two thirds of patients have stage 3 (old 
classification) lung cancer when diagnosed as having lung cancer 
(70). 
1.12. Treatment of Lung Cancer 
Once cancer has been diagnosed and histologically typed the most 
suitable treatment must be sought. Lung cancer treatment is very 
much dependent on the cancer type and the extent of its spread. 
There are currently 3 major forms of treatment: Surgery, 
radiotherapy and chemotherapy. For treatment purposes the 4 main 
different histological types of lung cancer are split into 2 
groups: Small cell carcinoma (SCC) and Non small cell carcinoma 
(NSCC). 
1.12.1. Surgical Resection 
NSCC's are best treated by surgical removal of the tumour (69). 
If the entire tumour can be removed the treatment can be 
curative. However, this requires that the cancer is in an early 
stage of development and has not metastasised (stage 1 or perhaps 
stage 2). Overall operable lung cancer has a 5 year survival rate 
of less than 10% compared with 69% for early operable lung 
cancers (57). Unfortunately, only 20% of patients are potentially 
surgically resectable. This treatment is especially promising in 
slow growing squamous carcinoma, in which metastases do not occur 
47 
until very late. It may prove satisfactory for SCC only in a very 
early stage but unfortunately for small cell carcinoma and large 
cell carcinoma metastases usually occur early in the tumour life. 
The amount of tissue removed in resection is dependant not only 
on the size of the tumour but also on the surgeons preferred 
resection method. Usually the treatment involves the removal of 
either a lobe of the lung or an entire lung but recently 
miniresections have been done on small peripheral lesions (71) 
without any increase in the mortality rate. This is particularly 
useful for older patients who may not cope well with a much 
larger resection. The remaining lung tissue must therefore cope 
with the entire output from the right ventricle of the heart. If 
the remaining lung tissue is normal then the patient should not 
display any symptoms such as breathlessness. 
Only rarely are SCC's found at an early stage. Less than 2% of 
patients with SCC are staged as either Ti or T2 with NO (72). By 
the time that they are detected the tumours are usually spread,at 
least as far as the lymph nodes. These SCC cases are commonly 
treated with chemotherapy and occasionally radiotherapy, which 
act by killing the fast growing cells within the body to produce 
tumour regression. Unfortunately all cells are not destroyed and 
so these treatments usually only prolong life. 
1.12.2. Radiotherapy 
The principles of radiotherapy are described elsewhere (73). 
Radiotherapy is provided locally and requires precise location of 
the tumour to enable regular treatments to be given to the same 
area of tissue and also to allow shielding blocks to be 
positioned so that normal tissues are protected. Generally 
radiation attacks cells on the boundary between the advancing 
tumour and normal cells where a plentiful blood supply is 
available (73). The cells, (both normal and cancerous) absorb 
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ionising radiation and the DNA, contained within the cell may be 
either destroyed or deformed. Deformed DNA may, however, be 
repaired by enzyme processes and the cell will continue to 
divide. Further irradiation is therefore required. For this 
reason radiation doses must be spread out over a period of time. 
A moderate radiation dose is generally regarded as between 
4000-5000 rads spread over several weeks and applied daily. Such 
radiotherapy often reduces tumour size but does not , in general, 
provide a cure. The tumour will divide at the same rate as before 
irradiation was commenced. Thus the treatment merely slows the 
tumour progress by the equivalent amount of time that is required 
for the tumour to regrow to its original preirradiated size (74) 
and this merely improves the 'oct term survival and reduces pain. 
Before radiotherapy can be expected to cure lung cancer, tumour 
cells will need to be made more sensitive to its effects. This 
may be effected using a drug which is taken up by the tumour, but 
as yet none have proved successful (40). Although radiation is 
applied only to the site of affected tissues the resulting side 
effects apply more generally. These include a general feeling of 
lethargy, headache, anorexia or vomiting. For radiation applied 
to the lung other side -effects include pneumonitis, an 
inflammation of the lung. 
1.12.3. Chemotherapy 
The principles of chemotherapy are described in detail elsewhere 
(75, 76, 77).Chemotherapeutic agents have a selectivity for 
cancer cells over normal host cells (4). Chemotherapy is used 
either for the majority of 5CC or when NSCC has metastasised. 
Common therapeutic agents include Cyclophosphamide, CCNU, 
methotrexate, 5-flourouracil (CMF), vincristine, adriamycin and 
hexamethylmelanine. Cytotoxic drugs do not actually kill tumour 
cells but affect cell division. They inhibit one or more of the 
steps in the cell cycle. Alkylating agents, such as chiorambucil, 
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cyclophosphamide, etc damage the DNA template and prevent 
replicoi. Vincristine and vinbiastine inhibit mitosis (4).The 
applied dosage of such agents is vitally important since small 
changes in dose can result in large changes in response rate. The 
dose chosen is very dependant upon the drug used, the age and 
physical condition of the patient and also on the tumour itself. 
Any previous therapy must also be considered. As in radiotherapy 
both tumour and normal cells can recover after chemotherapy and 
so the required dose is given in stages. Regular blood count 
readings will indicate if the cytotoxic effect on the immune 
system becomes excessive. The white cell count should not fall 
below 3,000 per mm3 or the platelet count below 80,000 per mm3 
(77). When a single drug is administered a response is achieved 
in 30% of cases (69). A given dose of cytotoxic drug disables a 
constant fraction of cells. To eradicate the entire population of 
cancerous cells it is necessary to increase the drug dose to the 
maximum tolerated by the body or to start treatment when the 
number of cells is low enough to allow the tumour destruction at 
smaller, more tolerable doses (4). Often combination chemotherapy 
(using several anti-cancer agents) proves more successful since 
between them they provide a wider attack front and also inhibit 
the formation of resistance to individual agents. The different 
chemotherapeutic agents can be administered at different stages, 
so preventing the tumour cells from becoming resistant to each 
drug. 
1.12.4. Combined Treatments 
Several treatment modalities may be combined to improve the 
prognosis. 
If an NSCC has progressed to the extent that surgical resection 
will not remove the whole tumour then aggressive radiotherapy may 
be used pre-operatively to reduce the tumour size. Radiotherapy 
or chemotherapy may be used post-operatively should a cancer 
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recur or a metastasis be discovered (78, 79). 
Combining radiotherapy with combination chemotherapy can also 
increase the length of patient survival (69). 
1.12.5. Side Effects 
These therapeutic treatments are successful because they are 
toxic to fast growing cells such as cancers. There are many 
naturally occurring fast growing cells within the body, including 
hair, skin, nails,etc as well as the mutant cancer cells. As a 
result several unpleasant side effects occur which include 
nausea, vomiting, hair loss, low blood count, toxicity to bone 
marrow,high risk of infection, etc. It is possible to minimise 
such side effects and provide an acceptable quality of life for 
such patients. 
1.12.6. Current Research 
Several new treatment modalities are currently being researched. 
Most include some form of immunotherapy. 
BCG is normally administered as part of the TB prevention 
process. It induces cell-mediated immunity to produce increased 
resistance. Post surgical BCG administration for early NSCC's may 
help prevent recurrence of cancer but for advanced NSCC and for 
all SCC BCG shows no effect (44, 78). 
Monoclonal antibodies to specific antigens may be radiolabelled 
and/or toxin-labelled and could possibly be used to direct 
therapeutic agents to the site of antigen production, ie the 
tumour cells (80, 81). 
Interferons are known to have a potent anti-tumour effect. They 
initiate cells to activate an anti-viral state and also enhance 
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the immunoregulatory system by activating NK cells. The exact 
method by which interferons act on tumour cells is unknown but it 
has been proposed that the interferons bind to the tumour 
cell-surface molecules and trigger off a 'messenger' which 
depresses the host genome. However, interferons provide 
disappointing results in NSCC of the lung in human trials (82). 
It is suggested that immunotherapy may be best used post 
operatively in NSCC since it does not appear to have as severe 
side effects as the cytotoxic drugs used in chemotherapy (69, 
81). 
1.13. Lung Cancer Patient Survival Rate. 
The definition of 'cure' as regards lung cancer patients is 
variable. Many believe that lung cancer is an incurable disease 
and that all such patients die of some cancer related disease - 
either another primary cancerous growth (a recurrent disease) or 
alternatively of a metastasis. Others believe that if a patient 
survives a certain length of time without cancer recurrence of 
any form then he has been cured. The commonly used endpoint for 
this theory is the 5 year disease free survival rate. 
Rate of survival is very dependent on several factors: Patient 
age, nutrition, psychologic state, histologic type of lung 
cancer, stage of lung cancer progress ion and the state of the 
patients immune system (83) as well as the tumour location. 
Peripheral lesions have a much higher associated survival rate 
than centrally located lesions. 
Treatment success is generally measured in terms of years of 
disease free survival. The overall 5 year survival rate for lung 
cancers is approximately 10-15% (16). 










Table 1.6 - Table 1.11 - Available survival rates in terms of Cancer 
Group and Stage of Progression. 
Table 1.6 Cancer Type - SCC 
Stage - 1 
Stage % Survival at Indicated Year Treatment 	Comments 
15 10 	5 	4 	3 	2 	1 
T 1 N°M° 	59 	 resection 11 survivors 
(both peripheral 
and central 
lesions in 5 
year survival) 
80 resection 	peripheral 
and chemoth. survivors 
68 resectiocl 	in 5 years 












Table 1.7 Cancer Type - SCC 
Stage - 2 
Authors Stage 	% Survival at Indicated Year 	Treatment 	Comments 
15 	10 5 4 	3 	2 1 
Meyer T 2 N'M° 50 resection 	4 patients 
(106) and combination 
chemotherapy 
Shields T 1 N'M° 31 resection 
(105) T 2N'M° 9 resection 
Rosenow and 2* 5 unspecified 
Carr (16) 
Maurer et limited* 24 unspecified 
al (107) 
Inde et limited* 8 8 	8 	13 52 	combination 	32 patients 
al (108) chemotherapy 
Table 1.8 Cancer Type - SCC 
Stage-3 
Author Stage % Survival at Indicated Year Treatment 	Comments 
15 	10 	5 	4 	3 	2 1 
Meyer T 3 N°,T 3 N 1 25 resection 	4 patients 
(58) and chemotherapy 
plus cranial radiation 
N 2 0 radiation 	4 patients 
Shields 3.6 resection 
(105) 
Rosenow 3* 3.8 unspecified 
and Carr 
(16) 
Inde 	extensive* 	3 	5 	12 42 	combination 	73 patients 
(10) chemotherapy 
Table 1.9 Cancer Type - NSCC 
Stage 1 
Authors Stage % Survival at Indicated Year 	Treatment 	Comments 
15 10 	5 4 	3 2 1 
Martini 1 85 87 93 resection 
et al 	(109) 
T'N°M° 89 91 94 resection 
T 2 N°M° 80 83 91 resection 
Jensik 	T 1 N°M°,T 2 25 33 	53 resection 
(110) 
Cooper 1 6 radiotherapy 	operable 
(111) lung cancer 
but refused 	(72% 
squamous cell) 
Faber 1 28 	38 sleeve resection 
(79) 
Paireselo 1* 69 84 resection 
(112) 
1* 56 resection 	all types 
1* 70 resection 	squamous 
1* 65 resection 	adenocarcinoma 
1* 66 resection 	large cell 
T'N° 80 resection 	all types 
(<20 patients) 
T 2 N° 63 resection 	all types 
(<20 patients) 
T'N° 70 wedge resection 
T'N° 68 lobectorny 
Little 1* 55 resection 
(67) 
Rosenow and 	1* 47 unspecified 	squamous 
Carr (16) 
1* 46 adenocarcinoma 
1* 43 large cell 
Mountain et 	1* 31 	38 53 unspecified 
Paulson 
( 	14) 
43 73 resection and 
pre-op. 	irradiation 
Shields T'N° 54 68 resection 
T2 NO 40 54 resection 
(1 
-F 
Table 1.10 Cancer Type - NSCC 
Stage - 2 
Author Stage % Survival at Indicated Year Treatment 	Comments 
15105432 1 
Holmes T'N' 75 resection 	squamous 
(78) 
TIN' 52 resection 	adenocarcinoma 
T 2 N' 53 resection 	squamous 
T 2 N' 25 resection 	adenocarcinorna 
Little 2* 30 resection 
(67) 
Pairelero N',N 2 7.4 resection 
 
Faber (79) 2 20 sleeve resection 
Martini N 2 30 resection 
 
Selawry 2 30 resection 	all types 
(42) 
Jensik 1,2* 11 	31 	52 mini resection 
(71) 
Rosenov and 2* 40 unspecified 	squamous 
Carr (16) 
2* 14 adenocarcinoma 
2* 13 large cell 
Mountain 2* 9 	12 31 unspecified 
 
Williams T'N' 53 resection 	all types 
(112) 
T 2 N° 50 wedge resection 
T 2 N° 49 lobectomy 
Paulson N',N2 15 resection with 
 pre-op irradiation 
Shields TIN' 37 resection 
 
T 2 N' 40 resection 
tn 
Table 1.11 Cancer Type - NSCC 
Stage - 3 
Author Stage Z Survival at Indicated Year Treatment 	Cojnments 
15 	10 	5 4 	3 2 	1 
Jensik 3 9 miniresection 
(71) 
Little 3* 15 resection 
(67) 
Pairelero T 3N°M° 54 resection 	all patients 
(116) 
T 3N°M° 59 resection 	NSCC patient 
T 3N°M° 85 resection 	under 60 yrs 
T 3N°M° 28 resection 	over 60 year 
T 3 N°M° 54 resection and 
radiotherapy 
Burt 	(70) T 3 7 13 22 resection 
T 3 M° 2 21 29 resection 
T 3 M° 22 22 30 resection and 
radiation 
T 3 M° 0 9 incomplete 
resection 
T 3 M° 10 unoperated 
Faber (79) 3 15 all types 
Selawry 3 15 all types 
(42) 
Rosenow and 3* 12 unspecified 	squamous 
Carr (16) 
3* 8 adenocarcinoma 
3* 13 large 
610 
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Early cancers have a much better prognosis than well progressed 
cancers. Tables 1.6 to 1.11 summarise the available survival 
rates in terms of cancer group and stage of cancer progression at 
the time of treatment commencement. Unfortunately discrepancies 
arise because of the recent alterations in the TNM staging 
criteria. Some references state merely the stage, not the TNM 
classification, and it is hence not possible to 'restage' such 
results to the new system. Where this has occurred the results 
remain within the authors stated stage but have been indicated 
with an asterisk. For all NSCC's surgery has been the chosen 
treatment, resulting in 5 year survival rates ranging from 38% to 
70%. In one trial patients who refused surgical resection as a 
treatment were given radiotherapy: A 6% 5 year survival resulted. 
Patients with surgically resectable NSCC have the best chance of 
complete recovery although in a limited number of cases patients 
are curable with aggressive chemotherapy (84). 
Stage 2 NSCC's again undergo resection as the preferred 
treatment, 5 year survivals ranging from <5% to 75%. Squamous 
carcinoma have a much better prognosis than adenocarcinoma. In a 
few cases adjuvant treatment, in the form of post-operative 
radiotherapy, was administered and appeared to greatly improve 
results from 5% to 31% survival at 3 years. 
Stage 3 NSCC's have a wide band of survival rates, 0 to 58%, 
depending upon the treatment administered. 5 year survival rates 
for resection alone range from 2 to 58%. Post operative 
radiotherapy appears to increase the 2% survival to 22% (70). 
Patients over 60 years of age undergoing resection have a 5 year 
survival of only 28% while those under age 60 have 85% survival. 
Thus surgical resection is the best treatment for NSCC, either 
alone or with radiotherapy, but in unresectable NSCC radiotherapy 
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can, in some cases, provide disease free survival for 3 or more 
years (85). 
SCC's are usually found in an advanced state and have hence been 
treated only with palliative therapies to improve the length and 
quality of remaining life . However, in a few cases, SCC's have 
been found in stage 1 and various treatments have been tried. It 
should be noted that the number of patients per trial is small, 
often fewer than ten. Early resection in SCC, especially 
peripheral lesions, can have promising results when compared with 
the traditional treatments.However adjuvant therapy may prove 
necessary to ensure that small, undetected metastases, if 
present, are destroyed. 
Stage 2 and stage 3 SCC's, commonly treated with combination 
chemotherapy (i.e using several anti-cancer agents) have very low 
survival rates: 3 years for stage 2 and 5% at 3 years for stage 3 
patients. It is generally accepted that radiotherapy is not an 
effective treatment for SCC. Attempts at resection appear 
encouraging with 5 year survival rates between 9 and 50% for 
stage 2. However there are very few patients in each set and 
these are, presumably, preselected. 
Generally SCC is not at present ably treated, due mainly to its 
advanced stage at diagnosis. NSCC, if found early can have 
promising 'curative' results. 
It is therefore apparent that to improve longterm survival and 
cure rate of cancer patients requires that new and more effective 
treatments are found as well as improving the methods of 
detection to allow cancers to be diagnosed at an early stage 
while they are potentially curable. The present screening 
techniques detect lung cancer only after the lesion has reached 1 
cm in diameter. Lesions less than 2cm, however, are not 
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accurately diagnosed since they are difficult to locate within 
the chest. It is proposed to devise a computerised biopsy machine 
to attach to a rotatable fluoroscope with which more accurate 
biopsies may be carried out, thus improving the diagnostic 
accuracy of the biopsy technique, especially for small and deeply 
located lesions within the chest. 
To do this it is essential to understand the mechanics of 
respiration and to appreciate difficulties involved in the biopsy 
procedure currently practised so that such problems may be 





ANATOMY OF THE CHEST 
2.1. Introduction 
The chest wall is constructed from twelve pairs of ribs attached 
to the sternum at the front and the vertebral column at the back. 
The lowest point along any rib is at the side of the body with 
the anterior end being lover than the posterior, as shown in 
Figure 2.1 
A network of muscles exists, illustrated in Figure 2.2 These: 
are attached between adjacent ribs (intercostals) 
span several ribs between attachments (subcostals) 
connect the ribs to the sternum or vertebrae (transverse 
thoracis and levatores costorum) 
A further thin dome-shaped muscle, the diaphragm, separates the 
thorax from the abdomen. It-is attached around its outer edge to 
the vertebrae, the ribs and the sternum. When relaxed, pressure 
from the abdomen pushes it upwards into its dome shape. 
Gray's Anatomy (86) details the relative positions of the lungs, 
heart, diaphragm, etc within the thorax. 
Keith (87) states that the lung is composed of air sacs which are 
the distensible element of the lungs. The quantity and size of 
sacs in any part of the lung control the degree of extensibility. 
These sacs are not evenly spread with the result that there are 
varying degrees of extensibility throughout the lungs and hence 
they do not expand equally but move in certain definite 
directions during inspiration. 
The dotted line represents the 
dome of the Diaphragm at the 
resting position. 









nal part of diaphragm 
Figure 2.2 - The Network of Muscles which Surround the Ribs. 
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A membrane, the visceral pleura, covers the lung surface and 
another, the parietal pleura, covers the inner surface of the 
chest wall and the diaphragm and rises to cover the structures 
which lie in the middle of the thorax, as shown in Figure 2.3. 
The lung surface lies against the chest wall and a thin mucus 
film between the two pleura allow them to slide gently over each 
other. The lungs, however, do not completely fill the pleural 
cavity. A small section between the lungs and the diaphragm, 
called the costo-diaphragmatic recess, is empty. 
2.2. Mechanics of Respiration. 
There is a small negative pressure between the pleura, about 
-2.5mm at the resting position, which keeps the lungs expanded 
against the chest wall. During inspiration, caused by the 
combined action of the above muscles, the chest and diaphragm 
move away from the lungs, causing a larger negative pressure 
which pulls on the lungs and draws in air to fill them. 
During gentle or quiet respiration fewer muscles act and 
according to respiration 'is possible without diaphragmatic 
movement or without the intercostals, but not without both. 
The major contribution to quiet respiration comes from the 
diaphragm. On contraction it descends, pulling the bottom of the 
pleural cavity downwards, as shown in Figure 2.4 increasing the 
longitudinal dimensions of the thorax and resulting in 
inspiration while at the same time compressing the abdominal 
contents. The abdominal muscles relax, allowing the abdominal 
organs to descend and move forwards. This process accounts for 
most of the 500m1 of air inspired. There is no movement of the 
upper two pairs of ribs. Rib pairs 3-7 follow two different types 
of movement at the same time. Firstly the 'bucket-handle' 
movement as illustrated in Figure 2.5, in which the rib pivots 
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parietal pleura (mediastina] 
visceral pleur 
parietal pleura (costs 
hlum of 1w 
lun, 





Figure 2.3 - A Section Through the Right Side of the Chest. 
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Figure 2.4 - An outline drawing illustrating the change in shape 
of the thoracic contents resulting from contraction of the 
diaphragm alone. 




Figure 2.5 Movements of the ribs. The upper ribs move about two 
axes. Movement about axis A will elevate the anterior end of the 
rib, producing the 'pump handle' type of movement. Movement about 
axis B will elevate the middle of the rib, producing a 'bucket 
handle' type of movement. The lower ribs open out like calipers, 
as shown in the diagram at the top right. 
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around its anterior and posterior ends, moving upwards and 
outwards, increasing the lateral dimensions of the rib cage. 
Secondly the 'pump-handle' movement, which involves raising the 
anterior end of the rib and hence the sternum. This increases the 
anteroposterior (AP) dimension of the rib cage. The lower ribs, 
7-10, undergo a caliper-like movement, increasing the lateral 
dimension but decreasing the AP dimension. These slight rib 
movements account for only a very small fraction of the air 
inspired during gentle respiration. 
On slow relaxation of the intercostal muscles and the diaphragm 
gentle expiration occurs as the lungs undergo gradual elastic 
recoil and return to their resting position. 
In deep inspiration the movements described above are greatly 
enhanced as the external intercostal muscles contract with 
greater force. The neck muscles also come into play raising the 
first and second rib pairs. Thus a much larger proportion of the 
lungs are used for respiration. In this enhanced breathing the 
rib cage movement is great, each 1cm increase in circumference of 
the chest increasing the chest capacity by around 200ml up to a 
maximum tidal volume of around 3 litres. 
Forced expiration is caused by contraction of the abdominal 
muscles forcing the abdominal contents upwards against the 
diaphragm which returns to its dome shape, while at the same time 
pulling downward on the rib cage thus decreasing the volume of 
the chest cavity. To a lesser extent the internal intercostals 
also act by pulling the ribs downwards. 
2.3. Lung Movement 
It is desirable to know to what extent the lungs move during 
respiration. These movements are difficult to characterise 
because different breathing mechanisms act over different areas 
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of the lung. They are also modified by effects of posture. 
2.3.1. Effects of Posture 
Several Texts describe the effects of posture on respiration. In 
the standing position gravity acts on the diaphragm and abdomen 
in the inspiratory direction and on the rib cage in the 
expiratory direction. In the sitting position the abdominal wall 
pulls the ribs downwards and inwards due to the abdominal weight. 
The resulting change in shape of the chest wall causes a 
corresponding change in shape of the lung although Campbell (88) 
suggests that the elastic recoil of the lung away from the chest 
wall and diaphragm does not change appreciably. In the supine 
position gravity acts on both the rib cage and the abdomen in the 
expiratory direction and the resting volume is reduced. Campbell 
describes the probable distribution of pressure on the pleural 
surfaces at the resting volume and in the upright and lateral 
positions. In the upright position the lung recoils inwards, away 
from the diaphragm, as shown in Figure 2.6, with a pressure 
nearly equal to the pull of the abdominal weight whereas in the 
lateral position the diaphragm is distended by the lung and the 
abdomen which exert a cranial force on the lower section. Lung 
recoil in this lowermost region is probably nil whereas the upper 
region of the diaphragm is pulled cranially by the lung and 
caudally by the abdomen. 
In the upright position the rib cage exerts a force equal and 
opposite to the lung recoil, but in the lateral position the 
weight of the chest fixes the lower part of the chest wall and 
only the upper chest wall moves. 
2.3.2. Post Mortem Experimentation 
Unfortunately experiments carried out on lungs either removed 








Figure 2.6 Diagram illustrating the probable distribution of 
pressures in the respiratory system at the end of a spontaneous 
expiration in the upright and lateral postures. The effect of 
gravity on the chest wall and lung is accounted for. 
P1 = pressure exerted by the lung 
Pab = pressure exerted by the abdomen 
Pdi = pressure exerted by the diaphragm 
Prc = pressure exerted by the rib cage 
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lung expansion during normal respiration. Rigor mortis and post 
mortem muscle changes invalidate any observations and inflation 
of the lung causes expansion in the direction of least resistance 
which is not the case during normal respiration where the action 
of the thoracic walls and/or the diaphragm determine the area and 
degree of lung expansion. 
2.3.3. Positioning Within the Lung 
Keith divided the lung into three different anatomical zones: 
The root zone close to the main tract containing the 
bronchus, artery, vein, lymph glands and fibrous tissue. This 
zone is essentially less distensible than others. 
The intermediate zone containing bronchial branches, veins 
and pulmonary tissue. Varying degrees of extensibility occur, 
the veins being the least distensible and the pulmonary 
tissue the most. 
The outer or peripheral zone, up to 30mm deep with a more 
even and greater degree of extension. 
Generally the air sacs are smaller in the root zone and larger in 
the outer zone and also smaller in the apical part and larger in 
the base of the lung. Correspondingly during inspiration the 
peripheral section of the lung extends more than the root and the 
base more than the apex. 
In healthy bodies, therefore, by considering different areas of 
the lung it is possible to predict the directions and extents of 
these respiratory movements. 
In the apex of the lung, during shallow breathing, very little or 
no movement might be expected as the upper ribs are stationary 
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and hence direct lung expansion is unlikely. However, Keith (87) 
describes anterior apical descent and attributes the effect to 
large diaphragm contractions. During deep respiration the dorsal 
part of the apex remains stationary and the anterior part again 
descends. This is an unexpected result since it was assumed that 
the anterior part would follow the general upward movement of the 
first and second rib pairs. However the diaphragm contraction 
must obviously generate a greater force. 
In the lowest section of the lung, where most 'breathing' is 
conducted, relatively large movement due to lung expansion would 
be expected at all times, even during shallow breathing. During 
inspiration the lung expands and moves downwards following the 
diaphragm. As rib action is still present during shallow 
breathing a small amount of forward movement is expected, both 
movements being greatly enhanced during deep respiration. However 
Keith states that sometimes (infrequently) during deep 
respiration, the diaphragm descends and then rises to a higher 
position than when at rest as the abdominal viscera, instead of 
air1 are drawn into the thoracic cavity. In this case the 
resulting longitudinal movement would be upwards. 
In the mid-section, however, movement is uncertain. The rib cage, 
during inspiration, would tend to pull the lung upwards and 
outwards. The diaphragm, however, pulls down on the lung 
stretching it longitudinally. Although it has been stated above 
that the root of the lung displays little extensibility, Keith 
(87) mentions movement of the mediastinal surface, i.e. adjacent 
to the heart, trachea, etc. This occurs because the heart follows 
the movement of the sternum as well as the diaphragm, on which it 
rests. Since the heart is firmly attached to the root of the 
lung, the lung will undergo a translation following the direction 
of the heart movement. During shallow inspiration the diaphragm 
will probably exert the greater force, resulting in an overall 
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downwards movement of the mid-section, but in deep respiration 
the combined effect of the three movements is unknown, although 
almost certainly both the outward anterior and lateral movements 
will still take place. Keith summarised qualitative lung movement 
in a diagram, shown in Figure 2.7. 
To obtain quantitative or qualitative information from experiment 
will require a large number of patients with readily identifiable 
lesions in different lung positions. Since it is unlikely that 
each individual will conform to the same size or shape and may in 
fact exhibit different rib cage movement, depending upon the 
shape of the skeleton or on habit, individual quantitative 
results may prove misleading or not generally representative. 
however upper limits on possible movement in different lung 
regions will prove useful information when considering the 
likelihood of a 'direct hit' with the biopsy needle. 
2.3.4. Experimentation and Estimation Methods to detect the 
Extent of Lung Movement 
In the case of the lowest lung section adjacent to the diaphragm, 
it may be possible to estimate probable lung (lesion) movement by 
examination of movements of the diaphragm, the abdominal wall or 
its contents during respiration. This has the advantage that any 
patient can provide the necessary information as a suitable 
identifiable lesion is not required. For many detailed abdominal 
examinations described in the literature ultrasound has been used 
in place of X-rays as the patient is not submitted to potentially 
harmful radiation and more detailed images may be obtained. 
Little is available in the literature as regards the relationship 
between diaphragm and lower lung movements. 
As stated previously not all the lung and diaphragm are in 
contact: The costo-diaphragmatic cavity exists. Gray's Anatomy 
(86) states that in quiet respiration the lower limit of the lung 
vertabral column -• 
anterior border (inspirat: 




lower border (expiration) 
lower border (inspire 
Figure 2.7 - Mediastinal aspect of the right lung to show the 
respiratory movement of the root. The arrows indicate the 
direction of the inspiratory movement of the various parts of the 
lung. 
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lies about 5cm above the lower limit of the pleura. Keith (87) 
estimated that 250 cm 2 of the diaphragm is in contact with the 
lungs. According to Hoover (90) excursion of the lower border of 
the lungs cannot be used to estimate diaphragm movement and cites 
a 6cm lung descent caused by a 1cm drop in diaphragm position. He 
does, however, refer to the Litten Diaphragm phenomenon (in 
which under certain lighting conditions a shadow can be seen 
passing down the chest between the lower ribs, caused by the 
diaphragm movement) as being appropriate in estimating movement 
of the lower border of the lungs. Assuming that diaphragm 
excursion will reveal some information on lower lung movement a 
general examination of the literature was carried out. 
For diaphragm movement to be useful it is essential that it is 
not consciously controllable by the patient. Wade (94) 
investigated the extent of conscious control and concluded that, 
contrary to popular belief, the diaphragm is not under any direct 
control, the extent of its movement being determined solely by 
the depth of breath taken. During his studies he noted that the 
skeleton extends during deep respiration and he measured the 
extent of this vertical movement at the front of the thoracic 
cage using a Bowden cable attached to a small perspex plate 
strapped firmly to the patient's chest over the sternoxiphisternal 
joint. He concluded that the extent of vertical movement of the 
thoracic cage varies with different individuals, the effect being 
more enhanced in erect than supine subjects. With this finding, 
Wade realised that previous diaphragmatic measurements could be 
unreliable, since they were affected by vertical movements of the 
thoracic cage with deep respiration. He therefore measured and 
adjusted diaphragmatic movement accordingly, after allowing for 
geometric distortion to the image. His adjusted results revealed 
around 1.6cm average diaphragm movement when the patient is 
sitting or standing and 1.7cm when supine during quiet 
respiration. During deep respiration, however, this increased 
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dramatically with movement varying between 7cm and 13cm, 
averaging out at 10.3 cm when upright and 9.9cm supine. Table 2.1 
illustrates results of other workers from which it is apparent 
that there is little difference in the extent of diaphragm 
movement during quiet respiration in different postures. Campbell 
(88) states that during quiet respiration the diaphragm 
contribution to tidal volume is estimated to be around 2/3 in 
sitting and standing positions and around 3/4 in the supine 
position. This agrees in general with the results in Table 2.1, 
with supine movement being greater if only fractionally. 
As mentioned previously the anterior abdominal wall will often 
protrude during inspiration and indent during expiration, due 
respectively to the descent and ascent of the diaphragm with 
respiration. However the abdominal muscles may be consciously 
contracted by the patient and the degree of protrusion hence 
lessened. This often occurs when patients know that they are 
being examined and so breathe in an abnormal manner. 
The abdominal wall is also affected by rib movement which serves 
to counteract the effects of diaphragm movement by pulling 
longitudinally on the abdominal wall as the vertebral column is 
lengthened. Observation of the abdominal wail is hence 
unsatisfactory for determining the degree of diaphragm movement 
and hence movements of the lover lung. 
The abdominal contents will be affected by any movements of 
either the diaphragm or the abdominal wall. It may be possible to 
determine diaphragm movement in any patient by examination of the 
movements of certain of these abdominal contents with 
respiration. 
The abdomen contains many organs The stomach, liver, intestines, 
etc for digestion and for excretion the kidneys, bladder, etc. 
The liver, kidneys and fundus of the stomach are in direct 
Table 2.1 - Summary of reported diaphragm movements with 
different postures and extents of respiration. 




Wade (94) 1.6cm 	1.7cm 10.3cm 	9.9cm 
(range 7-13cm) 
Fick (95) 1.5cm 3cm 
Hulkrantz (96) --- 10cm 
Weiss et al (91) 0.810.4cm 	1.310.5cm (range 1.2-7.5cm) 
Gray's Anatomy(86 1.5cm (range 6-10cm) 
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contact with the diaphragm as shown in Figure 2.8, and are 
therefore more likely to reflect its excursions. Hoover (90) 
states that the descent of the liver during inspiration is an 
exaggeration of diaphragm movement because the liver rotates on a 
transverse axis during inspiration. However Weiss et al (91) 
assumed that hepatic excursion was a vertical translation without 
plastic deformation and compared diaphragm excursion with hepatic 
excursion in both erect and supine positions. They found results 
to be similar during quiet respiration, as shown in Table 2.2. 
Suramo et al (92) investigated cranio-caudal movements of the 
liver, pancreas and kidneys with the patient supine. Their 
results, along with others, are shown in Table 2.3. The liver 
appears to be the most mobile reaching a maximum excursion of 
around 8cm during maximum respiration but averaging out to around 
5.5cm during maximum, 2.5cm during quiet and 0.9cm on suspended 
respiration. There is a discrepancy between the two results for 
liver movement during quiet respiration. Weiss' results were 
obtained using a gamma camera and adjustments made for motion 
correction. Suramo, however, used ultrasound. 
It therefore seems obvious that diaphragm and hence cranio-caudal 
lower lung excursion is considerable, even in quiet respiration. 
As previously stated, the lower lung is the most extensible and 
hence its excursion should be the maximum expected of any part of 
the lung. 
2.4. Reproducibility of Breath Holding 
It is desirable to minimise this lung movement and hence 
stabilise the position of any lung lesion prior to X-raying and 
sampling. 
The normal procedure in X-raying is to 'take' while the patient 
holds his breath at the end of deep inspiration, the point in the 
breathing cycle at which breath holding is generally most 
aphragm 
spleen 
right kidney 	 left kidney 
Figure 2.8 - The anatomy of the abdomen illustrating how several 
of the abdominal organs lie in contact with the diaphragm. 
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Table 2.2 - Hepatic and right hemidiaphragm excursion 
during quiet respiration (91). 
Computer determined 	Radiographically 
hepatic excursion determined 
(cm) 	 hemidiaphragm 
excursion (cm) 
Erect 0.8 0.2* (n=18) 	 0.8 0.4 (n=26) 
Supine 1.1 0.3 	(n=12) 	 1.3 0.5 	(n=25) 
* = standard deviation 
Table 2.3 - Movement of organs in respiration examined by ultrasound. 
Mean and Range (92). 
Organ Excursion 
Maximum respiration 	Normal respiration 
(cm) (cm) 
Liver 5.5 (3-8) 2.5 (1-4) 
Pancreas 4.3 (2-8) 2.0 (1-3) 
Right Kidney 4.0 (2-7) 1.9 (1-4) 
Left Kidney 4.1 (2-7) 1.9 (1-4) 
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reproducible. One thus obtains X-ray images detailing the 
expanded lung. 
In a lung biopsy procedure two X-ray views are taken, one PA the 
other lateral, with a marker positioned on the patient's chest. 
Direct distance measurements of the lesion from the marker are 
taken from the radiographs and the lesion position found. the 
needle biopsy is then carried out while the patient breathes 
quietly. A fluoroscope ensures that the needle insertion point is 
directly above the lesion, the needle inserted to the required 
depth (taken from the lateral radiograph) and a further X-ray 
image is used to check the needle position prior to sampling. If 
the initial lesion positioning is erroneous then the needle will 
require repositioning. This is an unsatisfactory situation, 
especially if the lesion lies in the mediastinal region, since 
the risk of complications is increased. 
If these X-rays are taken at full inspiration they will give a 
false impression of lesion position and depth. It is appropriate 
to X-ray at the mid-breathing-cycle. Reproducibility of breath 
holding mid-range is unreliable but even so, lesion position 
determination at this point must be more accurate than at full 
inspiration. However should breath holding reproducibility prove 
to be a problem several means exist by which it may be improved. 
The most obvious is probably spirometry, in which the patient 
breathes into a mouthpiece and the volume of air inhaled and 
exhaled is measured. The patient is asked to hold his breath when 
an indicator reaches a preset, marked position. 
Alternatively a suspended horizontal bar may be used as an 
indicator (92). The supine patient breathes in until the bar, 
suspended above the chest, just touches the skin. Reported 
results (Table 2.3) showed considerable improvement, as shown in 
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Table 2.4, with the 0.9cm liver excursion during suspended 
respiration decreasing to 0.2cm excursion, when using the bar. 
Jones (93) describes a respiration monitor for use with body 
scanning as shown in Figure 2.9. It measures body circumference 
and displays the results by means of a pressure module linked to 
an LED bar. The patient inhales and holds his breath when the LED 
bar lights to a preset level This method, designed for use with 
CT scanning, does improve reproducibility of breath holding, as 
shown in Figure 2.10. 
2.5. Conclusions 
The process by which lung cancer becomes established and evades 
and confuses the immune system is not understood. Many substances 
have been proven carcinogenic (of which tobacco smoke is the main 
one) and much resources have been expended on public health 
education in an effort to reduce the lung cancer incidence rate. 
However the desired decrease has not yet materialised. There are 
probably three main reasons for this: 
Lung cancer risk does not dramatically decrease immediately 
smoking is ceased but takes 10 years to approach the 
non-smoker level. 
By the time that lung cancer is detected it will have been 
man t.fested for several years. 
The general public reacts slowly to ;uch health warnings. The 
general attitude may be that smoking did not adversely affect 
their parents' health and so will not affect their own health. 
It is therefore important that general practitioners 
continually emphasise the health risks associated with 
smoking. 
11 
Table 2.4 - Difference in the position of the organs (Mean and 
Range) 
Organ Difference 
Suspended Respiration Suspended Respiration 
(cm) + bar (cm) 
Liver 0.9 (0-2.5) 0.2 (0-0.5) 
Pancreas 0.6 (0-2) 0.1 (0-1) 
Right Kidney 0.4 (0-2) 0.1 (0-1) 
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Figure 2.9 - A respiration monitor developed to limit organ 


















Figure 2.10 - Typical chart recorder traces for three cycles of 
held inspiration. The left hand diagram illustrates the results 
without using the respiration monitor and the right hand diagram 
illustrates the results when the respiration monitor is used. 
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Thus in the case of smoking, the reduction in the lung cancer 
incidence rate may not appear until many years after the initial 
non-smoking campaign began. 
Screening can detect lung cancer at an early stage when lesions 
are around 1cm in diameter. However, present sampling techniques 
do not supply reliable diagnostic information until the lesions 
are greater than 2cm in diameter. 
If the lung cancer is diagnosed at an early stage then available 
treatments can, in some circumstances, be curative. However, if 
diagnosed in a late stage then treatment can only prolong and 
improve the quality of remaining life. 
New treatment modalities are constantly under investigation but 
as yet no 'wonder-drug' has emerged and it hence appears that, at 
the present time, the best means of improving longterm survival 
of such patients is to improve the available diagnostic 
techniques. 
One of the main problems in diagnostic lesion sampling is 
respiratory movement during which the lesion can move by as much 
as 13cm during deep respiration and 1.7cm during shallow 
breathing. Techniques exist to aid reproducibility of breath 
holding to limit the extent of such movement while X-raying and 
needling. 
Another problem is the accurate needling of suspect lesions in 




DEVELOPMENT OF A PATIENT MARKER FOR THE BIOPSY MACHINE. 
3.1. Introduction 
The diagnostic accuracy of the needle biopsy technique for 
sampling small peripheral lung lesions is poor. Small, early, 
cancerous lesions, less than 2cm in diameter, are the most 
favourable for complete cure provided that they are correctly 
diagnosed and the cancer type is known. 
The aim of this project is to develop a cheap and simple - and 
hence widely available - mechanical means of guiding a biopsy 
needle through the patient's chest wall to a point within the 
lung identified by the radiologist as a site of suspected cancer. 
At present there are two stages in the biopsy procedure. 
The detection of the lesion position within the lung. This 
is presently done using two perpendicular X-rays with an 
external marker positioned on the patients chest. The lesion 
position is estimated relative to the external marker. 
Insertion of the needle through the chest wall and lung 
into the estimated lesion position. 
Errors arise in both these stages. Lesion location is done with 
two perpendicular X-rays using the normal radiographic technique 
in which the full size X-ray appears on radiographic film. 
However, between these X-ray takes and the actual needling 
procedure the patient will probably have moved from the X-ray 
table and may also have changed posture, in which case the lesion 
position will have changed relative to the marker taped to the 
patient's chest. The actual needling itself is also error prone, 
especially since no quantitative guidance is used in angling the 
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needle to point towards the expected lesion position. It would be 
more satisfactory if the X-raying and needling were carried out 
without the patient moving between the two stages and also if the 
needle angling and depth of insertion were quantified and related 
by calculation to accurate measurements of the lesion position. 
It was suggested to us by the late Professor D C Flenley that the 
relatively cheap, commercially available, C-arm X-ray machine 
might be used to answer many of these difficulties. The C-shaped 
arm, carrying the X-ray source and detector, may be rotated to 
lie at different angles relative to the patient and its X-ray 
pictures are displayed on a T.V. monitor. The different views 
needed to locate the lesion could hence be obtained without 
moving the patient. 
It remained to devise some means of obtaining all the relevant 
dimensional information from each X-ray view to enable the lesion 
position to be calculated so that the sampling needle can be 
directed to it. 
3.2. Methods of Angle Determination 
In the existing lung biopsy process two perpendicular X-rays are 
taken - one PA (post-anterior), the other lateral. A radio-opaque 
marker, positioned on the skin acts as an external reference 
point to which cranio-caudal and lateral distances, as well as 
lesion depth, can be measured directly from the chest radiographs 
with a ruler. 
This technique is in principle sound because: 
1) In normal radiography the magnification on the 
detector is negligible since the source-detector distance 
is commonly around 6 metres and the patient is positioned 
close to the detector.Both recorded images are to the 
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same scale and are approximately actual size. 
2) Since the X-ray views are essentially horizontal and 
vertical, the x and y coordinates of the lesion are 
recorded directly from them. 
The rotatable C-arm X-ray machine consists of a point source of 
X-rays and an image intensifier, mounted on either end of a 
C-shaped arm, only 93cm apart, giving large magnification, 
dependent on the source-patient distance. The C-arm can be 
rotated through 1200, tilted and moved laterally, as shown in 
Figure 3.1 , (and locked at any position within this range) 
permitting a large angle range from which to choose appropriate 
angles of view. The patient is positioned lying on the trolley, 
between the source and the detector. The C-arm is rotated to a 
suitable angle of view and an X-ray taken. The procedure is 
repeated at a different angle and the images are displayed 
immediately on a T.V. monitor. 
The geometry of the system is shown in Figure 3.2. To enable 
calculations of the lesion position to be made from image 
measurements, it is necessary to know the angles of orientation 
of both views and a conversion factor to relate the distances 
between points on the displayed T.V. image to the real 
corresponding distances, thus taking care of both view-dependent 
foreshortening and magnification effects. Angles of view may be 
obtained by several methods. The C-arm carries an angle scale, 
but it is not sufficiently finely graduated, nor is the structure 
carrying it sufficiently rigid, to furnish the required 
information with the necessary precision. Thus some alternative 
means of angle input or angle calculation is required. This might 
be obtained either directly from the C-arm itself using 
transducers or by comparison of the marker dimensions with the 





Figure 3.1 - Diagrammatic representation of the C-arm indicating 
the directions of rotation and lateral movement. 
View 7 
vie 




Figure 3.2 - Geometry of the Situation. 
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It is unsatisfactory to use transducers fixed to the C-arm 
mechanism for several reasons: 
The C-arm angle scale reading is not necessarily the true 
viewing angle of the X-ray relative to the marker. That angle 
is also determined by marker orientation within the view. 
It is undesirable to have trailing connections 	to 
transducers on the x-ray equipment. 
The transducers would require regular calibration. 
The C-arm equipment is not rigid so that angles would not 
be measured from a stable base. 
The system would be specific to each particular X-ray 
machine 
The angle required is that of the C-arm source above the plane of 
the marker and patient, rather than that of the C-arm orientation 
alone. This angle may be more easily and accurately determined 
from length measurements, taken from the image of a suitable 
marker system located on, or in a known relation to, the patients 
chest. If the radio-opaque marker (to which the lesion position 
is referred) is correctly designed, comparisons of its known 
dimensions with the measured dimensions of its image may be used 
to evaluate both the angle of view and the magnification for each 
scene. Image measurements of apparent lesion distance from the 
marker for two or more scenes taken at different viewing angles 
can yield values of the true coordinates of the lesion relative 
to the marker. 
3.3. The Patient Marker 
The prime requirement of such a marker is that it should allow 
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evaluation of a magnification factor, to convert magnified T.V, 
image dimensions into the corresponding true dimensions projected 
onto the image plane. This is achieved using a sphere as a 
component of the marker, as its viewed diameter will -not be 
affected by the angle of view. Thus the magnification factor F, 
is given by: 
F=T.V. image diameter / sphere diameter 
and takes account of the magnification due to the formation of 
the X-ray image by divergent rays from a point source. 
It is also necessary to know the angle of orientation of the 
source to the marker for each view. This can be obtained from the 
image of the marker, if it incorporates X-ray opaque rods of 
known length. By comparing real and apparent rod lengths at known 
magnification, F, and using basic trigonometry, the centre-line 
viewing angle is derived, as illustrated in Figure 3.3, as: 
Oci = sin( (image length / F) / rod length) 
In the 3-dimensional case the image has to be located in two 
planes and at least two rods are required as components of the 
marker, preferably perpendicular to each other, lying in a 
horizontal plane on, or in a known relation to, the patient's 
chest. 
3.3.1. Errors of Lesion Position Estimation 
If image lengths are taken from the T.V. screen inaccuracies will 
arise from these measurements through imaging and measurement 
errors. It is estimated that these combined errors will be no 
larger than #1mm for each length. It is not immediately obvious 





Figure 3.3 - Illustration showing how the centre-line viewing 
angle 8c4is determined. 
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calculated lesion position and preliminary testing is necessary 
to assess whether, or in what circumstances, the method is of 
sufficient precision for practical use. 
To determine the accuracy with which the lesion position (x,y,z) 
may be calculated in terms of marker dimensions, angles of C-arm 
orientation, errors in image measurement, distance of the source 
from the marker and different methods of angle determination is 
both complicated and difficult. It was therefore decided to 
reduce the problem initially to a 2-dimensional one and to carry 
out the investigation using a mechanical analogue. 
3.4. Mechanical Analogue 
A half scale, 2-dimensional lesion plotter apparatus was devised 
to investigate these error effects. For convenience this is based 
on the assumption that the centre of the marker 'sphere', point 
P, lies on the normal to the detector plane through the X-ray 
source, as shown in Figure 3.4. 
3.4.1. Background Geometry 
The basic geometry of the system, as proposed for use with the 
C-arm X-ray machine is shown in Figure 3.5. The X-rays from the 
point source cast shadows from both the rod and sphere marker and 
the patient on to the detector. The size of the images is 
dependent on the source-marker distance and the angle from which 
the system is viewed. It is necessary to work from the image 
lengths to the real system using available information. Initially 
only the marker dimensions, the image lengths and the 
source-detector distance are known. The extreme rays grazing the 
sphere in an actual observation correspond to lines drawn from 
the source to the extremities of a diameter of the image sphere 




Figure 3.4 - The marker P0 and an illustration of the assumptions 
used in the mechanical analogue. 
marker sphere 
sphere 	 'marker rod 
image length 
Figure 3.5 - Basic geometry of the proposed system of lesion 
location by X-ray imaging. 
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a full-scale drawing and moved towards or away from the point 
representing the source until both rays extending from the source 
are just tangent to the actual sphere, the correct source-sphere 
distance is obtained, as illustrated in Figure 3.6. Maintaining 
the centre of the sphere at this distance and rotating the marker 
about the sphere centre until the end of the rod coincides with 
the ray which intersects with the corresponding image point gives 
the correct orientation of the marker rod relative to the (X-ray) 
optic axis. This is the basis on which the apparatus has been 
designed. 
3.4.2. The Mechanical Equipment 
The mechanical analogue or plotter used to evaluate the effect of 
measurement errors on this scheme of lesion location is shown in 
Figure 3.7. It consists of two coplanar steel straight edges, Si 
and S2, one of which (normally Si) represents a ray grazing the 
sphere, the other,S2, a ray passing through the end point of the 
rod. Si and S2 rest on the horizontal draughting surface and are 
hinged together at one end, the lines of the opposed edges 
intersecting at the hinge axis, H. This axis is fixed 
perpendicularly in a third arm, A, which is in a plane parallel 
to that of Si and S2, a little above the draughting surface. A 
has a vee-groove machined along the length of its underside, the 
centre line of which intersects the common hinge axis of all 
three arms. The intersection of the hinge axis with the 
horizontal drafting surface represents the point source of the 
X-rays. A graduated rule is fixed to the free end of A, 
perpendicular to A, parallel to the drafting surface. The 
perpendicular distance of its graduated edge from the hinge axis 
corresponds to that between the C-arm X-ray source and detector. 
The transverse scale of A rests on the upper horizontal faces of 
Si and S2, each of which is provided with a clamping mechanism so 
that settings of the edges of Si and S2 on the scale may be fixed 
c) Rotate sphere to position the rod 
/ 
d) Marker correctly positioned with 
respect to the source 'and detector 
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Figure 3.6 - Basic steps in optical determination of viewing 
angle. 
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Figure 3.7 - The lesion plotter apparatus. 
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during subsequent manipulations. The sphere of the marker system 
is represented in 2-D by a disc, fixed to the drafting surface, 
having a small steel ball bearing mounted at the centre of its 
upper surface, which locates in the vee-groove of the arm A. The 
disc centre defines the centre of the sphere of the marker 
system; a removable pin in the drafting table represents the 
other end of the marker rod, point Q. 
3.4.3. System Variables 
The proposal under evaluation is that the position of a lesion 
(coordinates x,y) is to be determined relative to the marker from 
measurements of apparent or image distances between lesion and 
marker sphere and of apparent marker dimensions obtained in two 
views. The operating variables are the distance of the source 
from the marker and the angles of orientation of the two C-arm 
views relative to the marker rod. Parameters are the sphere 
diameter and the rod length. 
3.4.4. Operation of the Mechanical Analogue 
The arm Si is set and locked at a graduation on the transverse 
scale such that its inner edge is at a distance from the vee 
groove axis corresponding to the radius of the image of the 
sphere. The instrument is then placed on the drafting surface so 
that the vee groove engages in the steel ball. The whole 
apparatus is then made to slide in the direction of the 
vee-groove, maintaining contact between the latter and the fixed 
ball and reducing the distance between the hinge the disc until 
Si comes into contact with the disc periphery. The distance 
between the hinge axis and the disc centre now registers the 
correct source-marker distance corresponding to the observed 
radius of the image of the sphere. The ball is locked to the vee 
groove at this setting and the equipment is now rotated about the 
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ball until the arm, s2, which has previously been clamped to the 
scale at the division representing the observed rod image length, 
contacts the pin representing the end Q of the marker rod. The 
pin is then removed. Keeping the apparatus at this orientation, 
the arm S2 is moved to read on the scale the image length of the 
distance of the lesion from the centre of the marker sphere. A 
line is then drawn on the drafting surface along the straight 
edge S2 to represent possible lesion positions. The whole 
procedure is repeated using data derived from a different view, 
and the lesion taken to lie at the intersection of the two lines. 
3.4.5. Reproducibility of the Mechanical Analogue 
Before making more exhaustive trials with this system it is 
desirable to know how reproducible the apparatus itself is 
without the involvement of measurement errors. This was 
determined by setting and locking the scale readings, removing 
and then replacing the instrument on the draughting surface in 
engagement with the ball. At angles in the range 10 0 - 500 
results are a pencil line width different at the end of the arm 
but at 60 0 - 90° these differences become much larger, up to 10 
pencil widths, although in the region of the actual lesion they 
are much reduced (2 pencil widths). This suggests that it is the 
rotation of the apparatus to contact with the pin representing 
the marker end which is at fault. The apparatus itself is fairly 
reproducible. 
3.4.6. Excluded Angles 
It is noted that there are two cases for which results will not 
be achieved using this apparatus. At 00  and 180 0 pin Q will not 
be located as the cylinder at P obstructs the view. Also when the 
lesion lies between -R' and R", the sphere image radius, on the 
scale, i.e. on a region of the drafting surface obscured by arm 
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A, its position cannot be recorded on the scale. 
3.4.7. Effects of Induced Errors 
The half scale image lengths of the marker rod (P'Q'), the sphere 
radius (P'R') and the distance of the lesion from point P (P'L'), 
as shown in Figure 3.8, were determined over the angle range 100 
- 1700 and + or - 1mm errors induced onto all the scale settings 
(+ 0.5mm in the case of the sphere radius). The 8 possible 
combinations of the induced errors on the 3 lengths have been 
investigated as shown in Figure 3.9. The lozenge formed by the 
outermost lines for each view is taken to be the largest error 
occurring. 
Results are charted in Appendix 1. 
At small angles in the range 100 - 30° the lines drawn are fairly 
reproducible but at larger angles the spread is much more 
diverse. Over the range 60° - 90 0 results are sometimes not 
obtainable. This is because as the centre line nears the 
perpendicular the marker image is close to its maximum viewed 
length which changes very slowly with increments in angle. Hence 
when induced errors are involved the combination of these errors 
becomes indefinitely large: As the apparatus is rotated about P 
the arm S2 acts as a tangent to a circle with centre P and radius 
greater than length P0 and contact with point 0 is impossible, as 
shown in Figure 3.10. 
The lesion is taken to lie within the quadrilateral or lozenge 
formed by the intersection of the extreme error bounds. The 
results noted for the uncertainties of lesion centre location are 
the radii of the smallest circle within which the error lozenge 
can be inscribed, as shown in Figure 3.11. The circle radius is 
thus an inverse measure of the accuracy of lesion location. The 
Figure 3.8 - The variables used during use of the mechanical 
analogue. 
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Figure 3.9 - Comparison of 8 possible combinations of the induced 
errors on the 3 lengths P'R', P'Q', P'L'. The lines drawn 
represent the line along which the lesion would be expected to 
lie. 
O3 
Figure 3.10 - A diagram to illustrate how unobtainable readings 
can occur when induced errors are involved. 
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image length with induced 'eirot 




Figure 3.11 - The lesion area or 'lozenge' showing how the error 
is measured. 
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values found for this radius are associated with the half scale 
equipment with induced errors of + or - 1mm. The value for the 
error lozenge radius will correspond to induced errors of + or - 
2mm in the full scale case, as shown in Figure 3.12. + or - 1mm 
induced error in the full scale case will produce an error 
lozenge radius half the size of that obtained for the half scale 
case. 
It is generally observed that results are better at acute angles 
of 10°, 20 0 , 160°, 170° for one viewing direction relative to 
axis PQ paired with a small angle in the other quadrant for the 
other direction of view. A 90 0 separation between the two viewing 
directions would intuitively be expected to give the best results 
but this is not the case. A 110° - 130° separation proves best. 
3.5. Effect of Marker Dimensions And Patient and Marker 
Positioning 
3.5.1. Sphere Diameter 
The effect of changing marker dimensions is also investigated and 
it has been found that increasing the sphere diameter from 2cm to 
4 cm decreases the errors involved in the position estimation and 
increases the allowable range of angle pairs. Charts 7&11, 8&12 
and 1&13 illustrate the effect of changing sphere diameter. It is 
assumed that + or - 0.5 cm (in the full scale case) will be 
satisfactory for the estimation of the lesion position. This 
corresponds to + or - 1cm lozenge radius in the charts. Such 
acceptable values have been stepped off in the charts in Appendix 
1. 
3.5.2. Marker Length 
Increasing the marker length from 10cm to 15cm does not, 





half scale case 
iced error 2e 
image plane for the full scale case 
Figure 3.12 - Diagram illustrating the relevance of the error 
lozenge results obtained from the half scale apparatus to the 
full scale case. 
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small difference in errors over the better values and a slight 
increase in errors at other values. Results are illustrated in 
Charts 1 & 14 and 2 & 15. 
3.5.3. Source-Patient Distance 
A decrease in the distance between the source and the patient has 
the effect of improving the results slightly in all regions, but 
more noticeably in those which are worst. It acts by magnifying 
the images to a greater extent, thus reducing the percentage 
errors involved in the measurements, but the effects are not so 
large as to improve the range of angles over which best accuracy 
is obtained (Charts 1, 2, & 3; 7 & 8; 8 & 9; 10, 11 & 12). 
3.5.4. Marker Position Relative to the Lesion 
The position of the lesion relative to point P, the centre of the 
marker sphere, is also important. The closer the lesion is to P 
the more accurately its position may be determined. For example, 
at 14cm from P the best accuracy is + 0.3cm but at 6.4 cm from P 
this reduces to - .0.2 cm (only a very small angle range is 
observed for 6.4 cm as the lesion is obscured by the disc in the 
range 120° - 170°) and the range of angles over which acceptable 
values are obtained greatly increases from a 70 0 separation to a 
40° separation (Charts 4, 5 & 6). 
3.5.5. Effect of Additional Angle Information 
In order to utilise viewing angles in the 60 0  - 900 region (i.e. 
the region which intuitively should reveal the best result) it 
would in principle suffice to use angular information from the 
C-arm machine itself. As the machine is neither rigid nor stable 
the best accuracy using position transducers would however, 
probably be + 5°. To estimate the consequential errors in the 
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viewing angle region of 600 - 90° the apparatus is set to the 
correct source-patient distance using sphere images and locked 
into position as before and is then rotated until the arm lies at 
the designated angle, the lesion distance is set and the line 
representing possible lesion positions drawn along the edge of S2 
in the usual manner. This method proves to be more reproducible 
than when angles in this range are estimated from measurements of 
PQ image length, but the error bounds and hence the error 
'lozenges' are large. In several cases, however, paired with 
sharp angles, estimates fall within the satisfactory region. 
If, instead of position transducers, an optical device were to be 
used over the whole angle range with + 0.5° error the error 
lozenges produced would be much smaller. For example, in the case 
of Charts 4 & 13 the angle of separation required is reduced from 
70 0 to 40 0 . 
Therefore if an optical device could be provided to measure 
viewing angles with this accuracy over the whole angle range it 
would be more advantageous to concentrate on this avenue of 
approach than to persist with angle determinations using the 
marker system. If, on the other hand less accuracy of angle 
determination was available a combination of the two methods will 
prove necessary. 
3.6. Conclusions 
The existing biopsy technique has been examined and it appears 
that some of its faults might be avoided by use of a rotatable 
X-ray machine. A rod and sphere marker has been developed to 
overcome the difficulties of variable image magnification and 
viewing angle determination inherent in the use of such machines 
for lesion location and the effects of errors of image 
measurement upon accuracy of lesion location have been examined 
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using a two dimensional mechanical analogue of the proposed X-ray 
system. Results from this analysis suggest that lesions of 2cm 
diameter or even less may be accurately located using dimensional 
information obtained from a radio-opaque marker provided that 
image measurements can be reliably taken to within +1mm. Smaller 
lesions may be accurately located provided that the angles of 
view are carefully selected. 
The optimum procedure leading to the best possible estimate of 
lesion position is to use information from at least two close 
views taken from sharp angles in opposite quadrants using a 
marker with as large a sphere as is reasonably convenient with 
the marker positioned above and close to the lesion. The sphere 
diameter appears to have a larger effect upon the accuracy than 




DEVELOPMENT AND TESTING OF MEASUREMENT TECHNIQUES FOR ACCURATE 
LESION LOCATION. 
4.1. Introduction 
A reference marker has been developed which has been shown to 
allow accurate determination of lesion position from the 
dimensions of X-ray images. It is now necessary to develop a 
means of obtaining dimensional information for images of the 
marker and lesion from the C-arm T.V. monitor to within an 
accuracy of * 1mm. Here we consider what technique of image 
processing would best serve this purpose. 
4.2. Image Analysis Applications 
Much work has already been done on image analysis techniques 
applied to robotics but so far successful applications have been 
limited. One such application is automated inspection i.e. 
quality control of objects on a conveyor belt where all objects 
are required to be identical (within stated tolerances). A 
camera, in a fixed position above the conveyor belt and focussed 
on it, televises each object passing through its field of view. 
The televised image is processed and the object either accepted 
or rejected. A robot arm removes the offending object from the 
conveyor. 
This application involves both image processing and pattern 
recognition. To enable this pattern recognition the computer must 
be 'taught' exactly what to look for. 
This teaching phase involves 'showing' different orientations of 
the object to the camera. Significant characteristics are 
memorised by the computer to act as a reference description. This 
description is comprised of parameters which are not affected by 
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either object position or orientation on the focussed surface, 
such as area, perimeter, second moment of area, etc. (118). It is 
hence important that each object is clearly separated from other 
objects around it, as well as illuminated to prevent shadowing 
which will result in image distortion. Inherent in this 
recognition phase is the assumption that the camera-object 
distance is constant, thus allowing apparent area, perimeter, etc 
to be used as identifying characteristics. This, however, 
dramatically limits the possible applications of the program. 
4.3. An Image Analysis Technique - Digitisation 
Digitisation is probably the most common image analysis technique 
for processing picture data. In this the image is decomposed into 
small areas or points called pixe\r - 
4.3.1. Binary Digitisation 
The simplest image analysis involves binary pictures, i.e. in 
which the pixels - are composed of only two colours - black and 
white. Binary pictures are obtained by 'thresholding' in which 
each pixeL is examined in turn and compared with a preset level. 
Pixels- lying on one side of this level are set black, the 
remainder white. Binary image analysis techniques employ mainly 
edge following algorithms. Initially a point on the image 
boundary is found and the next connecting boundary point is 
located. This process is repeated until the initial point is once 
again reached, by which time the perimeter of the object has been 
traced. By registering the direction of each edge point relative 
to the previous point a description of the object outline is 
obtained. This description may be compared with a reference to 
enable an object to be accepted or rejected. To allow a good 
quality object which has been moved or rotated round in the image 
plane to be accepted the algorithm locates the centroid of the 
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image and rotates the image about this point until the two 
descriptions match. 
Binary imaging techniques are applicable only when all of an 
object's possible orientations are limited to rotations in a 
plane parallel to the image plane. Obtaining satisfactory binary 
images, however, is often difficult. The image boundary between 
the object and background can become indistinct and lighting is 
hence critical. Binary images are therefore generally restricted 
to use with two-dimensional or thin objects. If two or more 
objects touch or overlap the outline is destroyed and all the 
objects are rejected. 
4.3.2. Grey Level Digitisation 
Digitisation, with each point having a grey level resolution, is 
most often used. A higher level of detail is obtained with grey 
level systems compared with the silhouette image obtained with 
binary digitisation. 
4.3.3. Analysis Techniques 
The major problem with digitisation systems is the separation of 
the object from the background. Shadows cause edge blurring and 
the image is hence complicated. Techniques capable of analysing 
the data exist but are complex, time consuming and restricted to 
simple tasks. 
Such techniques work satisfactorily provided that the objects 
neither touch nor overlap each other. 
4.3.3.1. Overlapping Objects 
A method for locating touching or overlapping two-dimensional 
objects which contain recognisable features such as holes or 
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corners is described (119). It relies upon matching several, but 
not all, of the features of an object with its description and 
proposes the remaining part of the object's position in the 
layout. Repeating the procedure the general arrangement of the 
objects is achieved. Parts which do not fit in with the object 
description are regarded as defective and may be rejected. 
However, defective objects, with the defective part obscured are 
accepted. 
4.3.3.2. Boundary Recognition Problems 
Problems arise with all these analysis systems. Picture cells on 
the image boundary will be composed of more than one grey level 
and the cell will thus have an intermediate value resulting in 
boundary recognition problems. This effect is enhanced if the 
picture cells are large. 
4.3.3.3. Noise Filtration 
Noise in the picture may result in some cells having erroneous 
grey levels. Horn (120) recommends a process of filtering and 
mentions two methods: 
-Comparing cells with neighbouring points and adjusting 
'outliers' to have the maximum or minimum grey level of any of 
its neighbours. 
-Comparing with neighbouring cells and using the neighbourhood 
average. 
These filtering processes cannot, however, be applied at an image 
boundary and their use is therefore limited to image recognition. 
114 
4.4. The C-arm Image 
Generally, in the case of the C-arm monitor a high resolution, 
digitised grey level system exists. It is desired to pick out the 
marker and the lesion from the televised image but the associated 
image analysis is extremely complicated for several reasons: 
-Although the sphere is of uniform diameter its image 
diameter varies, depending upon its distance from the 
detector. Thus although the general shape will remain the 
same at the image plane the important reference parameters 
will vary (i.e. diameter, perimeter, area, e.t.c.). 
-It is possible that the sphere will appear as overlapping 
another object on the image. Although the overlapping sphere 
may not be lost the grey level across the circle varies and 
it is difficult to specify a set threshold value to determine 
the outlines in the overlapped area. 
-No two lesions are of the same size or shape. Hence they 
cannot be recognised in any way by the computer. 
-The ribs appear in any view of the chest and lungs and 
overlap with the sphere and lesion images. Although their 
outlines may be clear they drastically complicate the 
situation. Even if it were possible to accurately locate the 
marker images in isolation it would be extremely difficult to 
separate them from those of the ribs. 
4.4.1. Low Resolution Analysis 
The high resolution digitised image from the memoryboard is time 
consuming to analyse. Lower resolution digitisation would reduce 
image processing time but induces inaccuracies into the system. 
The error analysis carried out previously revealed how sensitive 
115 
estimates are of lesion position, calculated by means proposed in 
Chapter 3, are to small errors in image measurement, especially 
when viewing has to be done from certain directions.It is hence 
necessary to reject low resolution digitisation as a step in 
obtaining image dimensions in this case. 
4.4.2. High Resolution Analysis 
If it were possible to carry out this analysis at a high 
resolution, a complex image digitising system involving several 
threshold values would be required, i.e. a multiple grey level 
system. This, however, would require a lot of computer space to 
cover the complete analysis. The image appears on the T.V. 
monitor showing ribs, marker, lesion, internal organs, etc in 
varying grey levels. The particular grey levels are very 
dependent upon the particular patient (how fat or thin he or she 
is) and the lesion position within the lung, the characteristics 
and state of the X-ray machine, its mA and kV settings, the 
absorption of the trolley bedding, etc. Thus. variable threshold 
values for the grey level changeover are necessary and it is 
impossible to stipulate exactly in which grey levels each object 
will appear. The marker will be semi-opaque and 'change colour' 
at the overlap region. 
To provide a satisfactory automated image analysis procedure 
would thus in itself be a large project of dubious outcome. It 
was therefore decided that image recognition procedures should be 
rejected in the current programme and image analysis information 
input to the computer manually. 
4.5. Manual Image Analysis System 
A system has been devised to input 	the required image 
information. A BBC microcomputer, connected to a genlocking 














Figure 4.2 - The computer generated menu 
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picture to be superimposed on the video picture on the monitor. 
An AMX mouse is connected to the computer and a mouse-controlled 
pointer is displayed on the T.V. screen, superimposed over the 
X-ray image. The mouse is moved on a flat surface until the 
screen pointer is positioned over the relevant point. Pressing 
the mouse button causes the x and y coordinates of the designated 
point to be registered with the computer 
Using this equipment a computer generated 'menu', as shown in 
Figure 4.2, is superimposed over the X-ray image and appears 
along the bottom of the screen. The menu contains symbols 
representing all the information required for lesion location 
An arrow indicator, travelling along the bottom of the menu, 
indicates which feature of the image is to be measured and 
registered next and the operator moves the mouse until its screen 
pointer lies over the required point. Pressing a mouse button 
registers the position of the point into the computer and the 
menu indicator moves to point at the next piece of information 
required. If an inputting error is made simply positioning the 
pointer over the word 'REDO' and pressing a mouse button moves 
the indicator backwards. The correct information can hence be 
input. 
Once all the information has been input to the computer the 
pointer is positioned over the word 'FINISH', the button pressed 
and the registered variables are used to calculate the distance 
of each sphere from the X-ray source and the angle of view and 
postulates a line along which the lesion must lie. Inputting a 
further image from a different view results in another line. 
Solving the two simultaneous equations reveals the lesion 
position relative to the marker. 
4.6. An Optical Simulator 
It was necessary to evaluate this technique extensively. However, 
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access to the C-arm machine, located in the City Hospital at 
Edinburgh, is limited: Medical staff, naturally, have priority 
over its use. Therefore a full scale model of the C-arm set-up 
was designed and built. Visible light is used in this model 
instead of X-rays, conveniently forming similar images without 
risk to personnel. 
4.6.1. The Apparatus 
The apparatus is illustrated in Figure 4.3. A light source with a 
250W bulb and adjustable iris set to a small aperture is used to 
represent the X-ray point source. A 17cm diameter translucent 
plastic screen set 93cm away from this point source represents 
the X-ray detector. This section of the apparatus is surrounded 
by black screens to reduce interference from background light. A 
black and white T.V. camera with a 16mm lens is mounted on a 
three-axis adjustable support behind the plastic screen on which 
it is focussed. The image signal is sent to the black and white 
T.V. monitor so that the C-arm source and image detector are thus 
modelled. 
4.6.2. The Patient Model 
When using the C-arm X-ray machine itself the patient remains 
stationary and the different views are taken by rotating the 
C-arm. Literal modelling of this would require a large framework 
to support the various pieces of equipment and maintain them at 
the correct relative positions. In this simulation, therefore, 
the imaginary patient is rotated and the relatively large optical 
equipment remains fixed on the bench. A two dimensional system 
has again been used to prevent a cluttered system. 
Throughout the diagnostic procedure the actual patient must 
remain in a fixed relation to the marker. Accordingly, in this 
simulation the patient is represented simply by a rigid structure 
Figure 4.3 - The optical simulator 
-D 
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Figure 4.4 - Marker and lesion system 
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comprising the 2-dimensional marker and the lesion which are 
constructed from spheres and connecting rods , as shown in Figure 
4.4. One sphere, P, is used to determine the scaling factor, F, 
mentioned previously, and the centres of this and of a second 
sphere, 0, define the ends of the marker rod, R. R is a sliding 
fit in a diametral hole in 0, which can be locked in place at any 
convenient distance from P by a screw. This enables the length of 
R to be varied. The 'lesion', a smaller (1cm diameter) sphere, S, 
is fixed to the end of one arm of an L-shaped rod, L. The longer 
arm of L is a sliding fit in a diametral hole in P, in which it 
can be locked in place with a nylon screw. This marker sphere, 
together with the associated system of rods and spheres, can turn 
about a fixed support, F, so that the 'patient' can be rotated 
relative to the optical system. As in the 2-dimensional 
mechanical system, this axis of rotation was made perpendicular 
to the plane PQS containing the two marker spheres and the 
'lesion'. 
4.7. Distortion Effects 
Graduated rulers were televised and the image measurements from 
the T.V. monitor reveal that distortion effects with this 
apparatus are negligible. 
A sphere of known diameter was positioned at various distances 
between the source and detector. Measurements of its image reveal 
that the optical system approaches pinhole optics with negligible 
error. 
4.8. Calculation Method 
The method of lesion position calculation is similar to that used 
in the mechanical analogue analysis: It differs in that sphere Q 
(the additional sphere used to indicate the position of the rod 
end) is now used to obtain an estimate of the marker viewed 
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length, MVL. The image and actual diameters of sphere Q are used 
to obtain the conversion factor, F, between the TV image and 
lengths referred to point 0, the end of the marker rod. This 
conversion factor is used to obtain an estimate of the marker 
viewed length, MVL, from the televised image. 
MVL= TV image length 
F 
The true rod length is known and thus the angle of view, ec, is 
thus calculated, as shown in Figure 4.5. 
The position of the lesion is measured relative to the centre of 
sphere P. A cartesian coordinate system is used, the centre of P 
representing the origin, the marker PQ (normally approximately 
horizontal in the intended clinical application) as the X-axis 
and the perpendicular to P0 at P (approximately vertical when the 
patient is horizontal) as the Y-axis, as shown in Figure 4.6. All 
viewed lengths are referred to the plane through point P, 
parallel to the image plane, as shown in Figure 4.7. Thus the 
dimensions of the images are found as their projections on the 
x-axis. The calculation method for lesion location is detailed in 
Appendix 2. 
4.9. Reproducibility of Results 
Reproducibility of results has been investigated. Six sets of 
readings were taken, in sequence, from identical views. The raw 
image data was not processed at this stage but stored on a disc. 
This has been repeated for views in the 8c angle range 00 to 
180 0 for the identical marker and lesion arrangement. All the 
collected data was then processed. Every set of readings was 





Figure 4.5 - Illustrating how the marker viewed length (MVL) is 








Figure 4.6 - Illustrating the Cartesian coordinate axes. 
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Figure 4.7 - Geometrical basis of lesion location. 
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estimates of lesion position are obtained from nominally 
identical pairs of views. The general reproducibility trend is 
shown in Figure 4.8, in which the spread of these estimates of 
lesion position is plotted on a vertical scale against the 
corresponding viewing angles. The general form of such plots 
reflects the original sensitivity analysis results obtained with 
the mechanical analogue, ie best reproducibility is obtained at 
Oc separations of between 90° and 1100, etc. However the results 
over the range 85°-95 0 in Figure 4.8 above are misleading, as on 
several occasions the calculated image length was larger than the 
actual rod length and therefore the angle of view ec could not be 
calculated. To avoid the program crashing it was modified in such 
a way that such data are intercepted and a message to this effect 
is printed on the screen, before the program continues as before. 
It is instructive to determine how results from lesion targetting 
by the purely optical technique, shown in Figure 4.9 compare with 
those obtained using angles determined independently (eg read 
from the C-arm, using position transducers). Lesion estimates 
based on direct measurements of viewing angles are shown in 
Figure 4.10 over the range 0°-180° at the same lesion position as 
for the optical technique and using otherwise identical data as 
used to construct Figure 4.9. Results of the two methods are 
readily compared with the aid of Figure 4.9 and 4.10 to determine 
which is most appropriate over what angular range..Over the range 
70 0-110° the precision of the lesion location using the angle 
input method is much better, giving precise location within 1 cm, 
allowing this range to be used if the viewing angle can be 
accurately determined by some additional means. 
4.10. Redundant Measurements 
The error analysis carried out experimentally on the mechanical 
analogue revealed how susceptible lesion location is to small 
Marker dimensions 
sphere diameter 	2.5cm 
rod length varies from 4.3cm to 19.1cm, depending upon the 
viewing angle. 
lesion position (6.1,3.6) 
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Figure 4.10 - Radius of lesion location error circle generated by 
data collection errors as a function of viewing angles, using 
optical data supplemented by direct measurements of viewing 
angle. 
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errors, especially at angles of view within the 600_1200 range. 
It is desirable to know more generally, for the optical system, 
how accurate or precise any estimate of lesion position is likely 
to be and to what extent it is feasible, if necessary, to use 
redundant measurements to improve these estimates. 
4.10.1. Mathematical Analysis 
There are five measurements associated with each image: Two 
tangent locations for each of the two marker spheres and the 
lesion location. It is possible to express the lesion equation 
y=(PL 1 _x)tan(6L) 
in terms of the five directly measurable variables and hence in 
principle to analyse the effects of errors in these variables on 
the final lesion estimate. Since errors occur in both the 
independent and dependent variables and the problem is 
non-linear, the set of equations, detailed in Appendix 3, is 
complicated and appears insoluble. It has hence been put aside 
and experimental studies undertaken. 
4.10.2. Results Improved by use of Additional 	(Redundant) 
Measurements 
At least two views are required to estimate the two dimensional 
lesion position (x,y). In the case of redundant measurements n 
views are taken, where 02. This provides d4(i-1) estimates of 
lesion position. By combining these d estimates a more accurate 
single estimate, (x,y)av is obtainable. There are several methods 
of combining t liese estimates, the most basic being simple 
averaging, ie 
a 	 d. 
=(y) 
"I 
4L 	 OL 
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Table 4.1 shows the percentage of simple average results which 
lie within 1cm and 0.5cm errors for different lesion positions 
when using sets of three views. 
Since data has not been collected from similar viewpoints the 
results at the different lesion positions cannot be compared 
directly. Certain ranges of view have been omitted. These 
omissions arise for two different reasons: 
The lesion is obscured by one of the marker spheres. In 
the optical analogue the spheres are opaque and thus if the 
lesion is situated behind one of them it will be completely 
obscured. In the X-ray system however the spheres will be 
semi-opaque, showing up on the monitor but still revealing 
dense structures behind them. Thus this range of views will 
not be forbidden in the X-ray system (provided that the 
lesion is sufficiently dense). 
The lesion is offscreen. If the lesion lies deep within 
the body then at sharp angles either the marker or the 
lesion may lie offscreen. Reducing the marker rod length 
may, in some cases, decrease the overall image size but 
generally this problem is inherent with both the optical and 
X-ray systems. 
Consequently an overall improvement in results is apparent if the 
obscured range lies close to 90° or a deterioration in results if 
the range lies away from 90°. 
From studies of errors associated with the three viewing angles 
it is apparent that the results are most markedly improved where 
errors are largest,ie when one or more of the angles lie close to 
Table 4.1 - Percentage of results which are within the indicated 
error bounds for different lesion positions when using redundant 
measurements. 
Lesion Position X within +1cm error % within ±0.5cm error 
0,2.4 83.6 77.5 
0,4.8 84.5 70.2 
0,7.2 46.5 33.5 
-0.2,10 52.2 21.9 
-0.4,14.2 36.0 15.1 
2.9,2.3 88.4 77.8 
3.0,4.8 49.5 24.6 
3.0,7.2 56.9 43.5 
2.9,9.9 24.1 13.9 
2.9,15 32.7 10.5 
6.0,2.4 66.2 50.0 
6.1,3.6 98.6 88.2 
6.4,4.2 82.1 61.9 
6.1,4.8 63.4 47.5 
6.1,6.1 63.8 54.6 
6.6,8.6 23.2 11.5 
9.8,2.4 86.9 67.0 
9.8,4.8 27.2 11.5 
10.3,7.4 38.5 23.1 
10.2,9.8 20.7 9.1 
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90°. 
4.10.3. Quadrant Flips 
Occasionally, however, results when utilising views around 90 0 
are noticeably erroneous, often ridiculously so. Even the 
application of redundant measurements has little overall effect. 
For example, consider the following viewpairs: 
28 0 , 87 0 , 63° give 4.5cm error 
19 0 , 60 0 , 63 0 give 5.8cm error 
Such results occur when one or more of the viewing angles are 
assigned to the wrong quadrant. This tends to occur in the 
60°-120 0 range (In the above two examples a viewing angle of 117 0 
has been wrongly assigned as 63°.) The further the viewing angle 
from 900  the worse is the final position estimate should such a 
quadrant 'flip' occur, ie an 85° view may assume a 95° view 
position, an error of 10 0 , whereas a 750  view may assume a 105 0 
view position, a 30 0 error. 
The quadrant is determined within the computer program by 
comparison of the image and actual diameters of the two identical 
marker spheres to calculate their distances from the X-ray 
source. Combining these distances with the rod length an estimate 
of the source x-coordinate is made and the quadrant thus 
determined. Close to 90° these spheres are roughly the same 
distance away from the source and thus their image diameters are 
similar: The slightest error in their measurement can result in a 
large error in these calculated distances and thus result in the 
adoption of the wrong quadrant. 
4.10.3.1. Location of Quadrant Flip Occurrences 
It is desirable to locate and correct such erroneous quadrant 
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allocations or 'flips'. This is done within the program by 
flipping every angle in the 600_1200 range as it occurs and 
calculating the different possibilities of lesion position when 
paired with another angle. If only one of the view pairs lies in 
this flip range then two lesion position estimates result, but 
for two pairs within the flip range then four estimates are 
obtained per angle pair. 
A series of tests is applied within the program to each position 
estimate to eliminate the ridiculous or obviously erroneous 
positions. These elimination tests take several forms, depending 
upon how many views lie within the 600_1200 range. A flowchart 
describing the process is shown in Figure 4.11. 
Initially any estimate which lies above the patients body or 
further than 25cm from sphere P, as illustrated in Figure 4.12, 
is eliminated. If, during this removal of estimates all pairs 
involving one angle in one quadrant are eliminated then that 
quadrant is removed as a possible viewpoint for that angle and 
the remaining quadrant assumed correct, as described in Appendix 
4. 
Once the system can no longer be reduced by the above method then 
all remaining possible viewing angles are organised into sets of 
three possible views, as in Appendix 5, and the. corresponding 
lesion estimates tested to ensure that they all lie within the 
constraints described above. The first set that provides a 
complete group of estimates is assumed correct (the sets are 
ordered so that those requiring the least amount of alterations 
to calculated viewing angles appear first). If there is no 
complete set of estimates then either the original calculated 
viewing angles are assumed (if the number of possible angle flips 
is 3) or the set with the smallest separation between its 
estimates is chosen. The system is thus reduced until all 
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Figure 4.13 - Effects of simple averaging and quadrant flips on 
lesion position estimates during redundant measurements. 
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possible flip angles are assigned to a quadrant and the lesion 
position estimates calculated. An example, shown in Figure 4.13 
and based on lesion position (0,7.2), illustrates the overall 
effects of all these changes. 
4.10.4. Application of Quadrant Flips to Redundant Measurements 
Table 4.2 shows the percentage of average results within 1cm and 
0.5cm errors for different lesion positions with induced quadrant 
flipping. The raw data used was identical to that used to 
generate the results in Table 4.1. In most cases the quadrant 
flipped results are a great improvement. For example, comparing 
Table 4.1 and Table 4.2 , at lesion position (10.3,7.4), averaged 
results have improved from 38.5% to 70.2% within 1cm error and 
from 23.1% to 40.5% within 0.5cm error. This difference is large 
because the viewing range is small and the number of wrongly 
assigned angles is large. However, in a few cases results are 
slightly worse. At lesion position (6.1,3.6) all angles are 
initially correctly assigned. Over one third of the angles lie 
within the 600_1200 flip range. On applying quadrant flips a few 
angles are reassigned and hence results deteriorate slightly, for 
example from 98.6% to 96.9% within 1 cm error and 88.2% to 87.0% 
within 0.5cm error on simple averaging. These tend to occur when 
either 3 similar angles or 2 similar and a third close to 900 are 
used, ie all 3 pairings give bad estimates. 
Hence, generally, applying quadrant flips improves results 
greatly and should be used with redundant measurements. Some 
results are shown in Figure 4.14 as plots of percentage within 
error range against error, superimposed on the original results 
obtained without applying quadrant flips. Once again graphs at 
'U 
Table 4.2 - Percentage of results which are within the indicated 
error bounds when quadrant flips are induced. 
Lesion Position % within +1cm error % within +0.5cm error 
0,2.4 96.9 91.2 
0,4.8 97.7 84.8 
0,7.2 85.4 68.9 
-0.2,10 52.2 21.9 
-0.4,14.2 36.0 15.1 
2.9,2.3 96.8 85.8 
3.0,4.8 78.9 42.9 
3.0,7.2 91.0 72.7 
2.9,9.9 51.8 23.2 
2.9,15 32.7 10.5 
6.0,2.4 89.7 75.1 
6.1,3.6 96.9 87.0 
6.4,4.2 83.3 60.7 
6.1,4.8 88.1 72.3 
6.1,6.1 90.3 77.6 
6.6,8.6 28.4 11.3 
9.8,2.4 87.0 69.4 
9.8,4.8 54.1 27.6 
10.3,7.4 70.2 40.5 
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Figure 4.14 - Graphs of percentage of results within the error 
range against error (cm) for different lesion positions. 
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different lesion positions cannot be directly compared. 
4.11. Attempts at Estimate Improvement 
4.11.1. Application of Lesion Constraints on the Possible 
Estimates 
In an attempt to further improve the lesion location estimation 
procedure the bounds within which acceptable estimates lie were 
reduced by application of a further constraint on lesion depth. 
The maximum depth below the patient's skin at which a lesion must 
lie, assuming that the patient lies either prone or supine, is 6 
inches, ie 15cm, as shown in Figure 4.15. (6 inches is also the 
maximum length of biopsy needle available). The marker sphere 
radius is 1.25 cm and hence the vertical lesion distance from P 
when that touches the skin surface may reach a maximum of 16.5cm. 
Allowing for errors and some working clearance between the 
patient and marker, the constraint on depth has been set at 20cm 
maximum. 
Results for shallow lesions are identical to those previously 
observed. However for deep lesions, for example (-0.4,14.2) 
results are noticeably worse. This occurs because often when a 
90 0 view is involved the inaccurate true estimate may lie deeper 
than 20cm and is hence eliminated from the averaging process. The 
depth constraint has therefore been relaxed back to 25cm. 
4.11.2. Alteration of the Applicable Range for Quadrant Flips 
Narrowing the flip range from 60°-120 0 again causes results to 
deteriorate as many results which have been wrongly assigned are 
then ignored. Increasing the range to 55°-125° improves results 
for lesion position (3.0,4.8) as shown in Figure 4.16, which has 
one angle flipped from 125 to 55°. However, more generally, 
'4.' 
Figure 4.15 - Typical human body dimensions 
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results deteriorate. The quadrant flip range is hence taken as 
600_1200 and the constraints on lesion position estimates as: 
X2+ y 2  < 252 
y > 1.0 
4.12. Number of Views (Extent of Redundancy) Necessary to Ensure 
Accurate Lesion Position Estimate 
It is necessary to decide upon a strategy for the number of views 
which must be taken. 
If the surgeon is provided with information regarding good/bad 
views and uses only good views, then only two such views are 
required. 
However, in some cases, two good views are not always available, 
for example when the lesion is obscured except for a very small 
range of angles. This can occur when the lesion lies in the apex 
of the lung and can be viewed only from close to 90°. In this 
case redundant measurements must be used. 
To obtain any more than three views becomes excessively time 
consuming and increases unacceptably the total dose of radiation. 
Therefore, a maximum of three views should be used. 
As the surgeon may not be privileged to information regarding 
good/bad views, three views should be used as standard. 
An alternative possibility is for the computer to 'ask' for 
another viewpoint should one of the initial two views lie in a 
bad range. 




Figure 4.17 - Perpendicular marker arrangement for the two 
dimensional situation. 
Figure 4.18 - Quadrant determination from the image appearance. 
1st quadrant view 
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4.13. Improvement of Angle Estimation 
Accuracy for viewing angles close to 900 may be improved by 
substituting a nearly vertical rod perpendicular to the original 
marker rod presently used, as shown in Figure 4.17. Changes in 
viewed rod length with angle are hence large when close to 90 0 . 
To use this method, however, is not as simple as it first 
appears. Although the calculated angle may be more accurate the 
quadrant cannot be determined merely by combining the calculated 
distance from the X-ray source to the sphere with rod length as 
before. Hence additional information is required. The system may 
be completely defined by inclusion of the original horizontal 
marker, ie by using two marker rods perpendicular to each other. 
The spheres P and Q on the horizontal rod enable the quadrant to 
be determined as previously. However this involves quadrant 
flips. Alternatively, and probably more accurately, examining the 
relative image positions of spheres P, 0 and R will determine the 
quadrant, as shown in Figure 4.18. However the image becomes 
cluttered for the two dimensional situation with the lesion and 
the three spheres, all of which must be uniquely distinguishable, 
lying on the image line. This is undesirable since it leads to 
operator confusion when picking off the image points with the 
mouse. Hence for the two dimensional machine a single marker rod 
is used as standard although for a later three dimensional 
machine a perpendicular marker arrangement for each rotation 
plane may be less clumsy since the image will appear as a plane, 
not as a single line and the images hence appear more spread out. 
4.14. Conclusions 
Due to the complexity of the X-ray image field containing 
anatomical structures, suspected lesion and reference marker, it 
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is not practicable to identify the relevant image points 
automatically by using conventional image analysis techniques. A 
manual system, which depends on the skill of the operator to 
recognise relevant features, and using a mouse pointer to measure 
their dimensions, has been devised and tested and found to give 
sufficiently accurate and reproducible estimates of lesion 
position when using a full-scale optical analogue of the C-arm 
machine and patient arrangement. Redundant measurements have been 
demonstrated to improve results when viewing angles are in the 
range 600_1200 from the horizontal reference marker. Quadrant 
flips further improve the estimates. Use of a perpendicular 
marker would eliminate the need for redundant measurements and 
additional X-ray takes. However imaging requires location of 
three spheres instead of two. The image becomes cluttered and 




DEVELOPMENT OF THE BIOPSY MACHINE. 
5.1. Introduction 
Methods have been established for image analysis and position 
location of 'hidden' objects by using an optical reference 
marker. It remains to combine all these techniques and develop a 
biopsy machine which will enable accurate positioning of a biopsy 
needle to sample the lesion. The various design stages of the 
machine are detailed in the sections that follow. 
5.2. Basic Operations. 
It is necessary to examine the proposed sequence of operations 
(based on the existing biopsy method) which will be carried out 
during the computerised biopsy procedure. Figure 5.1 outlines the 
basic procedures. 
5.3. Design Criteria 
At this stage several points are apparent: 
The positions of the marker (on or near the patient's 
chest), the lesion, the chosen needle insertion point on the 
skin must be known relative to some common reference. 
The surgeon must choose the point, on the patient's skin, 
at which the needle will be inserted. At this stage he will 
know the calculated lesion position. The insertion point must 
be chosen to allow a direct approach towards the lesion 
avoiding ribs, arteries, and other internal organs such as 
the heart. Some means of registering this chosen location for 
the insertion point with the controlling computer 	is 
therefore necessary. 
_____ 	 _ 	Align th C-arm 
START 	
Position the 	
biopsy machine 	 Orientate 	Position patient patient 
and lesion 
the C-arm 	 marker 
Take X-Ray 
N 	I Choose needle Calculate the  Another 	__ Input the image 
Insertion point lesion position view using a mouse 
Calculate angle 
Position the 
needle so that Push the needle Withdraw the 
needle and send 
and depth of its tip lies on the insertion 
.into the patient 
and sample the the tissue sample needle insertion 
point and points lesion for pathological 
towards the lesion testing 
0 
FIG 5.1 - Proposed sequence or operations for the computerised biopsy procedure 
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Several conclusions have been drawn from previous analyses: 
The marker rod length must be adjustable to allow a wider 
range of viewing angles. 
The marker should be positioned as close as possible to 
the patient (and thus to the lesion) for most accurate 
results. 
A bar, positioned above and close to the patient's chest, 
will assist in reproducibility of breath holding. 
The marker rod length may be adjusted between views, 
provided that the sphere representing the origin (for lesion 
location), remains fixed. 
The patient (and supporting trolley) must remain in the 
same position between views - only the X-ray machine may be 
moved. 
The needle must remain sterile. 
The machine must be capable of accommodating needles of 
various lengths and thicknesses. 
It is apparent that the machine must comprise three distinct 
functional parts: A patient marker, an insertion point indicator 
and a needle holder/angling device. All three must be able to be 
freely positioned wherever required relative to the patient but 
their positions, and that of the lesion, must be known relative 
to some fixed datum. Some connection must therefore exist between 
the frame of the machine and all three devices. 
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5.4. The Biopsy Machine. 
A horizontal arm, cantilevered from the floor, spanning the 
patient and trolley and having the necessary devices suspended 
from it was chosen as the most suitable method of support and is 
shown in Figure 5.2. 
It was decided to fix the three devices onto a single rail, along 
which each can travel. Transducers determine the relative 
positions of each device on the rail. 
The devices are of two types: The marker and needle insertion 
point indicator require manual positioning relative to the 
patient but the needle positioning thereafter is fully specified 
and positioning may be done automatically. It seems prudent to 
mount the two manually positioned devices on the same carriage so 
that the rail may be less cluttered. 
The machine therefore consists of a main rail from which two 
carriages are suspended: One is manually driven, the other is 
motorised. 
5.4.1. The Manual Carriage. 
The manual carriage contains both the patient marker and the 
needle insertion point indicator, both of which require to be 
positioned by the operator. 
The manual carriage has a telescopic extension, the far end of 
which is connected to a linear transducer running the full length 
of the support rail: The position of the free end of the 
telescopic section on the rail at any instant can thus be 
determined. 
Hand wheel for 
height adjustment 
Biopsy machine suspended 
from the cantilever arm 
overhanging the patient 
trolley 
Stops bear against edge 
of base of trolley 
/ 	Foot pedal operates Pedal operated plungers 	,( trolley Plungers lock against underside 
of patient trolley 
Base fits under patient trolley 
0 
Castors allow horizontal transport 
Figure 5.2 - The general arrangement of the machine support. 
's 
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Normally the telescopic section is retracted into the main 
carriage and the two sections move as one along the rail. A 
manual lever on the main carriage faceplate enables the main 
carriage to be locked to the rail. This action at the sathe time 
releases the telescopic section and allows it around 15 cm of 
unrestricted movement away from the main carriage as shown in 
Figure 5.3. A further locking device on the telescopic section 
fixes it to the rail. Both locking levers act against continuous 
strip switches, adapted from those provided for bus passengers to 
sound the 'stop' bell. These also run the full length of the 
rail, and indicate to the computer when each locking action is 
completed. 
5.4.1.1. The Patient Reference Marker. 
The patient marker consists of two red lead coated (and thus semi 
X-ray opaque) 1-inch spheres fixed to rods or stems which project 
out from the manual carriage front and are arranged to lie with 
their centres on a nominally horizontal line, as shown in Figure 
5.4. The line of centres is parallel to the direction of carriage 
movement along the rail, but displaced 10 cm out from the 
carriage front. The actual marker rod has been eliminated: The 
marker length is indicated by the distance between sphere 
centres. This has the benefit that the X-ray image appears less 
cluttered. 
One sphere, whose stem is attached to the main carriage, is used 
to represent the origin in lesion position calculations. When not 
in use it can be folded away. 
A second sphere is mounted on the telescopic section of the 
manual carriage. The line of centres of the two spheres, parallel 
to the rail, is used as the x-axis in calculation of the lesion 
position. Since the second sphere is fixed to the telescopic 
manual locking iever telescopic sect-ion locking device 
ISS 











Figure 5.4 Marker arrangement 
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section the separation distance between the two spheres can be 
easily altered. The linear transducer, although connected only to 
the telescopic section and the second sphere, can register both 
sphere positions. The position of the second sphere is first 
registered while the telescopic section carrying it is retracted 
and secured to the main section of the manual carriage on which 
the reference sphere is mounted. The main carriage is then locked 
in position on the rail by clockwise movement of a lever which at 
the same time releases the telescopic section. That section, and 
the second sphere, can then be moved the desired distance away 
from the first. Its new position is measured by the linear 
transducer and is then registered by the action of locking the 
telescopic extension to the rail. The difference between the two 
transducer readings, plus the offset between the two spheres when 
the telescopic section is closed, gives the true marker length, 
ie the distance between the sphere centres. The spheres are 
arranged so that their lowest points are well below the carriage 
structure. The patient marker spheres can thus be placed in 
contact with, or very close to the skin surface and thus as close 
as possible to the lesion allowing more accurate calculation of 
the lesion position. They may also assist in breath holding 
reproducibility instead of the chest bar previously recommended. 
5.4.1.2. Needle Insertion Point Indicator. 
The needle insertion point indicator is a small metal ring which 
is fixed to an arm forming part of the support of the reference 
sphere. The entire assembly is mounted on a vertical slide on the 
front of the manual carriage. To register an insertion point the 
sphere is folded out of the way and the indicator ring is swung 
into position about a vertical axis through a quarter turn, as 
shown in Figure 5.5. The indicator moves with the manual carriage 
along the rail but lies 5 cm closer to the rail than the marker 
spheres. 
'5' 
Figure 5.5 - The insertion point indicator 
a) original position 
	




c) needle insertion point 
indicator pulled out 
d) needle insertion point 
locked in x position. 
Telescopic section and slide 
now free for movement in the 
y direction 
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The manual carriage is slid along the rail until the indicator is 
positioned vertically above the chosen insertion point, the 
carriage is locked in place using the same locking lever as was 
used for the marker positioning but now rotated anti-clockwise, 
closing the lower 'bus-bell' switch. This action registers the 
position of the manual carriage on the linear transducer, thus 
giving the x-coordinate of the indicator. At the same time the 
anti-clockwise movement of the lever locks the main carriage to 
the rail and frees the telescopic section. It also couples the 
latter to the insertion point indicator pulley system. Turning a 
small knob on the main carriage front works the pulley and moves 
the indicator down its slide and at the same time moves the 
telescopic section away from the main carriage, as illustrated in 
Figure 5.6. When the indicator touches the patient's chest the 
surgeon indicates by keystroke to the computer to register the 
transducer reading. The difference between the x-coordinate 
reading and the latter reading indicates the depth through which 
the indicator has moved. Adding on the known depth or y 
displacement offset from reference sphere P gives the 
y-coordinate of the chosen insertion point . The insertion point 
is thus specified relative to sphere P, as illustrated in Figure 
5.7. 
5.4.2. The Motorised Carriage. 
Once all the manual inputs have been entered and the lesion 
position calculated by the computer it remains to position the 
needle for accurate lesion sampling. This is done automatically. 
The motorised carriage is served by three 1.8 0 four-phase stepper 
motors located in the fixed framework of the machine. A nut, 
fixed in the carriage, engages a multi-start leadscrew extending 
the full length of the rail One motor turns the screw and so 
traverses the carriage along the rail. A 10-turn potentiometer 
verti 
insertior 
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registers the position of the carriage. 20 turns of the screw are 
required for the carriage to traverse the full rail length and so 
the 10-turn potentiometer is located on the low speed side of a 
2:1 step-up gearbox as shown in Figure 5.8. 
The two further motors each turn splined shafts, placed one above 
the other, parallel to the rail and extending its full length. 
10-turn potentiometers, at the free ends of the shafts, indicate 
the number of shaft rotations. The shafts pass through nuts, 
shown in Figure 5.9, and are free to slide upon them but 
constrained by the splines to turn with them. Each nut is 
journalled in a ball race fixed in the motorised carriage and is 
coupled to a toothed wheel connected, via a toothed belt, to a 
pulley wheel on each of two gearboxes which are contained within 
the carriage (illustrated in Figure 5.10). 
The two gearboxes installed inside the carriage lie one behind 
the other and the output shaft from the back gearbox runs through 
the bore of a hollow tube which forms the front gearbox output 
shaft. The needle guide is secured directly to the outer tubular 
shaft; the chain-wheel which drives the needle depthing mechanism 
is secured to the inner shaft. Turning the upper shaft operates 
the front gearbox and angles the needle guide shown in Figure 
5.11. The angling is restricted to approximately + or - 90° from 
the vertical by two stops on the front carriage face. These 
prevent unwinding of an anti-backlash spring located between the 
needle guide and the front face of the carriage. 
Needle insertion is not motorised but a motorised depthing 
mechanism is included. The lower splined shaft drives the back 
gearbox and turns the shaft which passes through the front 
gearbox and needle guide. A sprocket wheel on the end of this 
shaft engages an endless chain behind the needle slideway. This 
chain passes over tensioning wheels mounted on the slideway. One 
U01+ 
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Figure 5.10 - Connections between the drive shafts and the 
motorised carriage. Main carriage with faceplate removed. 
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of these drives a shaft extending through the slideway to the 
front, where it carries a second sprocket wheel which drives a 
further chain, positioned on the front of the slideway. A metal 
stop is carried by this second endless chain. A slider free to 
move up and down the needle slideway is locked to the upper end 
of the needle and cannot pass the stop on the chain, unless 
manually over-ridden by deflection of a spring latch. 
The biopsy needle, which must remain sterile, fits central holes 
drilled in each of two sterile brass holders, as shown in Figure 
5.12. These holders fit into two clamps- one fixed on the lover 
end of the needle slidevay and the other to the slide end. The 
upper holder can be locked to the needle. Moving the slider 
causes the needle to slide through the lower holder and out (and 
into the patient's chest). Several sizes of these close fitting 
needle holders will be required - one for each different gauge of 
biopsy needle. 
The needle stop is carried by an endless chain whose setting is 
uniquely determined by the angular position of the depthing 
sprocket wheel. Thus when the latter has turned through the 
computed angle corresponding to the required depth of needle 
insertion , the needle slidevay may be slid downwards through the 
guide as necessary without altering this depth. Thus the lower 
needle holder may be brought into contact with the patient's skin 
to give maximum support and guidance to the needle during 
subsequent insertion, without affecting the depth of penetration 
allowed by the stop setting. 
5.4.2.1. Additional Equipment Necessary. 
Basic electronic circuits are necessary in addition to the main 
biopsy machine equipment. The motors are driven by drive boards 
(one board per motor) which control the motor turning direction 
and speed. Speed is controlled by varying the rate of motor 
IbS 
Figure 5.12 - Needle holders 
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stepping. Each time the board receives a negative pulse the motor 
shaft turns through 1.8 0 . By varying the square wave period the 
stepping rate, and hence the motor speed, is changed. 
Transistor switches are used in all digital inputs and outputs 
from both the analogue and printer ports. LED's are also included 
on the motor clock inputs to indicate which line is operating and 
to assist in fault finding should any connections become faulty. 
5.5. Control Of the Biopsy Machine. 
A BBC Master personal computer is used to control and monitor the 
biopsy machine operation. The biopsy machine requires 
inputs/outputs for several different functions. The equipment and 
their requirements are detailed in Table 5.1. 
The BBC has several, easily accessible input and output ports 
available for digital and analogue(inputs only) signals as well 
as a 5V power supply, a 1.8V power supply and an earth line. 
These are shown in Table 5.2. 
However, the MIX mouse operates from the user port and these last 
channels are not available for use. 
It is hence obvious that the four analogue input channels on the 
'analogue in' port be used to register the readings from the 
three potentiometers and the linear transducer. The analogue 
input voltage range is 0-1.8V. The OV and 1.8V output pins can be 
used to supply the power to the transducers. 
The two digital inputs on 'analogue in' can be used to register 
when the two strip or bus-bell switches are operated i.e. when 
the different sections of the carriage are locked in place and 
hence which action is underway. 
1 -40 
Table 5.1. - Equipment Input/Output Requirements 
EQUIPMENT FUNCTION COMPUTER CONNECTIONS NO OFF 
Linear Transducer Indicates the position +5V 
of the telescopic OV 
section of the manual 1 Analogue Input 
carriage (and hence 
positions of the main 
section and entry point 
indicator). 
10-Turn Control and indicate +5V 
Potentiometers position of motorised 
(3) carriage, 	needle 1 Analogue Input 3 
angling and depthing 
devices. 
Drive Board Drives the motors and +5V 
controls the motor OV 
step rate and 
- 3 
direction of rotation. 2-Digital Outputs 
Each board requires an 
independent power 
supply of 15-30V. 
Bus-bell Switches Indicate when the +5V 
(2) manual carriage is OV 
locked in place and 1 Digital Input 2 
identify significance 
transducer signals. 
Table 5.2 - BBC Hardware Ports 
PORT INTERNAL POWER CONNECTIONS AVAILABLE 
SUPPLIES AVAILABLE 
Analogue In +5V 4 Analogue Inputs 
+1.8V 2 Digital Inputs 
OV 
6522 A side 8-bit -i-SV 8 Digital Inputs parallel printer Ov and/or Outputs port 
6522 B side 8-bit 	+5V 8 Digital Inputs user port 	 OV and/or Outputs 
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The motor drive boards require two digital computer inputs each - 
one to control the motor turning direction, the other to control 
the 'clock', i.e. the rate at which each motor step is made. A 
ground connection is also required. 
All digital inputs and outputs are via transistor switches. These 
switches prevent accidental overloading of the computer, which 
would result in component failure. The 'clock' outputs have, in 
addition, LEDs, which flicker as the clock signal changes. This 
assists in fault finding if faulty connections arise. 
A general overview of the arrangement of computer, biopsy machine 
equipment and associated electronic connections is shown in 
Figure 5.13. Figures 5.14 and 5.15 show more detailed diagrams of 
the connections. 
5.6. Machine Alignment. 
Machine alignment is a process of trial and error which involves 
minute adjustments to the positions of various equipment items. 
5.6.1. Efficient Mechanical Running. 
It is essential that the splined shafts and leadscrew are aligned 
with the main rail. The drive motors used have a low maximum 
torque, above which they slip. They have been selected on the 
principle that if anything should go wrong the motors will slip 
rather than continuing to drive the shafts and carriage, which 
could cause irreparable buckling to the machine. If the shafts 
are slightly mis-aligned the torque required to drive the 
carriage is sometimes excessive and the motor thus slips. The 
helical screw has one unattached free end and thus alignment is 
automatic. The splined shafts, however, are attached to 
potentiometers which are fixed to the endplate. Although they are 
2. 
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Figure 5.14 - Connections to the analogue input port 
I . Ll 
Figure 5.15 - Connections to the 6522 printer port, motors and 
motor drive boards. 
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connected at either end by universal joints this does not ensure 
automatic self alignment. It is critical, therefore, that careful 
shaft alignment is done each time that the link between the shaft 
and the drive motor is broken or any piece of equipment at the 
shaft drive end is moved, however slightly. 
5.6.2. Device Alignment. 
Any misalignment of the marker and needle devices can have 
drastic effects on the final needle positioning. The centres of 
the horizontal spheres define the x-axis for all calculations and 
needle positioning. It is essential, therefore, that these 
spheres lie on this axis when the carriage is at any position on 
the rail. Some independent external means of registering the 
sphere centres at various carriage positions is therefore 
necessary. 
A transparent Perspex mapping board has been constructed to 
assist in relating positions of different objects within the 
field of machine operation and is shown in Figure 5.16. The 
flexible board is stiffened by four metal strips which are fixed 
along each edge. A hole has been drilled in each corner of the 
board. Two 'claw' hooks latch over the main support bar from 
which the biopsy machine is suspended. Two wooden strips are 
fixed to the hooks. Metal spacers, fixed to the wooden strips 
contact the rail supports and have been designed to allow the 
wooden strips to hang approximately vertical. Four long bolts 
pass through holes drilled in the wooden strips and are locked to 
the wood. The bolts fit through the holes drilled in the corners 
of the Perspex board. Nuts fitted to the bolt on either side of 
the board enable it to be fixed in place on the bolts but at a 
large distance from the wooden strips. By adjustment of the nuts 
on each bolt the board can be positioned parallel to the needle 





Figure 5.16 - The mapping board. 
transparent Perspex board 
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It is essential that the marker sphere centres lie in a line 
parallel to the plane of needle movement. The two spheres have 
different adjustments available. The reference sphere on the main 
carriage (and connected to the needle insertion point indicator) 
has a vertical adjustment facility: The axial position of the 
vertical shaft assembly (to which the sphere and indicator are 
fixed) can be altered relative to the slide, as shown in Figure 
5.17. 
The sphere which is fixed to the telescopic section has a single 
adjustment which moves the sphere obliquely to the needle plane. 
The rod, to which the sphere is attached, lies at an angle to the 
carriage face, projecting downwards. A screw adjustment, at the 
back of the folding section, allows minor alteration of this 
angle and thus moves the sphere both vertically in the 
forwards/backwards direction, as shown in Figure 5.18. 
The mapping board is placed over the supports and hung in front 
of the machine. The needle carriage is moved along the rail and 
the needle projected out from the holder. A toolmaker's set 
square is used to find the perpendicular between the Perspex 
board and the needle tip and the relative perpendicular distance 
measured. Several measurements are made and compared. The board 
position is adjusted, using the locking nuts, until the board 
lies parallel to the needle movement plane (i.e. until the 
measured needle-board distance remains constant for different 
needle positions). 
The sphere, fixed to the telescopic section, is adjusted until 
the line of centres of the two spheres is parallel to the board 
(and thus the needle plane) as shown in Figure 5.19. The sphere, 
attached to the main carriage, is then raised/lowered until the 
line of the two spheres is parallel to the rail on which the 
carriages run, as shown in Figure 5.20. The manual carriage is 
slide operating knob 
moves indicator vertically 
IM 
insert 




Figure 5.17 - The manual carriage 
Figure 5.18 - Sphere on the telescopic section 
120 
Perspex board 
Figure 5.19 - Alignment of the spheres with the plane of the 
needle movement. 
- x axis 
incorrect alignment 
- - x axis 
correctly aligned 
Figure 5.20 Alignment of the spheres with the carriage rail. 
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thus aligned with the needle carriage. 
5.7. Machine Calibration 
Several parts of the biopsy machine require calibration. The 
quantities to be determined in such calibrations are of two 
kinds: 
a)Those measured once only for each machine, which thereafter 
remain fixed. Some are in the form of responses or gradients, 
representing the relationship between changes of transducer 
inputs and outputs. Examples include the responses of the 
linear transducer serving the manual carriage and of the 
three potentiometers on the motorised carriage. Others are 
constant offset lengths between equipment items which must be 
included in calibrations as illustrated in Figure 5.21. These 
calibrated values can be used within the software as 
constants. 
b)Those which require frequent re-calibration. These are the 
actual transducer readings at known positions, which enable 
the precise position of the various movable parts to be 
determined, sometimes relative to each other. Generally, if 
the machine has not been dismantled, some of these positions 
will not change and a one-off reading could be used, as in a) 
above. However, this particular machine is a prototype 
development model which is frequently dismantled and 
altered. It is also a piece of precision machinery which is 
easily upset by any slight manhandling. Since it is 
frequently transported between establishments it is liable to 
get out of alignment and so such readings often need to be 
made afresh. 
The transducer readings fluctuate slightly and so an averaging 
procedure has been used. When a transducer reading is required 
Figure 5.21 - Offset distances between various items of 
equipment. 
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the computer takes 100 consecutive readings and then calculates 
the average value. This has been shown to provide sufficiently 
accurate values. 
5.7.1. One-off calibrations 
Five response or gradient calibrations are necessary - one for 
the linear transducer, one for each of the three potentiometers, 
and one for the secondary effect of angling on the depthing 
mechanism. 
5.7.1.1. Linear Transducer: 
The manual carriage is moved along the rail and transducer 
readings paired with the measured distance of the main sphere 
from the faceplate on the left hand (unsupported) end of the 
rail. A linear regression analysis has been applied to the 
results and details are provided in Table 5.3. 
5.7.1.2. Leadscrev Potentiometer: 
The motorised carriage is positioned at several points on the 
rail and readings paired with the measured distance of the axis 
of needle rotation from the unsupported end faceplate. A linear 
relationship has been obtained, and is shown in Table 5.3. 
5.7.1.3. Depthing Potentiometer: 
The depth stop on the chain is moved along the needle slideway. 
Distance moved is recorded against output reading. A linear 
relationship has again been obtained. However, angulation of the 
needle guide about the wheel driving the depthing chain, when 
that is stationary, inevitably has the same effect as rotating 
this driving wheel through the same angle (in the other 
ql 
Table 5.3 Results of transducer and potentiometer calibrations. 
Source Measured Variable Rate of Change of Correlation y 
Transducer Output Coefficient intercept 
with Measured 
Variable 
Linear Distance of -66.989 transducer -0.99997 3476.9260 
Transducer reference sphere units per cm transducer 
from left hand units 
faceplate  
Pot'meter Distance of 66.9501 potentiometer 0.99999 -271.0200 
on helical reference sphere units per cm pot'meter 
screw (i.e. from left hand units 
travelling faceplate 
pot' meter)  
Pot'meter Angle of Rotation 9.189 potentiometer 0.99999 2007.835 
on angling units per degree pot'meter 
device units 
Pot'meter Depth of needle 94.8199 potentiometer 1.0000 580.8339 
on depthing insertion units per cm pot'meter 
device units 
Depth stop Depth of needle -462.583 potentiometer 0.9994 10562.6 




direction) with the needle guide fixed; it alters the position of 
the needle depth stop. The alteration of set needle depth with 
guide inclination has to be measured so that it can be allowed 
for in the computations determining the positioning of the depth 
stop for a desired depth of needle penetration at known 
inclination, as below. 
5.7.1.4. Angling Potentiometer: 
To rotate the needle guide from one extreme angular position to 
the other requires 3.5 complete rotations of the splined driving 
shaft and its potentiometer. Potentiometer readings have been 
taken for every 10 0 of needle guide rotation. The position of the 
depth stop on the needle slidevay has also been noted for each 
angle change and a substantial depth stop movement of around 7 cm 
noted over the entire 3.5 rotations. This must therefore be 
accounted for within the software. 
5.7.2. Repeated Calibrations 
These involve setting the various parts of the equipment in 
preselected and known positions thus indicating to the computer 
that the action is complete. The transducer reading is then taken 
to correspond to a known position coordinate. 
5.7.2.1. Linear Transducer: 
The manual carriage is positioned hard up against the left hand 
unsupported end. The distance of the sphere from the end 
faceplate is known and may thus be correlated with the transducer 
indication. 
5.7.2.2. Angling Potentiometer: 
The motorised carriage is driven into the middle portion of the 
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rail, thus providing adequate clearance for needle slidevay 
rotation. The angling motor is driven until the transducer 
reaches the setpoint at which the needle slideway should be 
positioned perpendicular to the horizontal marker. Provided that 
the carriage has not been mishandled adjustments should not be 
necessary. If, however, adjustment is required, the guide and 
slideway assembly may be slid round on its supporting shaft 
against the friction of a clamping device by applying a slight 
overpressure. 
5.7.2.3. Depthing Potentiometer: 
Two possible methods have been evaluated: 
a) Set the depth stop in a pre-indicated position and note 
the transducer reading. The needle does not need to be in 
place at this stage but this does require that the needle 
length is input into the computer at some stage prior to 
setting the depth stop for needling. 
b)The needle (of any length) is inserted into the holders. 
The motor driven depth stop, as it is carried by the chain 
along the needle slideway, encounters a spring latch on the 
needle slider. The hinge is restricted from operating in one 
direction. If moving downwards, the stop deflects the latch 
hinge and passes freely down the slideway without moving the 
slider and needle. On moving upwards, however, it cannot open 
it. The slider and the needle, whose upper end is clamped to 
it, is therefore retracted through the lower holder by the 
motion of the driven chain. If the motion of the chain and 
stop is arrested when the tip of the needle lies flush with 
the base of the lower brass support then the depth indicator 
transducer reading corresponds to the tip of the needle lying 
at this known point. When the insertion depth is calculated 
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and input to the computer the depthing motor stop moves down 
appropriately and the slider can also be moved down by the 
same depth. The tip of the needle will therefore protrude 
from the end of the needle holder by the correct amount, i.e. 
it should lie in the lesion. The actual needle length is, 
therefore, irrelevant in this mode of calibration. 
The latter method was chosen for this work. 
5.7.2.4. Leadscrew Potentiometer: 
The motor driven carriage is moved along to the right hand end of 
the rail. The distance between the needle guide and the left hand 
end faceplate is known. Since the same reference point is used, 
the motor driven carriage position is known relative to the 
manual carriage main sphere position. The two carriages, although 
working with different transducers, therefore use the same 
coordinate axes. 
The above outlined calibration procedure is therefore performed 
at the start of every run. 
5.8. Carriage Positioning. 
Operating the entire unit from a real-time feedback control 
system from the transducers would be slow and would require 
elaborate corrections to avoid positional offsets and carriage 
overshoots. The stepper motors have been used, in addition to the 
transducers, to do the necessary equipment positioning. The 
motors have been calibrated, in much the same way as the 
transducers, and the number of steps necessary for each 
dimensional unit of change is known. The required number of motor 
steps is calculated, the motor stepped for this quantity and the 
transducers used to check the positions (since motor slip can 
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occur if a high frictional resistance exists or if the motor is 
run too fast). If any slight alterations are necessary, again the 
required number of steps is calculated and the process repeated 
until the transducer readings are correct. 
5.8.1. Backlash 
The biopsy machine is required to locate the needle tip to within 
a millimetre or so of a designated point by means of angular and 
linear movements applied at relatively large distances from that 
point. Thus any backlash effects in these controlling movements 
must be minimised. Backlash arises in several places: 
Gearbox backlash affects carriage positioning, needle angling 
and needle depthing. The gearboxes purchased have low 
associated backlash. They are fitted, by the manufacturer, 
with anti-backlash spring-loaded split gears on the output 
shaft. 
The effects of backlash would be most harmful in the angling 
of the needle guide. Accordingly a large preloaded torque is 
applied about the hollow shaft carrying the guide by a spring 
located between the guide and the carriage front plate. This 
spring is strong enough to maintain a resultant torque of 
constant direction, despite variations in the direction and 
magnitude of the gravitational torque acting on the needle 
guiding and depthing assembly at different inclinations. 
Sprocket wheel and chain backlash will affect angling and 
depthing. This is minimised by correct adjustment of the 
chain tensioning wheels. 
The leadserew drive for the motorised carriage will have 
backlash positioning errors; but these are negligible for the 
proprietary ball-screw arrangement used. 
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Backlash effects are reduced by always using the same backlash 
extremes when positioning: Depthing is always done in the 
downwards direction; angling is done to the anti-clockwise 
extreme; and the motorised carriage (whose leadscrew backlash 
effects are limited by using an anti-backlash nut) is always 
positioned from the right hand end. 
Rocking and twisting 'lost motion' errors in the positioning of 
the motorised carriage are essentially eliminated for the loads 
encountered here by the semi-kinematic design of the proprietary 
ball-slide and track arrangement used. 
5.8.2. Biopsy Machine Positioning Accuracy 
Direct measurements have been made of mechanical errors in the 
final needle positioning. 
5.8.2.1. Procedure: 
The machine calibration procedure is run through and the main 
marker sphere positioned and locked to the rail. The sphere 
position is thus registered and the origin for the coordinate 
system fixed (and known). The sphere position is marked on the 
mapping board using the square. The manual carriage is unlocked 
and moved to the end of the rail to allow the needle carriage 
unrestricted movement. The computer is given a lesion position 
and an insertion point and the needle tip is positioned 
accordingly by the stepper motors. The final tip position is then 
read on the mapping board. 
Several different sets of trials have been done in an attempt to 
determine the effects of different variables on final positioning 
accuracy, as follows: 
Table 5.4 and Table 5.5 - Final Needle Position at Different Lesion 
Depths but Maintaining Insertion Angle Constant. 









(10,15) (25,0) (10,15) 21.1 
(10,13) (23,0) (10,13.1) 18.4 
(10,10) (20,0) (10,10.1) 14.1 
(15,15) (30,0) (15,15.05) 21.2 
(20,7) (24,3) (20,7.0) 5.7 
(30,7) (34,3) (30,7.0) 5.7 









(0,4) (0,3) (0.1,4.0) 1 
(0,6) (0,3) (0.1,6.0) 3 
(0,8) (0,3) (0 1 8.0) 5 
(0,10) (0,3) (0,10.0) 7 
(0,12) (0,3) (0,12.0) 9 
(0,14) (0,3) (0.1,14.0) 11 
(0,16) (0,3) (-0.1,16.0) 13 
(0,18) (0,3) (0.18.0) 15 
(0,20) (0,3) (-0.1,20.0) 17 
'4. 









(0,8) (10,0) (-0.2,8.1) 39 
(0,8) (9 1 0) (-0.2,8.0) 41 
(0 1 8) (8,0) (-0.1,8.1) 45 
(0 1 8) (7,0) (0.0,8.0) 49 
(0 1 8) (6,0) (-0.1,8.0) 53 
(0,8) (5,0) (-0.1,8.0) 58 
(0,8) (4,0) (0,8.1) 63 
(0,8) (3,0) (0.8.0) 69 
(0,8) (2,0) (0,8.1) 75 
(0,8) (1 1 0) (0,8.0) 83 
(0 1 8) (0 1 0) (0,8.0) 90 
(0 1 8) (-1 1 0) (0.05,7.99) 97 
(0 1 8) (-2,0) (0,7.9) 105. 
(0 1 8) (-3,0) (-0.05,7.9) 111 
(0,8) (-4,0) (-0.2,7.9) 117 
(0,8) (-5,0) (-0.15,7.95) 122 
(0,8) (-6,0) (-0.2,7.95 127 
(0,8) (-7,0) (-0.4,8.0) 131 
(0,8) (-8,0) (-0.3, 	7.95) 135 
(0 1 8) (-9 1 0) (0.3,7.95) 139 
(0,8) (-10,0) (-0.1,7.9) 141 
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5.8.2.2. Effects of depth of needle insertion (lesion depth) 
The insertion angle is maintained constant and the lesion depth 
varied. Tables 5.4 and 5.5 illustrate the resultant needle tip 
position when two different insertion angles, 135 0 and 90 0 , are 
used. They indicate that needle positioning error does not appear 
to alter greatly with depth of insertion provided that the 
machine is correctly calibrated initially. 
5.8.2.3. Effects of insertion point (angle of needle insertion) 
The lesion position is maintained constant as the insertion point 
is moved along a line parallel to the marker. The coordinates of 
the needle tip after it has been pushed home are shown for each 
insertion point in Table 5.6, from which it is apparent that 
largest errors occur at sharper insertion angles. The best 
results are obtained when the needle is inserted perpendicular to 
the marker. 
5.9. Conclusions 
A biopsy machine has been developed, compatible with the current 
biopsy procedure and techniques. Throughout the design the aim 
has been to retain some of the subtle features of the existing 
practice by allowing manual interaction, as in the manual needle 
insertion which retains tactile sensitivity, enabling the 
operator to feel when the lesion has been penetrated. 
Extensive machine testing has revealed that the mechanical needle 
positioning errors are small when compared with those arising 
from the image inputting and lesion position determination 
techniques. Errors of < 2mm in final placement of the needle tip 
relative to the lesion are normally achieved if the machine has 
been carefully calibrated beforehand. This is well within the 
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RESULTS AND CONCLUSIONS FROM TESTING OF THE BIOPSY MACHINE 
6.1 Introduction 
The biopsy machine and image analysis technique were both tested 
independently, as previously described, with the computer. It 
remained to connect all three sections together to test out the 
needle positioning accuracy of the networked equipment. 
6.2. Preliminary Testing 
Figure 6.1 indicates the network arrangement. Prior to testing 
with X-rays it seemed prudent to again verify and demonstrate to 
our medical colleagues the complete machine performance using an 
optical analogue , which more closely resembles the X-ray system. 
The optical simulator, described in section 4.6 was adapted so 
that it moves in a vertical plane and can be angled and 
positioned around the biopsy machine. The revised optical 
simulator is shown in Figure 6.2. Needle positionings have been 
done using a wide range of views. Reproducibility and error 
results in the final position are similar to those obtained 
previously, shown in Figures 4.8 and 4.9. It is obvious, from 
previous tests, that these errors are mainly the result of errors 
incurred during the image analysis procedure. 
6.3. The C-arm X-ray Machine 
The C-arm geometry has been described previously in Chapter 3. 
The C-arm X-ray machine (Kalliscope D, supplied by CGR Medical 
Ltd) can be used to obtain either radiographic or fluoroscopic 
images. For this purpose the fluoroscope will be used for image 
analysis. 
The X-rays hit an electron emitting screen below the detector 
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Figure 6.2 - The revised optical simulator for use with the 
biopsy machine prototype. 
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surface, as shown in Figure 6.3. The emitted electrons are then 
accelerated by a large voltage. Electrode rings, lying below the 
electron emitting screen focus the electrons before they hit a 
fluorescent screen and visible light is emitted. The light is 
focussed by lenses, reflected through 900 and the image is 
televised by a vidicon TV camera and digitised. 
The C-arm displays its image information on two T.V. monitors. 
One is used while the C-arm is 'screening' and displays the 
moving, real-time image. The other displays a memorised image. A 
memory board is updated from the screened image many times a 
second. When the screening process is ceased the last memorised 
image is stored and is displayed on the second T.V. monitor. 
6.4. Connection of the X-ray machine to the Biopsy Machine and 
Computer 
The digitised signals from the memory board have been intercepted 
prior to the T.V. monitor and have been redirected to the genlock 
system. The superimposed video and computer output signals from 
the genlock have been input to the X-ray machine T.V. monitor. 
The C-arm memory board image and the output monitor thus replace 
the TV camera and TV monitor respectively in Figure 4.1, as shown 
in Figure 6.1. Image analysis on the X-ray image can hence be 
done. 
6.5. X-ray assisted Biopsy Trial 
A series of preliminary trials has been done using a metal wire 
ring of approximately 2cm diameter, fixed inside a polystyrene 
box with removable side, to represent the lesion and patient 
respectively. The dummy patient rests on the patient trolley and 
the equipment is arranged around it, as shown in Figure 6.4. 
The biopsy machine, C-arm and trolley bases are clamped together 
2.03 
Figure 6.4 -General arrangement of the patient, biopsy machine, 
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Figure 6.5 - The reference grid 
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to prevent any uncontrolled relative movement during the biopsy 
procedure. 
6.5.1. The procedure 
The 'cantilever bridge', or overhanging arm, of the biopsy 
machine containing the marker and needle carriages, is swung 
round so as to lie parallel with the patient trolley. The bridge 
is raised until the lowest points of the marker spheres (the 
lowest points on the cantilever assembly) are at a greater height 
than the highest point of the 'patient' positioned on the 
trolley. The biopsy machine calibration procedure is run through 
and the cantilever arm is then swung across the patient and 
lowered so that the marker spheres are close to, or just 
touching the patient. The C-arm is positioned with the detector 
below the trolley and the source above the marker spheres, which 
project sufficiently from the main carriage support to allow the 
X-ray machine an unobstructed view of them. Preliminary screening 
is done to locate the lesion. The floating table top of the 
trolley bearing the patient is now moved longitudinally until the 
lesion lies in the same plane as the marker spheres. The main 
marker sphere is positioned with the aid of the TV monitor to 
ensure that the sphere and lesion are both visible on the screen. 
If necessary the marker is adjusted and screening recommenced. 
When in the correct position the first marker sphere is locked in 
place to the rail and the second sphere positioned, again by 
trial and error with the aid of the TV monitor. When it is 
finally in position and clamped in place screening is again done 
and the resulting image used for image analysis. The information 
is input to the computer using the mouse. The first view is then 
complete. 
The C-arm is swung through a suitably large angle (see Chapter 4) 
and the second view begun. The lesion and the first marker sphere 
must not be moved - only the second marker sphere position may be 
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adjusted between views. The second view must therefore contain 
the lesion and first marker sphere. If these cannot be observed 
together on the screen then the viewing angle must be altered. 
The second marker sphere is then positioned to appear in view. If 
the second sphere cannot be brought into view then the viewing 
angle must be altered accordingly. The second image is thus 
obtained and image analysis done. The lesion position is then 
computed automatically. 
Finally the telescopic section of the manual carriage is 
retracted, the marker spheres are folded away and the point of 
needle entry indicator is swung into position. The chosen point 
of needle insertion on the surface of the patient is then 
registered by the horizontal movement of the manual carriage and 
vertical movement of the indicator ring to coincide with that 
point. 
The needle angling and depthing mechanism is then positioned 
automatically so that the needle will pass through the chosen 
entry point and reach the lesion. 
6.5.2. Results of Preliminary Trials. 
Repeated tests using the C-arm machine revealed large variable 
errors in needle placement which are inconsistent with previous 
results using the optical analogue. The problem lies in the 
calculated lesion position, not in the biopsy machine needle 
positioning. It therefore appears that the X-ray machine either 
introduces a further error or increases an error which has 
previously been small and insignificant. 
6.6. Investigation to Find the Error Source 
The likely error source appeared to be image distortion in the 
imaging system of the C-arm machine. To check this a reference 
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grid, shown in Figure 6.5 was constructed from Perspex sheet, 
coated in red lead paint. The paint layer was scored down to the 
original Perspex sheet to form a grid of squares of 1cm side. 
This grid was placed over the X-ray detector. The X-ray machine 
was run with the grid in place but minus the genlock and computer 
connections. It was immediately obvious from the image that 
massive image distortion occurred. The service engineer 
subsequently improved the image quality but a large amount of 
distortion still remained. The straight lines appeared as curves, 
especially around the outer edge of the circular image, as 
illustrated in Figure 6.6. 
Possible sources of this error have been investigated, as 
follows: 
Since the X-ray machine was tested using the grid without 
any connections to the video mixer or computer it is clear 
that the distortions arise from errors within the X-ray 
machine set-up. 
The C-arm monitor was linked directly to the computer 
'video out' and a computer generated grid drawn onto the 
screen. The grid appears undistorted in the centre and 
barrel-shaped at the extreme outer edge, as shown in Figure 
6.7. This arises as a result of the monitor screen being 
slightly bevelled at the edges which causes a square grid to 
appear barrel shaped. This is normal and not significant for 
most of the field. The monitor is thus eliminated as the 
major source of distortion. 
The memory board was tested by connecting the monitor to 
the X-ray detector as normal and placing the grid on the 
detector surface. One line of the grid was differentiated by 
a notch, as shown in Figure 6.5. A transparency was placed 
Figure 6.6 - X-ray machine image distortion 







over the screening monitor surface and screening begun. 
While maintaining pressure on the foot switch (and thus keep 
the image on the first TV monitor) the differentiated line 
was traced onto the transparency. When the pressure is 
removed from the foot switch the memorised image was 
displayed on the 2nd monitor. The transparency was then 
removed from the screening monitor and replaced over the 
memorised image, ensuring that the notches matched. The 
memorised image was slightly magnified by about 11mm 
vertically and 4mm horizontally at the diagonals. However 
the transparency appeared similar to the memorised image, 
suggesting that the memory board does not cause the 
distortion effects. 
d) Terrestrial magnetic or electrostatic field effects were 
investigated by angling the X-ray arm. The grid was fixed to 
the detector and the C-arm machine angled at 0, 45, and 90 
degrees in the plane of the C-shaped arm as well as being 
tilted out of the plane by 90 degrees, as illustrated in 
Figure 6.8. Grid points on the resulting images were picked 
off using the mouse pointer and the nodal information stored 
on disc. Results revealed no apparent angling effects, 
although when a steel ruler was placed directly over the 
detector the image distorted badly. However the ruler has to 
lie right up against the detector before any effect is 
apparent. The patient trolley, partly fabricated in steel, 
might have had a larger effect than the steel ruler, so this 
was examined while the magnetic table locks were in 
operation. Little or no effect was apparent. 
It is hence apparent that the distortion arises between the 
curved detector and the camera, perhaps in the detector itself or 
in the image intensifier. We were advised that in neither case 
could we hope to remedy the defect directly with the resources 
9Q0 view 450 view 
view 
-arm tilted out 
the plane 
Figure 6.8 - Different C-arm angling positions used to determine 
terrestrial effects on the image 
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available to us. 
6.7. Distortion Calibration 
The Perspex grid was used to examine the precise nature and 
extent of the pincushioning distortion in an attempt to calibrate 
the output T.V. image. 
The positions of the grid nodes on the T.V. monitor were input 
using the mouse and stored on disc. The procedure was repeated on 
successive X-rays taken over three hour periods at constant 
machine settings and the following noted: 
The image stretches with time. The dimensions of the image 
circle on the T.V. monitor remain constant but the viewed 
area becomes gradually smaller as the gap between the grid 
lines increases. After around 1.5-2 hours the image size 
stabilises. It is interesting to note that throughout the 
warm-up period the horizontal part of the image does not 
alter significantly. However consecutive images are still not 
reproducible since the shapes of the distorted lines between 
views varies. 
After the X-ray machine has been operated (or even just 
left on) for around two hours the digitised image has a 
tendency to spontaneously disappear after a short time, 
usually before all the information has been input to the 
computer. 
The horizontal and vertical lines both vary in shape 
depending upon the position on the screen. Midway vertically 
down the image to the far left and far right the x 
coordinates have been stretched, turning the grid squares 
into rectangles. Midway across the image to the top and 
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bottom the y coordinates have been stretched , again giving 
rectangles but in a different elongation direction. On the 
outer edge of the image between the four areas mentioned 
above the squares become distorted in both directions, 
turning into parallelograms. 
The y-coordinate stretches at a much faster rate than the 
x-coordinate. Over the entire three hour period the central 
x-line did not vary much although the x-lines at the top and 
bottom of the circular image stretch greatly. 
The memorised image often displays horizontal interference 
smear lines. These lines obscure and further distort the 
image. They arise within the memory board when the screening 
process stops. The board updates its image from the screening 
monitor and saves the last image viewed. If, however, the new 
image is in the process of being saved when the screening is 
stopped then a combined image results and interference lines 
occur at the point at which the old and new image join. These 
interference lines may be small, severe or occasionally 
non-existent. The memory board in the C-arm machine at the 
time of our experiment was not that recommended by the 
manufacturers (the original broke down), but is an inferior 
board. This interference should not occur with the correct 
board in place. 
The images are, unfortunately, not reproducible with time, 
especially in their y (vertical) dimensions 	and 	this 
immediately invalidates any attempt at complete image 
distortion calibration. However the image dimensions in the 
horizontal direction and close to the horizontal mid-line of 
the field do not appear to vary greatly and it appeared 
possible to calibrate and use this central horizontal 
section. 
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6.7.1. Attempts at Calibration using the Horizontal section. 
Calibrations were done using the information obtained from the 
Perspex grid to relate the differences between TV image 
coordinates (x,y) to set distances on the image detector. However 
trials done using the polystyrene box 'patient' revealed that 
errors in needle placement are still unacceptably large. 
6.8. Results of Patient Trials 
Although it was apparent from the dummy patient trials that the 
C-arm X-ray machine has almost insolu-ble inherent problems, it 
was desired to assess the performance of the remaining equipment 
when used in a clinical situation. With the cooperation of 
medical staff of the Respiratory Diseases Unit of Edinburgh City 
Hospital, and with the full agreement of the patient, a lung 
cancer sufferer was positioned on the trolley with the biopsy 
equipment set up around him. 
A short series of patient trials (not including the final 
needling stage) was then done using the C-arm equipment. The 
results are detailed below. 
6.8.1. Ease of Positioning 
The trolley top, patient and relevant parts of the biopsy machine 
must lie between the source and detector on either end of the 
C-shaped arm. 
The source-detector separation distance is 93cm and hence the 
actual space available is very confined. The C-arm machine is far 
from rigid, even when locked to the trolley base, the structural 
members being fabricated of sheet metal and required to bear at 
their extremities the large overhung weights of the X-ray source 
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and detector. In positioning the unwieldy C-shaped arm it is 
difficult to avoid fouling either the underside of the trolley 
top with the detector or the biopsy machine with the X-ray 
source. The levers for C-arm adjustment are behind the main 
support framework and it is difficult to manoeuvre the arm and 
observe its progress at the same time. Collisions are thus 
inevitable. Setting or changing the angle of view invariably 
involves complicated sequences of angling, height adjustment and 
lateral movement of the arm because of the restricted clearance 
between this and the patient and trolley top. 
The patient trolley construction (also supplied by CCR Medical 
Ltd) has a couch top 2m long by 600mm wide which presents 
inherent problems. Although the trolley table top is x-ray 
translucent it has heavy deep steel beams running its full length 
along each side. These supports, which double as electromagnetic 
locks for the floating table-top, unfortunately obstruct the 
C-arm angling. The biopsy machine supports, although designed to 
lie out of the X-ray plane, interfere with the bulky housing of 
the X-ray source. Thus the equipment is difficult to position and 
manipulation of the C-arm machine is a real struggle. 
6.8.2. Available Angles of View 
The bulky X-ray source and detector housings and particularly the 
excessive width of the patient trolley top and the depth and 
X-ray opacity of its longitudinal supporting beams restrict the 
C-arm movement and reduce the achievable viewing angle range. 
Thus only a small range of views is available, the exact values 
being dependent upon lesion depth relative to the marker spheres. 
6.8.3. Ergonomics 
The biopsy machine calibration is done before the machine is 
positioned over the patient, as shown in Figure 6.9 and is 
2. 1 4 
Figure 6.9 - Position of the biopsy machine while the machine 
calibration is done. 
patient 
cantilever support bridge 
trolley table top 
biopsy machine stand 
biopsy machine turned / 
to lie laterally in line 
with the patient for 
calibration purposes 
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relatively simple. The cantilever is positioned over the patient. 
The actual alignment of the lesion and the marker spheres is done 
by screening and moving the floating table top until the lesion 
and spheres lie in line on the image. Arranging the views is more 
difficult. In principle the angle of view is chosen, the first 
sphere positioned and locked in place and then the second sphere. 
This however is difficult to do, since the sphere position must 
be altered manually and screening cannot be done while the 
surgeon's hands are within the X-ray field. Therefore a process 
of trial and error is necessary. On several occasions it became 
apparent, after the first sphere had been positioned and locked 
in place, that the second sphere would not fit into the image. 
Once locked in place the first sphere must not be moved until the 
entire screening process is complete (otherwise the entire 
process from machine calibration onwards must be repeated). The 
viewing angle must therefore be adjusted until the two spheres 
and the lesion can be observed in the view. 
Having obtained one view it remains to locate a second view (at a 
suitably large separation angle away from the first view) in 
which the locked first sphere, the lesion and the second sphere 
can fit. Again a process of trial and error results. 
C-arm manoeuvring constitutes the major problem. 
The actual inputting of image data is relatively straightforward 
and does not impose problems. 
Generally, the new biopsy procedure is not ergonomically sound. 
Even allowing for the fact that the procedure is new and strange 
to the medical team participating in these trials, many of the 
difficulties that appeared correspond to identifiable intrinsic 
faults. 
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6.8.4. Time Required for the Procedure 
It follows from the above mentioned problems that the process is 
extremely time consuming and tedious to carry out. Most time is 
spent manoeuvring the C-arm to obtain a suitable viewing angle 
which shows all the necessary information. The existing biopsy 
procedure takes approximately 10 minutes from X-raying to final 
lesion sampling. The new procedure takes close to 30 minutes to 
perform. This is highly unsatisfactory: The patient, distressed 
anyway by his condition, will be further distressed by all the 
activities happening around him. 
6.8.5. Image Clarity 
When using the polystyrene dummy patient the spherical markers 
are very clear, obvious and also semi-translucent, allowing 
objects overlapped by them to be clearly observed. In the patient 
trials, however, the lesion proved difficult to see, even when 
large. The marker spheres are visible but sometimes difficult to 
pick out since they are obscured by the more dense patient. 
6.8.6. Equipment Reliability 
During the needle guide positioning the splined shaft drives of 
the angling and depthing mechanism frequently jammed. In test 
procedures in the lab the previous day the machine operated 
smoothly. The long shafts are precision made and carefully 
aligned. Transportation between establishments evidently 
misaligned the equipment. 
6.9. Conclusions 
Using the optical analogue the needle can be positioned to within 
2 - 5mm of the centre of the lesion when selected viewing angles 
are used. The C-arm equipment is, however, clumsy to manoeuvre in 
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the obstructed environment of trolley, patient and biopsy 
machine. The viewing angle range is also drastically restricted 
by this environment and thus final needle positioning accuracy 
will be affected. In addition, because of poor imaging contrast 
and quality, it is often difficult to pick out the lesion even 
when it is large. 
Quantitative readings cannot be taken from the equipment. Like 
most medical imaging systems, the C-arm X-ray machine is designed 
for qualitative not quantitative analysis and distortion of the 
image is hence large, irregular and not reproducible. It 
therefore appears that the lung biopsy machine developed here 
cannot be used in locating and sampling lung lesions with real 
time X-ray machines having the imaging characteristics of the 
C-arm machine used by us due purely to distortion. 
The patient marker sphere system is large, clumsy, and difficult 
to position within a view, especially when the lesion lies deep 
within the patient's chest. Due to the patient density it is 
sometimes difficult to see the spheres on the image. 
The actual positioning of the needle itself is accurate. Needle 
positioning on an actual patient has not been done but trials on 
polystyrene blocks have proved promising. However, this is in one 
respect, perhaps, an unrealistic test; the density and 
consistency of the tissue within the patient varies along the 
path of needle penetration and the needle, if large gauge, may 
consequently bend. No tests of needle guidance have been made in 
media of the consistency or variability of human tissue. 
Tactility has been retained. The surgeon inserts the needle by 
hand by moving it along a slideway. The needle action still 
retains much of the sensitivity by which, in existing procedures, 
the surgeon may sometimes recognise a notable change in lung 
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consistency, often indicating that the lesion has been punctured. 
If the biopsy machine is to be used in a commercial application 
then an alternative source of image information must be found, 
superior in that respect to the C-arm machine used by us. At the 
time of purchase (mid 1980's), we were advised that the machine 
was in every way representative of available machines of that 






Several factors currently limit the use of the developed biopsy 
machine: 
The machine has been developed to operate in two dimensions 
only. This restricts the areas within the body which can be 
sampled by the biopsy needle. 
Clinical trials have shown that the C-arm rotating X-ray 
machine, and probably any similar fluoroscopy machine is 
totally unsuitable for the required application due to large 
inherent image distortion. 
Alternative imaging techniques are available but some cannot 
be used for imaging the lung. However the biopsy machine, 
although developed for sampling lung lesions, is not restricted 
to either respiratory medicine or to lesion sampling for 
diagnostic purposes. 
7.2. A 3-dimensional machine 
A lesion in the apex of the lung, for example, cannot be 
approached directly from either the anterior or posterior. The 
ribs are close together high in the chest and there is 
insufficient intercostal space for the needle to pass through. 
The scapula blocks any approach from the posterior. The apex can 
be approached by inserting the biopsy needle through the skin at 
a point low down in the chest wall and sharply inclining the 
needle in the cranial direction. This area of the lung cannot be 
approached using the 2-dimensional equipment. 
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7.2.1. Alterations Required 
To be able to sample lesions lying outwith the existing needle 
sampling plane would require the following: 
a further axis for image measurement. The existing image 
is already very cluttered when using the 2-dimensional 
marker: A less bulky 3-dimensional marker should be 
developed. 
Needle movement in the lateral direction 
Needle angling in the lateral plane. It is important 
that, during development of a 3-dimensional machine, a major 
aim should be to minimise the bulkiness of both the 
supporting equipment and the biopsy machine. 
7.3. Alternative Sources of Image Information 
Several alternative imaging systems are currently used in 
hospitals. These include X-ray plates or films, computerised 
axial tomography (CAT) and ultrasound. 
7.3.1. X-ray plates or films 
X-ray film displays essentially full scale, undistorted images. 
If the images are taken from different angles with the lesion and 
markers in view then all the necessary information will be 
contained on the films. At present the surgeon measures lengths 
directly, using a ruler, from two films obtained from 
perpendicular angles and then interprets the information to 
determine where the lesion lies relative to the marker positioned 
on the patient's chest . He then inserts a biopsy needle through 
the chest wall and into the lesion, estimating, rather than 
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calculating and measuring, the appropriate angles. 
If the X-ray films are televised and the manual image analysis 
technique used to read off the relevant dimensional information 
then the biopsy machine can be used to position the needle more 
accurately. However the X-ray equipment is large and immobile 
which requires that the patient moves, rather than the equipment. 
As such the patient marker must be fixed to the patient rather 
than the biopsy machine. Some means of relating the marker 
position relative to the biopsy machine will be required. 
7.3.2. Computerised Axial Tomography (CAT scanning) 
CAT scanning involves the recording of 'slices' of the patient 
with an x-ray scanner. The records are then integrated by the CAT 
computer to give a cross sectional image. The CAT scanner 
equipment is immensely expensive in comparison with the C-arm and 
it is unlikely that such equipment will be available in every 
general hospital. This technique is more accurate and revealing 
than the C-arm machine and is marketed for its image measurement. 
Internal software enables the coordinates of any indicated point 
to be calculated relative to the frame of reference within the 
equipment. 
The developed patient marker will thus not be required: Only the 
coordinates of the needle insertion point require to be input to 
the computer relative to the same frame of reference as the 
lesion. In addition the insertion point must be known relative the 
biopsy machine. Thereafter the angle and depth of the needle 
insertion are determined and needling is done as normal through 
the indicated insertion point. 
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7.3.3. Ultrasound 
Ultrasound, unlike X-rays does not produce harmful radiation and 
for that reason it is the generally preferred imaging technique. 
Ultrasound does not pass through air and cannot be used for 
viewing the lung. At other organs within the body, however, 
ultrasound can generate images with better detail than X-rays. It 
is a cheap and widely available technique. Like the CAT scanner, 
internal software enables accurate dimensional information to be 
obtained between two points indicated on the image. This 
eliminates the requirement of a patient marker to determine 
viewing angles, etc: Instead a frame of reference is required 
The needle insertion point requires to be input and hence 
requires an indicator to be positioned on the patient's chest 
which can also be viewed on the image. The needle can then be 
angled automatically and pushed home by the surgeon. 
7.4. Alternative uses of the Biopsy Machine 
Although the apparatus has been designed for lung lesion sampling 
for diagnostic purposes it may also be used for therapeutic 
purposes. Such possibilities include: 
insertion 	of 	radioactive 	isotopes 	or 	powerful 
chemotherapeutic agents local to a lesion so that small 
localised doses of radiation or tumour-destroying drug may 
be given to a patient resulting in reduced side effects. 
insertion of optic fibres into tumours which can then be 
destroyed by low powr U.V. laser irradiation. 
Both these require that the cancer is early and metastasis has 
not yet occurred. Many problems are common with those noted for 
the lung lesion case, such as respiratory motion. 
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7.5. Conclusions 
Although it is evident that the developed 2-dimensional biopsy 
machine cannot be used with equipment of the C-arm type the 
equipment can be used with other imaging systems provided that 
the images are not randomly distorted. Alterations to the 
software and equipment are required for use with the alternative 
imaging equipment but these are mainly minor and not 
insurmountable. The developed biopsy machine can thus, with 
modifications, be used in a wider capacity than was originally 
intended for both diagnostic and therapeutic purposes in all 
parts of the body for which regular images can be obtained and 
which can be accessed by a biopsy needle. 
225 
NOMENCLATURE 
A,B - known constants in the estimated differential equations for 
redundant measurements 
C1,C2,C3 - known constants in equations for estimated precision, 
1J 
d - no of estimates of lesion position which may be calculated 
from n views 
F - magnification factor to convert magnified TV image to 
corresponding true dimensions 
g. - constraint equation in redundant measurements 
k - unknowns in redundant measurements, ie x and y 
L. - lesion position on TV image 
A 
L. - estimate of Li in theoretical redundant measurement model 1 
n- no of X-ray views taken 
P - end of marker, indicated by sphere, to which all screen 
measurements are referred 
p - no of dependent variables in the lesion equation gi=O 
PL. - point at which the X-rays from the source to the lesion 
cuts the marker P0 
PT, PB. - diametrically Opposite sides of sphere P on TV image 
A 
PT., PB. - estimates of PTi and PBi in theoretical redundant 
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measurement model 
PQ - the marker length, which is measured between the centres of 
spheres P and Q 
0 - end of marker P0, indicated by sphere 0 
QT., QB. - diametrically opposite sides of sphere Q on TV image 
A A 
QT., QB. - estimates of OTi and QBi in theoretical redundant 
measurement model 
R - end of perpendicular marker PR, indicated by sphere R 
x - distance from P, in the 0 direction, along marker PQ 
(normally the lesion x-coordinate) 
X.. - independent variables in redundant measurements (ie PTi, 
PBi, ... etc) 
A 
X. 	- estimates of independent variables in redundant 
A 
measurements (ie PTi, PBi.....ete) 
(X,Y)av - averaged estimate of lesion position obtained from 
redundant measurements 
xoff - the horizontal offset distance between sphere P and the 
needle insertion point indicator when the latter is in 
its locked position 
xin - horizontal distance of the needle insertion point from the 
original position of sphere P when positioned on the 
insertion point on the patients skin 
Y - depth below marker P0 (normally the lesion y coordinate) 
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Y1 - dependent variable in redundant measurements (taken to be 
i , 
A 
Y1 - estimate of the dependent variable in redundant measurements 
(taken to be L.) 
yin - vertical distance of the needle insertion point from the 
original position of sphere P when positioned on the 
insertion point on the patients skin 
yoff - the vertical offset distance between sphere P and the 
needle insertion point indicator when the latter is in 
its locked position 
Ax - horizontal distance through which the marker carriage is 
moved when positioning the needle insertion point indicator on 
the patients chest 
AY - vertical distance through which the telescopic section is 
moved when positioning the needle insertion point indicator on 
the patients chest 
CL - angle of orientation of the source to the marker (as shown 
in Figure 3.3) when the centre line of the X-ray passes 
through point P 
ek,e - angle of orientation of the source relative to marker PQ 
taken about point P 
eL - angle at which the X-ray from the source to the lesion cuts 
P0 at point L 
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Appendix 1 
The following charts give the results of expe riments with the 
mechanical plotter for the error radii, in cm, of the circles 
drawn around the lozenges representing the possible lesion 
positions (Figure 3.11), for lesions of different known 
coordinates (x,y) relative to the marker si )here centre and marker 
rod. 
The figures down the side and along the top of the charts are the 
angles of view in degrees relative to the marker P0, as 
illustrated in Figure 3.8. 
In the case of the triangular charts the comparisons are drawn 
over two views taken at the same source-marker distance, XP, 
using the same marker dimensions, whereas when the complete table 
is filled the two views have been taken with at least one 
variable (other than orientation) different. 
This is an attempt to identify lesions of at most 1cm radius on 
the half scale apparatus, ie radii of 0.5 cm at most, in the full 
scale case, and the object is to find acceptable ranges of angles 
over which this may be achieved. Such viewing angles correspond 
to the chart regions bounded by the stepped lines. 
All charts, with the exception of Chart 13, use combinations of 
angle determination methods. Over the range 600_900 angular 
information is assumed to come from the C-arm and is used 
directly. Outwith this range the marker is used to determine the 
angle optically (as shown in Figure 3.6). 
tLiL 
Chart 1 
Sphere diameter D=2cm 
Source Marker distance Xpl=30cm 
Xp2=3Ocm 
Marker rod length P0=10cm 
lesion position (cm) = (10,10) 
Angle of View 1, degrees 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 
20 5.7 
30 3.0 7.5 
40 1.7 2.4 6.6 
50 1.6 2.2 4.2 	00 
60 1.4 1.7 2.7 8.9 	0° 
70 1.3 1.5 2.4 	4.4 	9.2 	: 
c 80 1.2 1.4 1.8 3.6 4.3 10.3 S 
.2 90 T]121.5 2.3 3.0 4.8 11.7 oo 
100 0.9 1.0 1.3 1.8 2.5 3.8 7.4 O 
110 0.7 0.8 1.5 1.5 1.9 2.6 3.9 7.3 00 = bO 
120 0.6 0.6 0.811.1 1.3 1.7 2.2 3.1 5.0 7.6 oo 
140 
150 0.5 0.5 0.5 0.7 0.8 1.0jl.1_1.3 1.5 1.4 1.4 1.7 




sphere diameter D=2cm 
Source marker distance Xpl=40cm 
Xp2=40 
Marker rod length PQ=lOcm 
lesion position (cm)= (10,10) 
Angle of View 1, degrees 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 
20 4.2 
30 2.3 6.2 
40 1.9 3.1 15.5 
50 1.7 2.3 4.1 :U 
60 1.4 1.9 2.9 7.8 °° 
70 1.2 1.6 2.1 3.9 25.0 =- 
80 1.2 1.4 1.8 2.8 5.9 8.1 00 
CJ 1 
90 1.0I1.2 1.5 2.2 3.6 4.2 9.5 oO 
W 
> 100 1.0 1.1 1.4 2.0 3.1 3.4 6.3 QO 	11 
4-4 
0 
110 0.8 0.9 1.0 1.4 2.0 2.1 3.0 4.8 13.1 	0 
bO 
120 0.6 0.6 0.7 1.0 1.4 1.4 1.8 2.5 3.4 5.6 	ca 
130 
140 
150 0.7 0.6 0.6 0.7 0.9 1.0 1.1 1.1 1.6 1.8 2.0 2.5 
	
160 0.8 0.6 0.6 0.7 0.9 0.9 1.0 1.2 1.4 1.4 1.6 1.7 	8.2 
170 0.9 0.7 0.7 0.7 0.8 0.8 0.9 1.1 1.2 1.3 1.4 1.4 	2.9 6.7 
:i 
150 0.9 0.9 0.9 0.8 1.3 1.3 1.3 1.6 1.9 2.3 3.0 3.5 5.4 
160 1.0 1.0 0.9 0.9 1.1 1.1 0.9 1.3 1.5 1.8 2.2 2.3 2.9 




sphere diameter 0=2 cm 
Source marker distance Xpl=50crn 
Xp2=5Ocm 
Marker rod length PQ=lOcm 
lesion position (cm)= (10,10) 
Angle of View 1, degrees 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 
20 5.0 
30 2.4 6.8 
40 2.3 3.3 oo 
50 1.8 2.5 4.8 00 
60 1.4 1.8 2.7 00 vo 
70 1.3 1.6 2.3 3.7 D 
80 1.2 1.4 1.9 2.6 10. 	11. 	oo 
90 1.1 1.2 1.6 2.0 5.2 5.5 9.0 	oo 
100 1.0I1.1 1.4 1.7 3.6 3.3 4.4 9.7 Oo 
110 0.9 1.011.2 1.5 2.7 2.7 3.1 4.6 9.6 	cO 
120 0.8 0.9 1.1 1.3 2.3 2.3 2.5 3.6 5.8 	00 	oo 












sphere diameter D=4cm 
Source marker distance Xpl=30cm 
Xp 2 = 30 
Marker rod length PQ=lOcm 
lesion position (cm)= (10,10) 
- 	 Angle of View 1, degrees 









1.3 2.0 10.1 
1.3 1.7 3.8 o- 
1. 2  1.5 2.5 5.5 00 
80 0.9 1.1 	1.3 	2.0 3.0 9.7 1 
90 0.8 1.0 1.2 1.7 2.2 4.2 11.0 - 
100 0.5 0.6 0.7 1.0 1.3 2.2 3.3 	8.6 	ccb  
110 0.3 0.4 0.5 0.7 0.9 1.4 2.1 3.1 6.4 oO 
120 0.3 0.4 0,4 0.6 0.8 1.2 1.7 2.1 3.1 3.3 7.3 
130 
140 
150 0.3 0.3 0.3 0.4 0.5 0.7 0.9 1.0 Ll.-J-1-0 0.9 11.3 












sphere diameter D=4 cm 
source marker distance Xpl=30cm 
Xp2=30 
marker rod length PQ=lOcm 
lesion position (cm)= (5,4) 
Angle of View 1, degrees 





%0.5 60 0.3 
70 0.3 2.9 	p 
80 0.3 0.4 0.5 0.84 2.2 COO  
90 0.3 0.3 0.4 0.6 1.0 1.3 4.4 00 
, 	100 0.2 0.3 0.3 0.4 0.6 0.71 1.3 3.4 0 
0 











sphere diameter D=4 cm 
source marker distance Xpl=30cm 
Xp2=3Ocm 
marker rod length PQ=lOcm 
lesion , position (cm) = (5,10) 
Angle of View 1, degrees 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 
20 2.1 
30 1.2 2.7 
40 1.1 1.7 4.8 
50 0.91.3 2.1 Ise 
60 0.911.2 1.7 3.9 00 
70 0.9 1.1 1.4 2.5 5.0 Oo 
80 0 . 8 TJl. 2 1.8 2.6 6.9 00 
90 0.6 0.7[.2 1.6 2.9 7.0 oo 
44 




140 0.3 0.3 0.3 0.5 0.5 0.7 0.9I4 1.0k! 






sphere diameter D1=2cm 
D2 = 2cm 
source marker distance Xpl=30cm 
Xp2=4Ocm 
Marker rod length P0=10cm 
lesion position (cm)= (10,10) 
Angle of View 1,degrees 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 
10 4.8 	2.6 2.0 1.4 	1.4 1.2 1.2 1.1 1.0 0.8 0.7 0.6 0.6 0.7 
20 00 10.2 3.8 2.1 	1.9 1.6 1.4 1.3 1.2 0.9 0.7 0.6 0.6 0.6 
30 3.9 	° 2 3.9 	3.0 2.2 1.9 1.6 1.4 1.1 0.9 0.7 0.6 0.6 
40 2.4 4.4 00  00 13.1 4.5 3.1 2.4 2.1 1.7 1.4 1.1 0.7 0.7 
50 1.8 2.6 6.5 00 00 oQ 8.8 4.5 3.3 2.7 2.0 1.5 
60 1.6 2.1 3.7 00  00 00 00 5.5 3.6 2.9 2.1 1.5 
70 1.4 1.7 2.4 6.1 00 00 00  00 6.8 4.9 3.0 2.0 
80 1.3 1.5 2.0 3.6 5.9 00  00 00 000 15.3 5.3 2.8 
90 1.1 1.3 1.7 2.6 3.5 6.1 15 P, 00 oo 00 I4 
.14 
100 1.0 1.2 1.4 2.2 2.9 4.6 10.5 00 cc oo 9.3 
44 
, 110 0.8 0.9 1.1 1.6 1.912.5 3.6 6.5 tc. 00 00 ao 
bO 
120 0.6 0.6 0.8 1.0 1.3 1.6 2.0 2.8 3.9 4.5 9.0 00 
130 
140 
150 0.6 0.6 0.6 0.7 0.9 
1.011.2 
 1.4 1.6 1.5 1.5 1.9 
160 0.6 0.6 0.6 0.6 0.8 0.9 1.011.2 1.4 1.2 1.2 1.4 















sphere diameter D1=2cm 
D2=2cm 
Source marker distance Xpl=30cm 
Xp2=SOcm 
marker rod length P0=10cm 
lesion position (cm)= 	(10,10) 
Angle of View 1, degrees 
10 20 30 40 50 60 	70 80 90 100 110 120 130 140 150 160 170 180 
10 2.8 1.8 1.6 1.2 1.2 1.1[l.0_1.0 0.9 0.8 0.6 0.6 0.7 0.7 
20 0° 4.4 2.9 1.8 1.7 1.5 	1.3 1.2 1.1 0.9 0.8 0.6 0.6 0.7 
30 11.5 OP 12.6 3.2 2.7 2.2 	1.8 1.6 1.4 1.2 1.0 0.8 0.6 0.7 
40 3.5 11.5 00 13.1 6.0 3.5 	2.5 2.1 1.8 1.5 1.3 1.0 0.7 0.7 
50 2.5 3.7 oa 0° om oo 13.5 6.1 4.1 3.5 2.6 1.9 1.2 1.0 
60 1.8 2.2 3.7 00 00 0014.0 6.3 4.1 3.4 2.5 1.8 1.1 1.0 
70 1.5 1.9 2.7 9.3 00 oo 	oa 13.2 5.6 4.4 3.0 1.9 1.1 1.0 
80 1.3 1.6 2.2 4.0 7.4 0° ao 00 I. 10.2 4.8 2.7 1.3 1.2 
90 1.2 1.4 1.8 2.8 3.9 7.2 	0° 00 00 cP 00 3.9 1.5 1.3 
100 1.0 1.0I1.5 2.1 2.7 3.9 	7.0 oO 0° 00 oO 8.2 1.8 1.6 
4-4 I 110 1.0 1.0l1.3 1.7 2.1 2.8 	3.8 6.5 00 00 0° 2.5 1.9 
bo 120 0.9 0.91.5 1.8 2.3 	3.0 4.5 8.9 0°  00 oo 2.8 2.1 
rd 
130 0.7 0.7 0.811.1  1.3 1.6 	2.1 1.5 3.4 3.6 4.9 0° 4.0 2.5 
140 
150 0.8 0.7 0.8 0.9 1.01.4 1.6 1.9 1.8 1.9 2.4 00 00 
160 0.7 0.7 0.7 0.7 0.92 1.3 1.5 1.4 1.4 1.6 6.3 0° 




sphere diameter D1=2cm 
D2 = 2cm 
Source marker distance Xpl=40cm 
Xp2=5Ocm 
marker rod length P0=10cm 
lesion position (cm)= (10,10) 
Angle of View 1, degrees 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 
	
10 8.9 13c 3.4 2.3 2.0 1.6 1.4 1.3 1.1jl.00.9 0.8 0.7 	0.9 0.9 1.0 
20 2.7 Do 	00 4.8 3.0 2.0 1.7 1.5 1.3 1.211.0 0.9 0.7 	0.8 0.8 0.8 
30 1.8 3.7 00 	oo 6.5 3.0 2.5 1.9 1.6 1.2 1.2 11.0 0.8 
40 1.5 2.4 6.9 COO 00 8.4 4.7 3.0 2.3 1.9 1.5 1.311.0 
50 1.4 2.0 3.4 12.200 oO oO 7.0 4.0 2.8 2.2 1.9 1.4 
60 1.3 1.7 2.7 5.1 00 00 00 10.8 4.6 3.0 2.3 2.0 1.4 
70 1.1 1.4 2.1 3.2 00 00 00 o° tee. 4.8 3.2 2.7 1.7 
80 1.1 1.4 1.8 2.4 8.0 8.8 00 00 00 11.5 5.0 3.7 2.4 
90 1.011.2 1.5 2.0 4.8 4.8 7.6 00 	00 10.9 6.2 3.1 
100 0.9[ , l.4 1.1 1.8 4.0 4.0 5.4 te. 4.3 
110 0.7 0.9 1.1 1.3 2.7 2.5 2.9 4.5 10.2 10.1 
120 0.6 0.6 0.8 1.0 1.8 1.7 1.8 2.4 3.4 5.9 	01  00 	00 
130 
140 
150 0.7 0.7 0.7 0.7j1.2 1.1 1.1 1.4 1.6 1.9 2.5 2.9 2.9 
160 0.8 0.8 0.7 0.7 1.1 1.0 1.01.2 1.4 1.6 2.4 2.1 2.6 










1.1 0.9 0.9 
1.3 1.1 0.9 
1.6 1.3 1.2 
1.8 1.5 1.2 
2.0 1.6 1.3 
2.5 1.8 1.4 




IL 6 Is 
Chart 10 
sphere diameter D1=4cm 
D2=2cm 
source marker distance Xpl=30crn 
Xp2=3Ocm 
marker rod length P0=10cm 
lesion position (cm)= 	(10,10) 
Angle of View 1, degrees 
10 20 30 40 50 	60 70 80 90 100 110 120 130 140 150 160 170 180 
10 oo 3.3 1.7 1.2 1.2 	1.2 1.111.0 0.9 0.6 0.5 0.4 0.4 0.5 
20 3.3 0° 3.1 2.2 1.5 	1.4 1.3 1.2 1.1 0.7 0.5 0.5 0.4 0.4 
30 2.1 8.2 00 7.2 2.6 	2.2 1.9 1.5 1.4 1.0 0.7 0.6 0.5 0.5 
40 1.3 2.2 5.0 0° o° 7.4 3.7 2.6 2.1 1.3 1.0 0.9 0.6 0.6 
50 1.3 2.0 3.3 °° °° 	00 8.3 3.9 2.8 1.7 1.3 1.1 0.8 0.7 
60 1.1 1.6 2.1 4.6 oo 	oo 00 9.8 4.5 2.5 1.7 1.1 0.9 0.8 
70 1.1 1.4 1.7 2.8 6.3 	010 o 00 11.4 3.7 2.2 1.7 1.0 0.9 
80 1.0 1.2 1.4 2.2 3.4 	10.0 ° 9.1 3.4 2.3 1.2 1.1 
90 0.9 1.0 1.2 1.7 2.3 4.3 11.1 	cOO, 0° 0° 7.2 3.3 1.3 1.2 
100 0.7 0.9 1.0 1.5 2.0 3.5 7.0 tPO cOO 00 coo 3.7 1.2 1.1 
44 
w 110 0.6 0.7 0.8 1.1 1.5 	2.4 3.7 7.0 0° 0° 6.5 1.2 1.1 
Cd 120 0.4 0.5 0.6 0.8 1.011.5 2.1 2.8 4.7 6.4 CJ° - 1.4 1.2 
130 
140 
150 0.4 0.3 0.3 0.5 0.5 0.8 1.0I1.2 1.4 1.1 1.1 1.6 -- 4.2 
160 0.4 0.4 0.4 0.4 0.5 0.7 0.9 
0 
1.2 1 1 . 0 	i.oJ 1.1 3.1 00  
170 
180 
16 4  
Chart 11 
sphere diameter D1=4cm 
D2=2cm 
source marker distance Xpl=30cm 
Xp2=4Ocm 
marker rod length PQ=lOcm 
lesion position (cm)= (10,10) 
Angle of View 1, degrees 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 
10 4.7 1.9 1.3 1.2 LO i.i 1.111.0 0.9 0.6 0.5 0.5 	0.5 0.6 
20 19.0 5.8 2.2 2.0 1.3 1.3 1.3 1.211.0 0.7 0.5 0.5 	0.4 0.5 
30 2.6 13.0 3.9 2.1 1.8 1.6 1.4 1.3 0.8 0.6 0.6 0.5 0.5 
40 2.0 4.4 00 c 7.0 3.9 3.0 2.1 1.8 1.2 0.8 0.8 0.7 0.6 
50 1.6 2.6 5.2 0<1 coo va 7.6 4.2 2.9 1.9 1.4 1.2 0.8 0.8 
60 1.3 2.0 3.0 10.3 	'° o° 00 5.3 3.4 2.1 1.5 1.3 0.8 0.8 
70 1.1 1.6 2.0 3.8 15.0 	00 00 0° 6.3 3.0 2.0 1.5 1.0 0.9 
80 1.1 1.3 1.7 2.7 4.6 ° 5.8 2.9 2.1 1.2 1.1 
90 TJi.2 1.4 2.0 2.9 5.8 °• 5.0 3.0 1.4 1.2 
100 0.9{ 1.8 2.4 4.3 10.0 00 0 - 1.5 1.1 
110 0.7 0.8 0.911.2 1.5 2.3 3.4 6.0 oø 00 010  -- 1.7 1.4 
120 0.5 0.6 0.6 0.8 1.0 1.4 1.9 2.4 3.6 4.1 11.6 -0 2.0 1.5 
130 
140 
150 0.5 0.4 0.4 0.5 0.6 0.8[1.1_1.2 1.5 1.2 1.3 1.7 00 8.3 














sphere diameter D1=4cm 
D2=2cm 
source marker distance Xpl=30cm 
Xp2=SOcm 
marker rod length PQ=lOcm 
lesion position (cm)= 	(10,10) 
Angle of View 1, degrees 
10 20 30 40 	50 60 	70 80 90 100 110 120 130 140 150 160 170 180 
10 2.5 1.4 1.1 1.10.9 0.9 0.9 0.9 0.8 0.6 0.4 0.5 0.6 0.6 
20 o 3.0 1.8 1.6 	1.4 1.2 	1.2 1.1 1.0 0.7 0.6 0.6 0.6 0.7 
30 4.9 o° 5.4 3.1 	2.0 1.7 	1.7 1.5 1.3 0.9 0.7 0.7 0.6 0.7 
40 2.6 coO oe> oo 4.2 3.0 2.4 1.9 1.7 1.2 0.9 0.8 0.7 0.7 
50 2.0 3.6 12.3 11.0 5.8 4.0 2.4 1.8 1.7 1.0 
60 1.6 2.2 3.0 11.0 00 00 11.0 6.0 4.0 2.5 1.8 1.5 1.0 1.0 
70 1.3 1.7 2.4 4.6 	0° coft 	oo 	12.8 5.6 3.0 1.9 1.6 L1.0 1.0 
80 1.1 1.5 1.8 2.8 5.3 cP vo co oo 5.3 2.8 2.1 1.2 1.1 
90 1.1 1.2 1.5 2.2 	2.3 6.5 	Oo 0° coo o° 4.8 3.0 1.5 1.3 
100 T11.1 1.3 1.7 	2.1 3.5 	5.7 0° O 0° 00 5.2 1.8 1.5 
110 0.9i1.1 1.5 	1.7 2.8 	3.6 5.8 00 00 00 oO 2.2 1.8 
120 0.8 1.01T1.2 1.4 2.1 	2.8 4.1 7.7 00 °° 00 2.4 2.0 
130 0.8 0.9 
0.711.2 
1.1 1.8 	1.8 2.3 3.1 3.2 4.7 00 3.7 2.2 
140 
150 0.6 0.6 0.6 0.7 0.8 1.0 jl.3 1.5 1.8 1.6 1.7 2.1 00 
160 0.5 0.5 0.5 0.6 0.7 0.9 	1.011.2 1.3 1.2 1.2 1.5 4.7 00 










Using the optical technique. The construction is done using 0.5 1 , 
ie P'Q' location is not required. 
sphere diameter D1=4cm 
source marker lenth Xp=30cm 
marker rod length P0=10cm 
lesion position (cm)= (10,10) 
Angle of View 1, degrees - 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 
20 2.3 
30 1.3 3.0 
40 0.8 1.4 2.8 
50 0.7 1.1 1.6 	3.2 
60 0.6 0.8,1 .1 	1.5 	3.6 
70 0.5 0.6 0.8 	1.0 1.7 	3.1 
80 0.4 0.5 0.6 0.7 1.1 1.5 3.4 
c..J 
90 0.4 0.5 0.5 0.6 0.9 1.1 1.7 3.0 
W 
100 0.3 0.4 0.5 0.5 0.6 0.8 1.1 1.5 	3.1 
44 
0 
110 0.3 0.4 0.4 0.5 0.6 0.7 0.9 1.0 	1.6 	3.4 
bo 
120 0.3 0.3 0.4 0.4 0.5 0.5 0.6 0.7 	1.0 	1.4 	3.1 
130 
140 
150 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.4 0.4 0.5 0.7 0.8 





sphere diameter D=2cm 
source marker distance Xp=30crn 
marker rod length P0=10cm 
lesion position (cm)= (10,10) 
Angle of View 1, degrees 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 
20 4.1 
30 2.1 6.9 
40 2.0 3.9 o- 
50 1.6 3.0 1 L 
60 1.6 2.5 5.5 0° 	o 
70 1.3 1.9 3.2 15t 9.5 CPO  
80 1.2 1.7 2.6 6.3 4.6 ° 
c-J 
90 1.0J1.1 2.2 5.4 3.9 8.7 oo 
44 
100 0.9L 1.7 3.3 2.7 4.3 8.1 Oo 	0-o 
w 110 0.6 0.81 1.1 2.0 1.5 2.3 2.7 4.8 4.5 	00 
bO 
co 120 0.6 0.8 1.0 1.6 1.3 1.8 2.0 3.1 2.5 4.4 	oO 
130 
140 
150 0.5 0.8 0.7 1.0 0.8{.11.1 1.5 1.1 1.3 1.3 1.9 




sphere diameter D=2cm 
source marker distance Xp=40cm 
marker rod length P0=15cm 
lesion position (cm)= (10,10) 
Angle of View 1, degrees 
10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 
20 4.5 
30 2.5 7.9 
40 1.9 3.2 ° 
50 1.7 2.5 '5.8 G 
60 1.6 2.1 3.4 15e Oo 
70 1.4 1.7 2.5 5.7 8.2 . 
80 1.2 1.4 1.9 3.3 3.8 8.2 0° 
90 1.1 1.3 1.6 2.5 2.8 4.4 9.2 Oo 
44 100 1.0 	2 1 7 2.7 3.0 4.8 11.6 
o 
110 0.7.1 1.5 1.7 2.2 3.2 5.1 13e- co ri 
bO 
120 0.7 0.7 0.911.2 1.3 1.7 2.2 2.9 4.8 5.9 00 
130 
140 
150 0.8 0.7 0.6 0.8 0.8 
l.0I1.2 
 1.3 1.7 1.5 1.7 2.0 
	
160 0.8 0.6 0.6 0.7 0.7 0.9 1.0 1.1 1.3 1.2 1.2 1.4 	6.0 
170 0.9 0.7 0.7 0.7 0.7 0.9 0.9 1.0 1.2 1.1 1.1 1.1 	2.6 4.9 
180 
FVW 
Appendix 2 - Lesion Position Estimation Method 
For each view the viewing angle 0 is determined. The lesion 
position is measured on each view relative to spheres P and 0. 
Figure 4.7 illustrates the situation. 
The lesion position is determined as follows: 














Thus for each view an estimate of 9L and PL is obtained. Solving 






tane(1).y 	 tan@L (2)= y 	O090 
PL(1)-x 	 PL(2)-x 
y = taOL(1)[pL(1)_x] = tane L (2)[pL(2)_xJ 




(1) - tane(2) 
r 
PL(l) 	- PL(2) 
tane(2) 
---I taneL  (1) 	1 tane (2) L 
y=[PL(1) - x] tan8 
L (1) 
Hence the lesion position (x,y) 
Vol 
Appendix 3 - Least squares approximation of the lesion position 
using redundant measurements. 
The following equations represent the minimised sum of squares 
for any non-linear model. 
n 
2: j - i Yj =0  
I.' (X -x 	-2 + (Y _y ' C2g = 0 	 (2) ik 	ik Xik 	 1 	' Yi 
ik 
where i=1,...,n 
p= no of dependent variables 
n=no of sets of results 
Along with the constraint equations: 
=0 	i=1,...,n 	 (3) 
A these may be solved for the unknowns Y1 •.,x 	..and b 	(the 11 1' 
coefficients of X
11• .. and any constants) 
In the model under consideration let L., the lesion point, be the 
independent variable, Y 1 , and PT., PB., OT., QB. the independent 
variables, Xk. 
A A A 	A PT i ,PBi  QT. ,QB and L. are estimates of the dependent and ' 
independent variables and are regarded as unknowns. 
The constants here are the lesion coordinates, x and y. 
TIVI 
Since all the variables are read directly form the screen they 
have the same error, i.e. =constant. 
Hence the above system becomes: 
	
j)d g. =2 	=0 (4) 
j=l 	y 	j=l 
n 	 n 
A 	 A 	A (L_L.)g• 
=2 (L -L ) tan ( 6L ) =0 	 (5) 
j=1 	ax j=l 
A 	 A 
(PT -PT ' + (L 
1
._L.)g = 0 	i=l,...n 	 (6) 
PT 
i 






j) + (L ._)g• = 0 	 (8) 
A 
OT. 
(QB 	 A 
1 
....QB
j 	 1 
) + ( L._L1)g• = 0 	 (9) 
d OB. 
1 
I'.. 	 A 
g Y[PL1_x]tan(Ø ' = 0 
L) 	 (10) 
1(03 
A 	 A 	
A A A A A where PL 1 . and tan(8) are functions of PT ,PB. ,QT ,QB. ,L 
Hence 5n+2 equations for 5n+2 variables 
The general method of solution is to use equations (6)-(9) to 
solve for PT i  ,PBi ,QT ,QB , in terms of L. 
Substituting into (10) gives L. 
1 
in terms of x and y. 
Inserting into (4) and (5) leaves two equations in x and y which 
are solved simultaneously. However the derivatives of gi are 
complicated, non-linear, trigonometric functions and analytical 
solution of (6)-(9) appears impossible. 





which seems reasonable since PT is an estimate of PT , the 
equations may be simplified by direct substitution of the known 
values of PT. ,PB ,QT ,QB and L. into these derivatives. The 
resulting derivatives are thus functions of x, of the form Ax+b, 
where A and B are known. 
Substituting into (6)-(10) and rearranging the equations solves 
I... 	
A. for PT.,... etc in terms of L. and x. Putting these PT 
values into (10) however leads to another non-linear equation in 
'S. 
terms of L., x and y which cannot be easily solved for L. 
7. (04 
Appendix 4 - Elimination of possible views to obtain the correct 
lesion estimate. 
Assume that all 3 views lie in the quadrant flip range. 
Possible views are: 
i or 
J or j' 
k or k' 
Possible estimates are formed from the following viewpairs: 
ii ik i'j ilk jk ilk 
ij' 1k' i'j' ilk , jk' j'k' 
Tests on the bounds eliminate the following: 
ij i'j' ilk j'k' ij' ik 1k' 
All possible estimates involving view i have been eliminated, 
therefore view 1' must be correct. 
The system has now reduced to 2 views with possible flips. The 
possible views are: 
i', j or j', kork' 
Possible estimates are formed from the following vievpairs: 
I 
i'j 	i'j' 	ilk 	ilk' 	jk 	jk' 	ilk 	j'k' 
The tests on bounds have already eliminated 
i'j' ilk 	j'k' 
i.e. all estimates containing j', therefore view j is correct. 
Possible views are now: 
1', 	j, 	kork' 
Possible estimates remaining are: 
i'j 	ilk 	ilk, 	jk 	jk' 
correct 
estimate 
Pick the jk or jk' estimate closest to i'j. 
View k or k' hence assigned. 
Appendix 5 - Reduction of Possible Viewing Angles by Testing Sets 
of Results. 
Assume that the following views remain after applying constraints 
to the lesion estimates. 
i or i' 
j or j' 
k 
Sets of possible views 
i j k 
i j' k 
P j k 
i' j' k  
Corresponding lesion estimates 
ij 	ik jk 
ii' 	ik 	j'k 
i'j 	ilk 	jk 
i'j' 	ilk 	j'k 
Assume that boundary conditions eliminate ij, ij' and jk. 
set 1) is eliminated by ii and jk 
set 2) is eliminated by ij' 
set 3) is eliminated by jk 
set 4) remains complete therefore P, j', k are assumed to be the 
correct viewing angles, ie flip view i, flip view j, leave view k 
